TWI284020B - Antibacterial compositions - Google Patents

Antibacterial compositions Download PDF

Info

Publication number
TWI284020B
TWI284020B TW089112409A TW89112409A TWI284020B TW I284020 B TWI284020 B TW I284020B TW 089112409 A TW089112409 A TW 089112409A TW 89112409 A TW89112409 A TW 89112409A TW I284020 B TWI284020 B TW I284020B
Authority
TW
Taiwan
Prior art keywords
composition
antibacterial
weight
sodium
surfactant
Prior art date
Application number
TW089112409A
Other languages
Chinese (zh)
Inventor
Timothy J Taylor
Earl P Seitz Jr
Priscilla S Fox
Original Assignee
Dial Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/338,654 external-priority patent/US6107261A/en
Application filed by Dial Corp filed Critical Dial Corp
Application granted granted Critical
Publication of TWI284020B publication Critical patent/TWI284020B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/65Mixtures of anionic with cationic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/83Mixtures of non-ionic with anionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/835Mixtures of non-ionic with cationic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/86Mixtures of anionic, cationic, and non-ionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/43Solvents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Abstract

Antibacterial compositions having enhanced antibacterial effectiveness are disclosed. The antibacterial compositions contain a phenolic anti-bacterial agent, a surfactant or a disinfecting alcohol, and water, wherein a percent saturation of the antibacterial agent in a continuous aqueous phase of the composition is at least 25%.

Description

1284〇2〇1284〇2〇

五、發明說明(1 ) 發明領域 本發明係關於具有改良抗菌功效之抗菌組合物,諸如個 人保健組合物,包括手部消毒凝膠。更特定言之,本發明 係關於抗菌組合物,其包含抗菌劑,以及界面活性劑或相 對少量之消毒醇,且其在一分鐘内提供格藍氏陽性及格藍 氏陰性細菌族群之顯著減少,如,超過99%。 發明背景 抗菌個人保健組合物係技藝中已知者。特別可用者係抗 W清潔組合物,其一般係用於清潔皮膚,並摧毁細菌及其 他存在於皮膚上之微生物,特別是使用者之手、手臂、及 臉部。 另一類之抗菌個人保健組合物係手部消毒凝膠。此類之 組合物主要係由醫療人員用於消毒手部及手指。手部消毒V. INSTRUCTION DESCRIPTION OF THE INVENTION (1) Field of the Invention The present invention relates to antimicrobial compositions having improved antibacterial efficacy, such as personal health care compositions, including hand sanitizing gels. More particularly, the present invention relates to antimicrobial compositions comprising an antibacterial agent, and a surfactant or a relatively small amount of a disinfecting alcohol, and which provides a significant reduction in the population of Gram-positive and Gram-negative bacteria within one minute, For example, more than 99%. BACKGROUND OF THE INVENTION Antibacterial personal care compositions are known in the art. Particularly useful are anti-W cleaning compositions which are generally used to cleanse the skin and destroy bacteria and other microorganisms present on the skin, particularly the hands, arms, and face of the user. Another type of antimicrobial personal care composition is a hand sanitizing gel. Such compositions are primarily used by medical personnel to sterilize hands and fingers. Hand disinfection

凝膠係施用並搓揉至手部及手指上,再允許該組合物自I 膚上揮發。並不需要將該組合物自皮膚上擦去,因現今手 部消毒凝膠之高醇含量可使該組合物自皮膚上快速且本質 上完全的揮發。 、 經濟部智慧財產局員工消費合作社印製 ----7---------裝·-- (請先閱讀背面之注意事項寫本頁) .線. 抗菌組合物一般係用於,舉例而言,保健產業、食品服 務產業、肉類處理產業、以及由個人消費者用於私人部 分。抗菌組合物之廣泛用途指出消費者相當重視控制皮膚 上(細菌及其他微生物族群。然而,重要者係使抗菌組合 物快速且無毒性及皮膚刺激性問題的提供微生物族群之顯 著及廣泛性減少。 特定言之,抗菌清潔組合物一般含有活性抗菌劑、界面The gel is applied and rubbed onto the hands and fingers, allowing the composition to evaporate from the skin. It is not necessary to wipe the composition from the skin because the high alcohol content of the hand sanitizing gel today allows the composition to evaporate rapidly and essentially completely from the skin. , Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Print----7---------Installation--- (Please read the notes on the back to write this page). Line. Antibacterial composition is generally used. For example, the health care industry, the food service industry, the meat processing industry, and the private sector are used by individual consumers. The widespread use of antimicrobial compositions indicates that consumers place considerable emphasis on controlling the skin (bacteria and other microbial populations. However, it is important that the antimicrobial compositions provide rapid and non-toxic and skin irritation problems that provide significant and extensive reduction in the microbial population. In particular, antibacterial cleaning compositions generally contain an active antibacterial agent, interface

1284020 Α7 Β7 五、發明說明( 經濟部智慧財產局員工消費合作社印製 >古性劑、以及各種其他成分,例如 節劑、增稠劑、皮膚調理劑等,包含於水性載體中。^禮 不同類型之抗菌劑已被用於抗菌清潔組合物中。抗菌劑之 實例包括雙胍(如,双氯苯双胍乙烷二葡糖酸鹽)、二苯基 化合物、卞醇、三__^_碳醯笨胺、四銨化合物、乙氧基 化酚、及酚化合物,諸如,鹵取代之酚化合物,如,pcn€ (即,對·氯-間·二甲苯酚)及三氣生(即,2,4,4,-三氯_ 2,_ !基-二苯醚)。根據此等抗菌劑之現今抗菌組合物具有範 圍廣泛之抗菌活性,自低至高不等,根據欲控制之微生物 及特定之抗菌組合物而定。 手部消毒凝膠含有高百分比之醇,諸如,乙醇。在該凝 膠中所含醇之高百分比了’該醇本身亦作為_種消毒劑。 此外1醇可快速揮發,免除對經該消毒凝膠處理之皮膚 進行擦拭或沖洗之必要。含有高百分比(亦即,該組合物約 或上重量比)醇之手部消毒凝膠傾向會使皮膚乾燥或 刺激皮膚。 二t而,大部分之市售抗菌組合物一般僅提供低至中等之 抗囷,性。抗菌活性係對抗廣泛種類之微生物進行評估, 已蕊氏陽|±及格監氏陰性微生物。由該抗菌組合物 之細菌族群對數減少,七β β ^ /数减乂 ,或疋減少百分比係與抗菌活性相 / $疋足接觸時間而言,一般介於15秒至5分鐘不等, 1《對數減少係最佳者,】_3之減少係較佳者, 係最不較佳者。因此,高度較佳之抗菌組合物 #(接料間中,對抗廣泛種類之微生物,具有3-51284020 Α7 Β7 V. Description of invention (Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives > Ancient agents, and various other ingredients, such as noodles, thickeners, skin conditioners, etc., are included in the aqueous carrier. Different types of antibacterial agents have been used in antibacterial cleaning compositions. Examples of antibacterial agents include biguanide (e.g., chlorhexidine digluconate), diphenyl compound, decyl alcohol, three __^_ Carbon hydrazine, tetraammonium compound, ethoxylated phenol, and phenolic compounds, such as halogen-substituted phenolic compounds, such as pcn€ (ie, p-chloro-m-xylenol) and tri-gas (ie, , 2,4,4,-trichloro _ 2, _ base-diphenyl ether. The current antimicrobial compositions according to such antibacterial agents have a wide range of antibacterial activity, ranging from low to high, depending on the microorganism to be controlled And the specific antimicrobial composition. The hand disinfecting gel contains a high percentage of alcohol, such as ethanol. The high percentage of alcohol contained in the gel is 'the alcohol itself is also used as a disinfectant. Can be quickly volatilized, eliminating the need to treat the disinfectant gel The skin is necessary for wiping or rinsing. A hand sanitizing gel containing a high percentage (i.e., about or above the weight ratio of the composition) alcohol tends to dry or irritate the skin. Second, most of the commercially available antibacterial The composition generally only provides low to moderate resistance to cockroaches. The antibacterial activity is evaluated against a wide variety of microorganisms, and has been negatively tested by the bacterial population of the antimicrobial composition, seven beta The β ^ / number reduction, or the percentage reduction of 疋 is related to the antibacterial activity phase / 疋 foot contact time, generally ranging from 15 seconds to 5 minutes, 1 "log reduction is the best," _3 reduction Preferably, it is the least preferred. Therefore, the highly preferred antimicrobial composition # (in the receiving room, against a wide variety of microorganisms, having 3-5

(請先閱讀背面之注意事項寫本頁) t! 一SJ. 1 -線 1284020 A7 B7 五、發明說明(3 ) 又對數減少。先前之揭示說明提供此等抗菌組合物之企 圖’其至今仍無法提供消費者所欲快速、廣泛之微生物控 制。 應 >王意者,在4及9之pH值下,已達成高對數減少,但此 等對數減少之情形至少部分係因為此等相對極端之pH值而 造成。具有此等pH值之組合物會刺激皮膚及其他表面,且 因此一般係被避免者。此種情形特別是就一般在使用後不 自皮膚上擦去或沖洗掉之手部消毒組合物而言。使用具有 約5至約8之中性pH值之抗菌組合物,特別是約6至約8者, 且不同時納入高百分比醇之情形下,一直不易或無法達成 高對數減少。 舉例而言,W0 98/01110揭示含有三氯生、界面活性劑、溶 劑、螯合劑、增稠劑、緩衝劑、及水之組合物。w〇98/〇ii⑴ 係關於藉由使用較少量之界面活性劑而減少對於皮膚之刺 激。(Please read the note on the back to write this page) t! One SJ. 1 - Line 1284020 A7 B7 V. Invention description (3) The logarithm is reduced. The previous disclosure illustrates the attempt to provide such antimicrobial compositions which have so far failed to provide rapid, extensive microbiological control by consumers. > Wang Yi, at a pH of 4 and 9, a high log reduction has been achieved, but these log reductions are due, at least in part, to these relatively extreme pH values. Compositions having such pH will irritate the skin and other surfaces and are therefore generally avoided. This is especially the case for hand sanitizing compositions which are generally not wiped or rinsed from the skin after use. It has not been easy or impossible to achieve a high log reduction in the use of antimicrobial compositions having an intermediate pH of from about 5 to about 8, especially from about 6 to about 8, and not including a high percentage of alcohol. For example, WO 98/01110 discloses compositions containing triclosan, a surfactant, a solvent, a chelating agent, a thickening agent, a buffer, and water. W〇98/〇ii(1) relates to reducing skin irritation by using a smaller amount of surfactant.

Fendler et al·,U.S· 5,635,462揭示含有PCMX及所選界面活性劑之 組合物。其中所揭示之該等組合物係不含陰離子界面活性 )命急非離子界面活性劑。 WO 97/46218及WO 96/06152揭示基於三氯生、有機酸或鹽、 增溶劑、及羥溶劑之組合物。 EP 0 505 935揭示含有PCMX,結合非離子及陰離子界面活性 之組合物’特別是非離子性嵌段共聚物界面活性劑。 WO 95/32705揭示一種溫和之界面活性劑組合,其可與抗菌 化合物結合,諸如,三氯生。 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----:----------裝--- (請先閲讀背面之注意事項>||!|寫本頁) I . 1線· 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 五、發明說明(4) (請先閱讀背面之注意事項β寫本頁) W0 95/09605揭示含有陰離子界面活性劑及烷基聚葡糖嘗界 面活性劑之抗菌組合物。 WO 98/55096揭示抗菌擦拭巾,其具有浸透抗菌組合物之有 孔片,該抗菌組合物含有活性抗菌劑、陰離子界面活性 劑、酸、及水,其中該組合物具有約3.0至約6.0之pH值。 N.A. Allawala et al.? J. Amer. Pharm. Assoc. - Sci. Ed.? Vol. XLII, no. 5? pp. 267-275,(1953)論及結合界面活性劑之活性抗菌劑之抗菌活 性。 A.G. Mitchell,J. Pharm. Pharmacol·,Bol. 16, ρρ· 533-537,(1964)揭示含 有PCMX及具有抗菌活性之非離子界面活性劑之組合物。在 Mitchell出版品中揭示之組合物在至少47分鐘之接觸時間後具 有抗菌活性,因此該等組合物並非高度有效者。 就手部消毒凝膠而言,Osborne et al·,美國專利No· 5,776,430揭 示含有chlorhexidine及醇之局部抗菌清潔哲彳。该等組合物含有 約50%至60%重量比之變性醇,以及約0·65至0.85%重量比之 chlorhexidine。該組合物係施用至皮膚上’搓揉至皮膚内’再 自皮膚上沖去。 經濟部智慧財產局員工消費合作社印製 歐洲專利申請案0 604 848揭示一種凝膠類型之手部消毒 劑,其含有抗菌劑、40%至90%重量比之醇、結合重量不超 過3%重量比之聚合物及增稠劑。該凝膠係搓揉至手上,再 允許其揮發,以提供經消毒之手。如EP 0 604 848所述,抗菌 劑之含量及種類並不重要,因該手部消毒凝膠含有高百分 比之醇以提供抗菌活性。該等揭示之組合物通常並無法提 供立即之消毒作用,且無法提供殘留抗菌功效。 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) l284〇2〇 A7 B7 五、 發明說明( 經濟部智慧財產局員工消費合作社印製 提11:?:並未說明抗菌組合物中之何種組合物成分可 、· ;,·.田囷之控制。先前之组合物亦未在约5至约8之中 對::了特別是在約6至約8下,提供有效、快速、以及 對於廣泛種類細菌之控制。 及 因為,之性質以及界面活性劑對於抗菌 ==組合物-直難以達成。舉例而言,數種活性抗 匕诸如、,酉分,在水中皆具有過低之溶解度,例如,三 軋 水中又落解度係約5至10 ppm (百萬分之一杧 :溶解度可藉著在组合物中添加界面活性劑而增:。:二之増加,以及组合物中抗菌劑量… 、、 疋θ &成抗菌功效之增加。 任二特定理論限制之情形下可推論,界面活性劑 性因〈各解度,但是—般卻亦降低抗菌劑之可獲 界面活性劑之臨界微膠粒濃度以±,界面活性劑 中形成為微膠粒。不同界面活性劑之臨界微膠粒濃 =有不同。微膠粒之形成相當重要,因微膠粒具有親脂 :觸:ίΓ及引並溶解抗菌劑,f因此使該抗菌劑不可在 觸:田囷時立即可獲,目而在短時間内(亦即, 下)控制細菌。 遲a以 ,面活性劑微膠粒中之抗菌劑可控制細冑 須 狀』對較長之時間期後。如抗菌劑係在水性溶液中呈自由 :、’且不被拘束於界面活性劑之微膠粒中時(亦即, :二可被吸引至細菌之親脂膜上,並快速展現其功; &囷w係被拘束於界面活性劑之微膠粒中時(亦即,未經 -8 - 本紙張尺度 _ (CNS)ATii-(2i〇 χ 297 ) (請先閱讀背面之注意事項 裝--- 寫本頁) •線- 1284020 A7 B7 五、發明說明(6) 活化)’該抗菌劑僅具有緩慢之可獲性,且無法在對於清潔 皮膚而言之實用時間内展現其功能。 此外’溶於微膠粒中之抗菌劑可在沖洗過程中輕易自皮 膚上洗去’且無法附著在皮膚上以提供殘留抗菌敛益。相 反的,抗菌劑會被洗去並浪費。 就消毒繼而,手部消毒凝膠一般含有:(a )至少重 量比之乙醇或低碳醇之組合,諸如,乙醇及異丙醇,(b) 水,(c )凝膠聚合物,諸如,交聯性聚丙烯酸酯物質,及(d ) 其他成分,諸如,皮膚調理劑、香味劑等。手部消毒凝膠 係由消費者使用,以在不以肥皂及水清洗,或在清洗之 後,藉著在手部表面搓揉該手部消毒凝膠,而有效消毒手 部。目兩市售之手部消毒凝膠係依賴高含量之醇來進行消 毒及揮發,因而具有缺點。特定言之,目前之手部消毒凝 膠因為組合物中所用之高含量醇而傾向於使皮膚乾燥或刺 激皮膚。同時,由於乙醇之揮發性,主要之活性消毒劑在 使用後並不會留在皮膚上,因而無法提供持續或殘留之抗 菌功效。 經濟部智慧財產局員工消費合作社印製 ----r----------裝--- (請先閱讀背面之注意事項寫本頁) 線. 在低於60%之醇濃度下,乙醇並不被視為一種消毒劑。因 此,在含有低於60%醇之組合物中,必需存在額外之抗菌 化合物以提供抗菌活性。然而,先前之揭示並未說明此種 抗菌組合物中之何種組合物成分可提供對於細菌之控制。 因此,就含有較低醇濃度之調配物而言,選擇同時提供快 速抗菌作用及持續性抗菌效益之抗菌劑係相當困難的。先 前之組合物亦未在約5至約8之中性pH值下,特別是在約6 -9- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(7 至約8下,提供有 制。 氏迷、以及對於廣泛種類細菌之控 因此,仍需要一插# # ▲ 效的對抗廣泛種類之二:t物,其可在短時間内高度有 中該抗菌功效主二及格藍氏陰性細菌’且其 ^ ^ ^ 4凡王係由組合物中活性抗菌劑之存在 而“。本發明即係關於此等抗菌组合物。 本發明係關於抗菌组人你 ^ 囷、,且口物,其可在少於一分鐘内提供格 二触杂及格監氏陰性細菌之顯著減少。更特定言之,在 八a彳彳中本發明係關於抗菌組合物,其包含活性抗 :因:劑、界面活性劑、及水’丨中當在室溫下測量時,該抗 #、丨,系乂至^5〇/〇飽和度之量存在於連續水相中(相對於存 在於微膠粒中)。本發明亦係關於抗菌组合物,其包含活性 抗菌劑、界面活性劑、纟、以及㈣劑及/或增溶劑,其 該抗菌劑係以至少25%飽和度之量 中當在室溫下測量時 存在。 在另一具體實例中 活性抗菌劑、消毒醇 (請先閲讀背面之注 意事項 裝—— 寫本頁) *I5J· i線· 經濟部智慧財產局員工消費合作社印製 本發明係關於抗菌組合物,其包$ 凝膠劑、及水,其中當在室溫下琪 I時,該抗菌劑係以至少5〇%飽和度之量存在。本發.明功 係關於抗菌組合物,其包含活性抗菌劑、消毒醇、凝瑪 劑、增溶劑、及水,其中當在室溫下測量時,該抗菌劑令 以至少25%飽和度之量存在。 ' 因此’本發明之一範疇係提供一種液態抗菌組合物,^ 包含:(a)約0.001%至約10%重量比之抗菌劑;(b )約〇 1% ^ -10- 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐 1284020 A7 B7 五、發明說明( 約40%重量比之界面活性劑,其選自CfCi8燒基硫酸鹽、& cis脂肪酸鹽、具有1或2莫耳乙氧基化之c8-C18烷基醚硫酸 鹽、C8-C18烷胺氧化物、(:8<18烷基肌胺酸鹽、C8-C18磺基乙 酸鹽、Cs-Ce橫基玻拍酸鹽、C8-C18燒基二苯基氧化物二磧酸 鹽、CVC1S烷基碳酸鹽、C8-C18 α _烯烴磺酸鹽、甲酯磺酸 鹽、及其混合物;及(c )水,其中當在室溫下測量時,該抗 菌劑係以至少50%飽和濃度之量存在於該組合物中。 本發明之另一範疇係提供另一具體實例之抗菌組合物, 其中該組合物含有: (a) 約0.001%至約1〇°/。重量比之抗菌劑; (b) 約〇.1%至約40%重量比之界面活性劑,其選自陰離子 界面活性劑、陽離子界面活性劑、非離子界面活性;、兩 性界面活性劑、及其混合物; (c )約〇%至約30%重量比之增溶劑; (d) 約〇%至約25%重量比之水溶性幾溶劑;及 (e) 水, 其中該组合物含有增溶劑及羥溶劑中之至少一 經濟部智慧財產局員工消費合作社印製 中當在室溫下測量時,該抗菌劑係以至少:::二:: 量存在於該組合物中。 /辰度< 具體實例之抗菌組合 ----.------------ (請先閱讀背面之注意事項寫本頁) Ί-線· 本發明之又另一範疇係提供另 物,其中該組合物含有: (a) 約0.001%至約10%重量比之抗菌劑; (b) 約〇至約10%重量比之界面活性 活性劑、陽離子界面活性劑、非離子 ^ 界面 界面活性劑、兩性界 -11 - 私紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) 1284020 A7 B7 五 經濟部智慧財產局員工消費合作社印製 發明說明() . 面活性劑、及其混合物; (請先閱讀背面之注意事項β寫本頁) (c )約0%至約40%重量比之增溶劑; (d) 約0%至約60%重量比之水溶性羥溶劑;及 (e) 水, 其中該組合物含有增溶劑及輕溶劑中之至少一者,其量 足以溶解該抗菌劑,且其中當在室溫下測量時,該抗菌劑 係以至少25%飽和濃度之量存在於該組合物中。 本發明之另一範轉係提供一種液態抗菌組合物,其包 含··( a )約0.05%至約5%重量比之抗菌劑;(b )約1%至約40% 重量比之消毒醇,諸如,C1-6醇;(c )約0.01%至約5%重量比 之凝膠劑,諸如,膠體或聚合凝膠劑;及(d )水,其中當在 室溫下測量時,該抗菌劑係以至少50%飽和濃度之量存在 於該組合物中。 本發明之又另一範疇係提供另一具體實例之抗菌組合 物,其中該組合物含有: (a)約0.05%至約5%重量比之抗菌劑; (b )約1%至約40%重量比之消毒醇; (c )約0.01%至約5%重量比之凝膠劑; (d )約0.1%至約30%重量比之增溶劑;及 (e)水, 其中當在室溫下測量時,該抗菌劑係以至少25%飽和濃度 之量存在於該組合物中。 本發明之又另一範疇係提供另一具體實例之抗菌組合 物,其中該組合物含有: -12- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 經濟部智慧財產局員工消費合作社印製 五、發明說明(1()) (a )約0.05%至約5%重量比之抗菌劑; (b )約1%至約40%重量比之消毒醇·,及 (c)水’ 其中該組合物含有消毒醇及選擇性之多炫,谷剛,其量 以溶解該抗菌劑’且其中當在室溫下測量時,該抗 以至少25%飽和濃度之量存在於該組合物中。 ·、 、本發明之又另-範疇係提供一種抗菌組合物,其… 接觸後,對抗格藍氏陽性細菌(即,金黃葡萄球菌^ 具有至少2之對數減少。 ) 本發明之又另-範疇係提供—種抗菌組合物,其在秒之 接觸後’對抗格藍氏陰性細菌(即,大腸样紅 s 少2·5之對數減少。 八j 土 本發明之另-範蜂係提供一種抗菌組合物,其對抗格龄 氏陽性及格藍氏陰性細菌具有顯著之對數減少,且 至約8之pH值。 〃 ^ '本發明之另一範轉係提供根據本發明抗菌組合物之消費 產品,例如’皮膚清潔劑、身體噴劑、手術刷洗劑、傷口 保健劑、手部消毒凝膠、消毒劑、漱口水、寵物洗髮精、 硬表面消毒劑等。 、本發明'另一範疇係提供一種在動物組織上(包括人類組 少格ϋ氏陽性及/或格藍氏陰性細菌族群之方法,其 藉由使該組織(諸如’真皮)與本發明之组合物接觸足夠^ 時間(諸如,約15秒至5分鐘),以使細菌之量減少至所欲之 量,並提供對於細菌量之殘留控制。可自皮膚上將該組合 13- 私紙張欠度適用中國國家標準(CNS)A4規格⑵◦ χ挪公爱 羥溶劑,其量 ------------.^裝丨— (請先閱讀背面之注意事項^^^本頁} · i-線」 -I I I · 1284020 五、發明說明(11) 物擦去或洗去。在部 > 且冑t d + 产士南 丨刀,、把只例中,其允許該組合物停留 在皮膚上,直到該组合物之揮發成分揮發為止。 1隹具邀度 納入活性抗菌劑之個人保綠 口 個人保健產已知多年。自從抗菌個 人保健產品之引薦以央,p古二也 # ·、,. 米已有诸夕陳請聲明該等產品提供 抗囷特性。然而,苦要成A县女 要成為取有效者,抗菌組合物應在儘 T能短暫之接觸時間内,對抗廣泛種類之微生物,提供高 量之對數減/作用。如s亥等抗菌組合物可提供殘留細菌控 制作用,其亦為有益者。 、如現*7所’配者’市售1液態抗菌琶組合物皆僅提供不 良至低量之限時滅殺功效,亦即,滅殺細菌之速率。表!摘 述市售產品《滅殺功效,其各含有〇 2%至〇 3%重量比之三 氯生(一種抗菌劑)及界面活性劑。 ----:----------裝—— (請先閱讀背面之注意事項\|1^寫本頁) · 經濟部智慧財產局員工消費合作社印製 表 市售液態洗手皂之限時滅殺功效 產品 微生物 (1分鐘接觸時間後之對數減少) 格藍氏陽性 S. aureus 格藍氏陰性 E. coli 格藍氏陰性 K. pnenm. 市售產品A 0.39 0.00 0.04 市售產品B 2.20 0.00 0.01 市售產品C 1.85 0.00 0.00 -14- -線- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 131284020 A7 B7 五、發明說明( 經濟部智慧財產局員工消費合作社印製 中之飽和/辰度。界面活性劑不僅可增加化合物在組合物連 續水相中之溶解度,其亦形成微膠粒,且可使該等化合物 溶於微膠粒中。 杬菌劑在任何組合物中之%飽和,包括含界面活性劑之 組合物,理想可表示為: %飽和= [C/Cs]xl〇〇% 其中C係孩抗菌劑在該組合物中之濃度,而q係室溫下該 抗菌劑在該組合物中之飽和濃度。在不希望為任何理論限 制之情形下,申請人相信,含界面活性劑之組合物中之連 續水相係與遠組合物之微膠粒假相平衡,同時,任何溶解 足種類’諸如,抗菌活性劑,皆係根據分配律而分布於該 水連續相及該微膠粒假相間。因此,溶於組合物中抗菌活 性劑之飽和百分比,或是相對熱力活性或相對化學勢在該 組合物中之各處皆為相同。因此,該抗菌劑「在組合物 中」、「在組合物水連續相」、及「在組合物微膠粒假相 中」之飽和百分比係可互換使用之詞彙,且如此使用於本 文之揭示内容中。 在使組合物及目极生物間活性劑熱力活性之差異最大 化時(亦即,當組合物之活性成分較為r飽和」時),可達 成取大之抗菌功效。影響抗菌活性之第二因子係組合物中 可獲性抗菌劑之總量,其可被視為「臨界劑量」。已發現 在給定相同熱力活性之情形下,活性劑在組合物連續水相 中之總含量可大量影響達成目標抗菌功效量之時間。因 此,影響活性劑在組合物中抗菌功效之兩項重要因子係: 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) t請先53讀背面Μ注意事頊 --- 寫本頁) 訂: 線· 1284020 A7 B7 五、發明說明(14) (1)其可獲性,其係由其熱力活性決定,亦即,其在組合物 (請先閱讀背面之注意事項β寫本頁) 連%水相中 < 飽和百分比,及(2 )可獲性活性劑在溶液中之 總量。 柷菌清潔組合物之一種重要成分係界面活性劑,其可作 為助溶劑、清潔劑、及起泡劑。界面活性劑可影響抗菌劑 在落液中之飽和百分比,或者,更重要者,其可影響活性 劑在組合物連續水量中之飽和百分比。此種作用可就極低 水溶性抗菌劑在水性界面活性劑溶液中之情形解釋,其中 该活性劑係分布於水(亦即,連續)相及微膠粒假相間。就 具有過低水溶解度之抗菌劑而言,諸如,三氯生,該分布 即強烈偏向微膠粒(亦即,相對於水相,大部分之三氯生分 子皆存在於界面活性劑微膠粒中)。 界面活性劑與抗菌劑之比例直接決定存在於界面活性劑 微膠粒中之活性劑量,其又影響活性劑在連續水相中之飽 .和百分比。已發現,隨著界面活性劑··活性劑之比例增 加’相對於活性分子之微膠粒數目亦會增加,其中隨著該 比例增加,該等微膠粒即比例較不為活性劑飽和。=於連 續水相中之活性劑係與微膠粒假相中之活性劑平衡,隨著 經濟部智慧財產局員工消費合作社印製 微膠粒相中抗菌劑之飽和度降低,連續相φ _ r又抗囷劑飽和 度亦降低。反之亦然。溶於微膠粒假相中之活性劑並不在 接觸微生物時立即可獲,而組合物之抗菌活性係由連巧^ 相中之活性劑飽和百分比決定。然而’界面活性劑 中之活性劑可作為活性劑之貯存物’以在活性劑耗盡時再 對連續水相進行補充。 ^ -17- 1284020 A7 -------B7 五、發明說明(16 ) 在室溫下測量時,皆具有連續水相中至少約25%之抗菌劑 係飽和百分比。此等組合物在30秒之接觸後,對抗格藍氏 陽性細菌具有約2之對數減少。此等組合物在3〇秒之接觸 後’對抗格藍氏陰性細菌具有約25之對數減少。 下文說明本發明之重要非限制性具體實例。 A· 面活性剗之抗_組会物 在本發明之一具體實例中,該抗菌組合物含有活性抗菌 劑、界面活性劑、及水。具體實例A之組合物具有迅速之 細菌滅殺作用,甚至是在無羥溶劑及增溶劑之情形下。羥 落劑及/或增溶劑之存在並不會逆向影響該組合物之抗菌 特性’但此等選擇性之成分並非必要成分。此等組合物可 進一步包括其他後文揭示之選擇性成分,諸如,調節 劑、染劑、及香精。 1. 抗菌劑 抗菌劍在本發明之組合物中係以約〇 〇〇1%至約1〇%,且較 佳係約0.01%至約5%組合物重量比存在。為達成本發明之全 部優點,該抗菌劑係以約〇 〇5%至約2%組合物重量比存在。 此等抗菌組合物可為即可使用之組合物,其一般含有 0.001%至約2%,較佳〇·〇ι%至約丨5%,且最佳約〇 〇5%至約 組合物重量比之抗菌劑。此等抗菌組合物亦可調配為濃縮 物,其可在使用前以1對約100份之水稀釋,以提供終用途 組合物。此等濃縮組合物一般含有大於約01%,且最高約 10%重量比之抗菌劑。本申請案亦涵括其中該終用途組合 物含有大於2%重量比之抗菌劑者。 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) :---------------裝--- (請先閱讀背面之注意事項HI寫本頁) 訂· .線- 經濟部智慧財產局員工消費合作社印製 1284020 經濟部智慧財產局員工消費合作社印製A composition comprising PCMX and a selected surfactant is disclosed in U.S. Patent 5,635,462. The compositions disclosed therein are free of anionic interfacial activity, a non-ionic surfactant. WO 97/46218 and WO 96/06152 disclose compositions based on triclosan, organic acids or salts, solubilizers, and hydroxy solvents. EP 0 505 935 discloses compositions comprising PCDX in combination with nonionic and anionic interfacial activities, particularly nonionic block copolymer surfactants. WO 95/32705 discloses a mild surfactant combination which can be combined with an antibacterial compound such as triclosan. This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ----:----------Install--- (Please read the notes on the back first>|| !|Write this page) I. 1 Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1284020 A7 B7 V. Invention Description (4) (Please read the note on the back before writing this page) W0 95/09605 reveals An anionic surfactant and an antimicrobial composition of an alkyl polyglucoside taste surfactant. WO 98/55096 discloses an antibacterial wipe having a perforated sheet impregnated with an antimicrobial composition comprising an active antibacterial agent, an anionic surfactant, an acid, and water, wherein the composition has from about 3.0 to about 6.0. pH value. NA Allawala et al.? J. Amer. Pharm. Assoc. - Sci. Ed.? Vol. XLII, no. 5? pp. 267-275, (1953) on the antibacterial activity of active antibacterial agents in combination with surfactants . A. G. Mitchell, J. Pharm. Pharmacol, Bol. 16, ρρ·533-537, (1964) discloses a composition comprising PCMX and a nonionic surfactant having antibacterial activity. The compositions disclosed in the Mitchell publication have antibacterial activity after a contact time of at least 47 minutes, and thus such compositions are not highly effective. In the case of hand-disinfecting gels, Osborne et al., U.S. Patent No. 5,776,430, discloses a topical antibacterial cleansing chlorin containing chlorhexidine and an alcohol. The compositions contain from about 50% to about 60% by weight of the denatured alcohol, and from about 0.65% to about 0.85% by weight of chlorhexidine. The composition is applied to the skin 'suck into the skin' and is washed away from the skin. The European Patent Application No. 0 604 848 of the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs discloses a gel type hand disinfectant containing an antibacterial agent, 40% to 90% by weight of an alcohol, and a combined weight of not more than 3% by weight. Compared to polymers and thickeners. The gel is applied to the hands and allowed to evaporate to provide a sterilized hand. The amount and type of antibacterial agent is not critical as described in EP 0 604 848, since the hand sanitizing gel contains a high percentage of alcohol to provide antibacterial activity. Such disclosed compositions generally do not provide immediate disinfection and do not provide residual antimicrobial efficacy. This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) l284〇2〇A7 B7 V. Description of invention (Issue of Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative Printed 11:?: No antibacterial combination Which composition of the composition can be controlled by, for example, 囷. The previous composition is also not between about 5 and about 8:: especially at about 6 to about 8, providing effective , rapid, and control of a wide variety of bacteria. And because of its nature and surfactants are difficult to achieve for antibacterial = = composition. For example, several active anti-caries such as, 酉, have in water Too low solubility, for example, in three-rolled water, is about 5 to 10 ppm (one millionth of a ton: solubility can be increased by adding a surfactant to the composition:: The antibacterial dose in the composition..., 疋θ & is an increase in the antibacterial effect. In the case of any two specific theoretical limitations, it can be inferred that the surfactant activity depends on the resolution, but generally reduces the availability of the antimicrobial agent. Critical micelle of surfactant The concentration is ±, and the surfactant is formed into micelles. The critical micelle concentration of different surfactants is different. The formation of micelles is very important, because the micelles are lipophilic: touch: Γ and Dissolving the antibacterial agent, so that the antibacterial agent can not be obtained immediately when it is touched, and the bacteria can be controlled in a short time (ie, below). The late antibacterial agent in the surfactant microcapsules The fine whisker can be controlled for a longer period of time. If the antibacterial agent is free in an aqueous solution: 'and is not bound to the micelles of the surfactant (ie, two: Attracts to the lipophilic membrane of bacteria and rapidly demonstrates its work; &w is restrained in the micelles of the surfactant (ie, not -8 - paper size _ (CNS) ATii- (2i〇χ 297 ) (Please read the precautions on the back - write this page) • Line - 1284020 A7 B7 V. Description of invention (6) Activation) 'The antibacterial agent has only slow availability, and It is not possible to exhibit its function in a practical time for cleansing the skin. In addition, the antibacterial agent dissolved in the microcapsule can be washed. It is easy to wash away from the skin during the washing process and cannot adhere to the skin to provide residual antibacterial benefits. On the contrary, the antibacterial agent will be washed away and wasted. In the case of disinfection, the hand disinfecting gel generally contains: (a) At least a combination of ethanol or lower alcohol, such as ethanol and isopropanol, (b) water, (c) a gel polymer, such as a crosslinkable polyacrylate material, and (d) other ingredients, Such as skin conditioning agents, fragrances, etc. Hand disinfecting gels are used by consumers to clean the gel by rubbing it on the surface of the hand without washing it with soap or water, or after washing. Effectively disinfecting the hands. The two commercially available hand sanitizing gels rely on high levels of alcohol for disinfection and volatilization, thus having disadvantages. In particular, current hand sanitizing gels tend to dry or irritate the skin due to the high levels of alcohol used in the composition. At the same time, due to the volatility of ethanol, the main active disinfectant does not remain on the skin after use and thus does not provide sustained or residual antibacterial efficacy. Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Print----r----------Install--- (Please read the notes on the back to write this page) Line. In less than 60% alcohol At concentrations, ethanol is not considered a disinfectant. Therefore, in compositions containing less than 60% alcohol, additional antimicrobial compounds must be present to provide antimicrobial activity. However, the foregoing disclosure does not teach which composition of the composition of such an antimicrobial composition provides control of the bacteria. Therefore, in the case of a formulation containing a lower alcohol concentration, it is quite difficult to select an antibacterial agent which provides both rapid antibacterial action and sustained antibacterial benefit. The previous composition was also not at a neutral pH of from about 5 to about 8, especially at about 6 -9 - the paper scale applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 , invention description (7 to about 8 under the provision of a system. The fans, as well as the control of a wide variety of bacteria, therefore, still need a plug # # ▲ effect against a wide variety of two: t, which can be in a short time The antibacterial effect is mainly caused by the presence of the active antibacterial agent in the composition. The present invention relates to such antibacterial compositions. The present invention relates to the antibacterial composition. The antibacterial group of people, you, and the mouth, which can provide a significant reduction in the number of cells in the two-touch and the stagnation-negative bacteria in less than one minute. More specifically, in the eight a 本 the invention relates to the antibacterial a composition comprising an active anti-drug: a surfactant, a surfactant, and a water hydrazine. When measured at room temperature, the anti-#, 丨, 乂 to ^5〇/〇 saturation amount is present in a continuous In the aqueous phase (as opposed to being present in micelles). The invention also relates to antimicrobial compositions, It comprises an active antibacterial agent, a surfactant, a hydrazine, and a (iv) agent and/or a solubilizing agent, which is present in an amount of at least 25% saturation when measured at room temperature. In another embodiment Active antibacterial agent, disinfectant alcohol (please read the precautions on the back - write this page) *I5J· i line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed this invention relates to antibacterial composition, its package $ gel And an aqueous solution, wherein the antimicrobial agent is present in an amount of at least 5% by mole when at room temperature. The present invention relates to an antimicrobial composition comprising an active antimicrobial agent, a disinfecting alcohol, a granulating agent, a solubilizing agent, and water, wherein the antibacterial agent is present in an amount of at least 25% saturation when measured at room temperature. 'Thus' one aspect of the invention provides a liquid antimicrobial composition, ^ Contains: (a) from about 0.001% to about 10% by weight of the antimicrobial agent; (b) about %1% ^ -10- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 x 297 mm 1284020 A7 B7 V. Description of the invention (about 40% by weight of surfactant, selected from CfCi8 alkyl sulfate, & cis fatty acid salt, c8-C18 alkyl ether sulfate with 1 or 2 moles ethoxylated, C8-C18 alkylamine oxide, (8 < 18 alkyl creatinine) Salt, C8-C18 sulfoacetate, Cs-Ce cross-base glass salt, C8-C18 alkyl diphenyl oxide dicarboxylate, CVC1S alkyl carbonate, C8-C18 alpha olefin sulfonate a methyl ester sulfonate, and mixtures thereof; and (c) water, wherein the antimicrobial agent is present in the composition in an amount of at least 50% saturated concentration when measured at room temperature. The category provides an antibacterial composition of another specific example, wherein the composition comprises: (a) from about 0.001% to about 1%. a weight ratio of the antimicrobial agent; (b) from about 1% to about 40% by weight of the surfactant selected from the group consisting of an anionic surfactant, a cationic surfactant, a nonionic surfactant; an amphoteric surfactant, and a mixture thereof; (c) from about 〇% to about 30% by weight of a solubilizing agent; (d) from about 5% to about 25% by weight of a water-soluble solvent; and (e) water, wherein the composition contains a solubilizing agent And at least one of the hydroxy solvents, the Ministry of Economic Affairs, the Intellectual Property Office, the Employees' Cooperatives, when printed at room temperature, the antimicrobial agent is present in the composition in an amount of at least ::::2::. /辰度< Antibacterial combination of specific examples----.------------ (Please read the note on the back first to write this page) Ί-line · Another category of the invention Providing another article, wherein the composition comprises: (a) from about 0.001% to about 10% by weight of the antibacterial agent; (b) from about 10 to about 10% by weight of the interfacial active agent, cationic surfactant, non Ion ^ Interface Interacting Agent, Gendery -11 - Private Paper Scale Applicable to China National Standard (CNS) A4 Specification (210 x 297 mm) 1284020 A7 B7 Five Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Invention Description () . Surfactants, and mixtures thereof; (please read the notes on the back before writing this page) (c) about 0% to about 40% by weight of solubilizer; (d) about 0% to about 60% by weight a water-soluble hydroxy solvent; and (e) water, wherein the composition contains at least one of a solubilizing agent and a light solvent in an amount sufficient to dissolve the antibacterial agent, and wherein when measured at room temperature, the antibacterial agent is An amount of at least 25% saturation concentration is present in the composition. Another embodiment of the present invention provides a liquid antimicrobial composition comprising: (a) from about 0.05% to about 5% by weight of an antimicrobial agent; (b) from about 1% to about 40% by weight of a disinfecting alcohol , for example, a C1-6 alcohol; (c) from about 0.01% to about 5% by weight of a gelling agent, such as a colloidal or polymeric gelling agent; and (d) water, wherein when measured at room temperature, The antimicrobial agent is present in the composition in an amount at least 50% saturated. Still another aspect of the invention provides an antibacterial composition of another embodiment, wherein the composition comprises: (a) from about 0.05% to about 5% by weight of an antimicrobial agent; (b) from about 1% to about 40% a weight ratio of the disinfecting alcohol; (c) from about 0.01% to about 5% by weight of the gelling agent; (d) from about 0.1% to about 30% by weight of the solubilizing agent; and (e) water, wherein when at room temperature The antimicrobial agent is present in the composition in an amount of at least 25% saturation concentration when measured. Still another aspect of the present invention provides an antibacterial composition of another specific example, wherein the composition comprises: -12- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 Ministry of Economy Intellectual Property Bureau Staff Consumer Cooperatives Print 5, Invention Description (1()) (a) about 0.05% to about 5% by weight of the antibacterial agent; (b) about 1% to about 40% by weight of the disinfectant alcohol, And (c) water' wherein the composition contains a disinfecting alcohol and a selective scent, Gu Gang, in an amount to dissolve the antimicrobial agent' and wherein the resistance is at least 25% saturated when measured at room temperature The amount is present in the composition. Further, the present invention provides an antibacterial composition which, after contact, has a logarithmic reduction of at least 2 against Gram-positive bacteria (i.e., Staphylococcus aureus). Providing an antibacterial composition which is resistant to Gram-negative bacteria after contact in seconds (i.e., the logarithm of the large intestine-like red s less than 2. 5 is reduced. A composition which has a significant logarithmic reduction against Age-positive and Gram-negative bacteria and a pH of about 8. 〃 ^ 'Another aspect of the invention provides a consumer product of an antimicrobial composition according to the invention, For example, 'skin cleansers, body sprays, surgical scrubs, wound care agents, hand sanitizing gels, disinfectants, mouthwashes, pet shampoos, hard surface disinfectants, etc.. A method of contacting a tissue, such as a 'dermis, with a composition of the present invention, on a tissue of an animal, including a human group, such as a 'stain' positive and/or a gram-negative bacterial population, such as, for example, 15 seconds to 5 minutes) to reduce the amount of bacteria to the desired amount and provide residual control for the amount of bacteria. This combination can be applied from the skin to the Chinese National Standard (CNS) A4 specification. (2) χ χ 公 爱 爱 羟 , , , ------ ------ ------ ------ ------ ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( 1284020 V. INSTRUCTIONS (11) Wipe or wash off the object. In the section > 胄td + 产士南丨刀,, in the case, it allows the composition to stay on the skin until the composition Volatile components are volatilized. 1 The personal health care products of the individual green-protected oral health supplements have been known for many years. Since the introduction of antibacterial personal health care products, the central government, p Gu Er also # ·,,. Chen please declare that these products provide anti-caries properties. However, if it is necessary to become a valid woman in A County, the antibacterial composition should provide a high logarithm against a wide variety of microorganisms during the short contact time of T. Reduced/acting. Antibacterial compositions such as shai can provide residual bacterial control, which is also beneficial. As the current *7 'matcher' commercial 1 liquid antibacterial sputum composition only provides the effect of killing bacteria to the limit of low to low, that is, the rate of killing bacteria. Table! Summary of commercially available products Killing effect, each containing 〇2% to 〇3% by weight of triclosan (an antibacterial agent) and surfactant. ----:----------Installation - (please first Read the notes on the back\|1^Write this page) · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperatives Printed Table Commercial Liquid Hand Wash Soap Time-killing Product Microorganism (log reduction after 1 minute contact time) Positive S. aureus Negan E. coli Negan K. pnenm. Commercial product A 0.39 0.00 0.04 Commercial product B 2.20 0.00 0.01 Commercial product C 1.85 0.00 0.00 -14- -Line - This paper size applies China National Standard (CNS) A4 Specification (210 X 297 mm) 131284020 A7 B7 V. Description of the Invention (Saturation/Chenness in the Printing of the Consumers' Cooperatives of the Intellectual Property Office of the Ministry of Economic Affairs. The surfactant not only increases the solubility of the compound in the continuous aqueous phase of the composition, it also forms micelles and allows the compounds to be dissolved in the micelles. The % of the bacteriostatic agent is saturated in any composition, including a composition containing a surfactant, and is preferably expressed as: % saturated = [C/Cs] x 〇〇 % wherein the C-based antimicrobial agent is in the composition Concentration, and q is the saturation concentration of the antimicrobial agent in the composition at room temperature. Without wishing to be bound by any theory, Applicants believe that the continuous aqueous phase in the surfactant-containing composition is in equilibrium with the micelles of the far composition, while at the same time, any dissolved foot species such as, antibacterial activity The agents are distributed between the water continuous phase and the micelle pseudo phase according to the distribution law. Thus, the percent saturation of the antimicrobial active in the composition, or the relative thermal activity or relative chemical potential, is the same throughout the composition. Therefore, the saturation percentages of the antibacterial agents "in the composition", "in the composition water continuous phase", and "in the composition micelle pseudo phase" are used interchangeably, and are used as disclosed herein. in. When the difference in thermodynamic activity between the composition and the macro-organic active agent is maximized (i.e., when the active ingredient of the composition is more saturated with r), a large antibacterial effect can be achieved. The second factor affecting the antimicrobial activity is the total amount of the available antimicrobial agent, which can be considered a "critical dose." It has been found that given the same thermodynamic activity, the total level of active agent in the continuous aqueous phase of the composition can greatly affect the time to achieve the desired amount of antimicrobial efficacy. Therefore, two important factors affecting the antibacterial efficacy of the active agent in the composition are: This paper scale applies the Chinese National Standard (CNS) A4 specification (210 X 297 public) t Please read 53 on the back and note the matter--- Write this page) Order: Line · 1284020 A7 B7 V. Description of invention (14) (1) Its availability, which is determined by its thermal activity, that is, its composition (please read the note on the back first) Write this page) in % of the aqueous phase < saturation percentage, and (2) the total amount of active agent in solution. An important component of the sputum cleaning composition is a surfactant which acts as a solubilizing agent, a cleaning agent, and a foaming agent. The surfactant can affect the percent saturation of the antimicrobial agent in the falling liquid or, more importantly, the percentage of saturation of the active agent in the continuous amount of water in the composition. This effect can be explained in the context of very low water solubility antimicrobial agents in aqueous surfactant solutions which are distributed between the water (i.e., continuous) phase and the micelle pseudophase. For antibacterial agents with too low water solubility, such as triclosan, the distribution is strongly biased towards micelles (i.e., relative to the aqueous phase, most of the triclosan molecules are present in the surfactant microgel) In the grain). The ratio of surfactant to antimicrobial agent directly determines the active dose present in the surfactant micelles, which in turn affects the saturation and percentage of the active agent in the continuous aqueous phase. It has been found that as the proportion of surfactant/active agent increases, the number of micelles relative to the active molecule also increases, with the proportion of such micelles being less saturated with the active agent as the ratio increases. = The active agent in the continuous aqueous phase is in equilibrium with the active agent in the microcapsule pseudo-phase, and the saturation phase of the antibacterial agent in the micelle phase is reduced with the Ministry of Economic Affairs, the Intellectual Property Office, and the continuous phase φ _ r The anti-caries agent saturation is also reduced. vice versa. The active agent dissolved in the microcapsule pseudophase is not immediately available upon contact with the microorganism, and the antibacterial activity of the composition is determined by the percentage of saturation of the active agent in the coincidence phase. However, the active agent in the surfactant can act as a reservoir for the active agent to replenish the continuous aqueous phase when the active agent is depleted. ^ -17- 1284020 A7 -------B7 V. INSTRUCTIONS (16) At room temperature, at least about 25% of the antimicrobial agent in the continuous aqueous phase is saturated. These compositions had a log reduction of about 2 against the Gram-positive bacteria after 30 seconds of contact. These compositions had a log reduction of about 25 against the Gram-negative bacteria after 3 seconds of exposure. Important non-limiting specific examples of the invention are described below. A. Anti-Composition Anti-Composition In one embodiment of the present invention, the antibacterial composition contains an active antibacterial agent, a surfactant, and water. The composition of Specific Example A has a rapid bacterial killing effect, even in the absence of a hydroxy solvent and a solubilizing agent. The presence of the hydroxyclay and/or solubilizer does not adversely affect the antimicrobial properties of the composition' but such optional ingredients are not essential ingredients. Such compositions may further comprise other optional ingredients as disclosed hereinafter, such as conditioners, dyes, and perfumes. 1. Antimicrobial Agents Antibacterial strains are present in the compositions of the present invention in an amount of from about 1% to about 1% by weight, and more preferably from about 0.01% to about 5% by weight of the composition. To achieve the full advantage of the present invention, the antimicrobial agent is present in a weight ratio of from about 5% to about 2% of the composition. Such antimicrobial compositions may be ready-to-use compositions which generally comprise from 0.001% to about 2%, preferably from about 5% to about 5%, and most preferably from about 5% to about the weight of the composition. Compared to antibacterial agents. These antimicrobial compositions can also be formulated as a concentrate which can be diluted with about 1 part to about 100 parts of water prior to use to provide a final use composition. Such concentrated compositions typically contain greater than about 01%, and up to about 10% by weight of the antimicrobial agent. The present application also encompasses those in which the end use composition contains greater than 2% by weight of the antibacterial agent. This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public):---------------Installation--- (Please read the note on the back first HI writing Page) Order · Line - Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1284020 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed

A7 五、發明說明( 如上所論,存在於組入榀士 u ?、 、σ物中抗囷劑 < 絕對含量並不如έ 合物中可獲性抗菌劑之冬 ^ ^ 、入θ . ^Α 又ηΐ重要。組合物中可獲性抗菌劑 <含里係與組合物中界面活,地才丨少储 4囬活性劑t種類、組合物中界面活 性劑之量、以及組合物中選擇性成分之存在相關。 斗為在短暫之接觸時間,諸如,15至卿、中,達成目標之細 囷滅殺作用’當在室溫下測量時,該組合物連續水相所含 .之抗菌劑量係該抗菌劑在水中飽和濃度之至少約5〇%,且 較佳至少約75%。為達成本發明之全部優點,該連續水相 係為該抗菌劑約95%至100%飽和。存在於該連續水相中之 抗菌劑含量可以組合物中抗菌劑之總量減去存在於界面活 性劑微膠粒中之任何抗菌劑而定義。測定组合物中抗菌劑 飽和百分比之方法揭示於後文。 可用於本發明之抗菌劑係酚化合物,其可由下列類型之 化合物例示: (a) 2-¾基二苯基化合物 (OK) 其中Y係氯或溴,Z係S02H、N02、或Crc4烷基,以系〇至3, 〇係0至3,p係〇或1,m係0或1,且η係0或1。 在較佳具體實例中,γ係氣或漠,m係0,η係〇或1 , 0係 -20- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)A7 V. Description of the invention (as discussed above, the anti-caries agent present in the group of gentlemen u?, σ, < absolute content is not as good as the available antibacterial agent in the compound ^^, into θ. ^Α Further, ηΐ is important. The available antibacterial agent in the composition<the inner layer and the interface in the composition, the amount of the active agent t, the amount of the surfactant in the composition, and the composition selection The existence of sexual components is related. The fight is the fine killing effect of achieving the target in a short contact time, such as 15 to qing, medium, 'the antibacterial contained in the continuous aqueous phase of the composition when measured at room temperature. The dosage is at least about 5%, and preferably at least about 75%, of the saturated concentration of the antimicrobial agent in water. To achieve the full advantage of the present invention, the continuous aqueous phase is about 95% to 100% saturated with the antimicrobial agent. The amount of antimicrobial agent in the continuous aqueous phase can be defined by subtracting the total amount of antimicrobial agent in the composition from any antimicrobial agent present in the surfactant micelle. The method for determining the percent saturation of the antimicrobial agent in the composition is disclosed The antibacterial agent which can be used in the invention is a phenolic compound It can be exemplified by the following types of compounds: (a) 2-3⁄4 benzyl diphenyl compound (OK) wherein Y is a chlorine or bromine, Z system is S02H, N02, or Crc4 alkyl, to 3 to 3, 〇 0 Up to 3, p is 〇 or 1, m is 0 or 1, and η is 0 or 1. In a preferred embodiment, γ is gas or desert, m is 0, η is 〇 or 1, 0 is -20- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)

| .----------裝---_----_--訂----_---Ί -線· (請先閱讀背面之注意事項HI寫本頁) A 1284020 A7 B7 五、發明說明( 18 1或2,r係1或2,且p係〇。 在特別較佳具體實例中,Y係氯,瓜係〇,11係〇 r係2,且p係0。 特別可用之2 -羥基二苯基化合物具有結構: 〇係1 C1 OH Cl 其具有採用之名稱二氯生’且可以商標名IRGASAN DP3〇〇自 Ciba Specialty Chemicals Corp·,Greensboro, NC以商業取得。另一可用 之2 -羥基二苯基化合物係2,2,-二羥基-5,5,-二溴二苯醚。 (b ) 鼢衍生物| .----------Install---_----_--Book----_---Ί-Line· (Please read the note on the back first HI write this page) A 1284020 A7 B7 V. INSTRUCTIONS (18 1 or 2, r is 1 or 2, and p is 〇. In a particularly preferred embodiment, Y is chlorine, melon is 〇, 11 is 〇r 2, and p System 0. A particularly useful 2-hydroxydiphenyl compound has the structure: lanthanide 1 C1 OH Cl which has the name diclosan, and can be marketed under the trade name IRGASAN DP3 from Ciba Specialty Chemicals Corp., Greensboro, NC. Commercially available. Another useful 2-hydroxydiphenyl compound is 2,2,-dihydroxy-5,5,-dibromodiphenyl ether. (b) Anthracene derivatives

(請先閱讀背面之注意事項m寫本頁) 經濟部智慧財產局員工消費合作社印製 其中Ri係氫、羥·基、CrC4烷基、氯、硝基、苯基、或^ 基,R2係氫、爽基、基、或鹵原子;化係氫、Ci(大 基、經基、氣、硝基、或以驗金屬鹽或録鹽形式存在^ 硫;R4係氫或甲基;且係氫或硝基。鹵原子係溴或,幸 佳者,氯。 酚衍生物之具體實例包括,但不限於,氯酚(鄰·、間_、 •21 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(19) 對〇、2,4 -二氯酚、對-硝基酚、苦味酸、二甲苯酚、對一 氯-間-二甲苯酚、甲酚(鄰_、間_、對·)、對·氯-間-甲 酚、鄰苯二酚、間苯二酚、4 ·正-己基間苯二酚、丨,2,3 · 苯二酚、間苯三酚、香芹酚、百里酚、對-氯百里酚、鄰_ 苯基酚、鄰-芊基酚、對_氯_鄰_苄基酚、酚、4 _乙基酚、 及4 - 橫酸。其他酚衍生物列於w〇 98/55096,其併入本文作 為參考文獻。 (c ) 二苯基化合物 ----·----------裝--- (請先閱讀背面之注意事項HI寫本頁)(Please read the precautions on the back m to write this page.) Ministry of Economic Affairs, Intellectual Property Bureau, Staff and Consumer Cooperatives, which prints Ri hydrogen, hydroxy-based, CrC4 alkyl, chlorine, nitro, phenyl, or ^, R2 a hydrogen, a sulphur group, a base, or a halogen atom; a hydrogen group, a Ci (macro group, a thiol group, a gas, a nitro group, or a metal salt or a salt); the R4 is hydrogen or a methyl group; Hydrogen or nitro. Halogen is bromine or, preferably, chlorine. Specific examples of phenol derivatives include, but are not limited to, chlorophenol (o-, _, • 21 - this paper scale applies to China National Standard (CNS) A4 size (210 X 297 mm) 1284020 A7 B7 V. Description of invention (19) For hydrazine, 2,4-dichlorophenol, p-nitrophenol, picric acid, xylenol, p-chloro-inter-di Cresol, cresol (o-, m-, p-), p-chloro-m-cresol, catechol, resorcinol, 4 · n-hexyl resorcinol, hydrazine, 2, 3 · Hydroquinone, phloroglucinol, carvacrol, thymol, p-chlorothymol, o-phenylphenol, o-nonylphenol, p-chloro-o-benzylphenol, phenol, 4 _Ethylphenol, and 4-wasonic acid. Other phenols The organisms are listed in WO 98/55096, which is incorporated herein by reference. (c) Diphenyl compounds----------------------- Matters HI write this page)

« . 其中X係硫或亞甲基,心及%係羥基,R2、R,2、化、R,3、 R4、R’4、R5、及r’5各獨立係氫或鹵原子。二苯基化合物之具 體非限制性實例係六氯苯、四氯苯、二氯苯、2,3 -二羥基_ 5,5 ’ -二氯二苯硫、2,2,二羥基_ 3,3,,5,5,-四氯二苯硫、 2,2’-二羥基 _3,5’,5,5,,6,6,'六氯二苯硫、及3,3,_ 二溴· 5,5、二氣-2,2’ -二羥基二苯胺。其他二苯基化合物列於 W0 98/55096,其併入本文作為參考文獻。 2 · 界面活性逾ι| 除抗菌劑外,本抗菌組合物亦包含界面活性劑。該界面 活性劑係以約〇·1%至約40%,且較佳約〇 3%至約2〇%組合物 重量比存在。為達成本發明之全部優點,該抗菌組合物含 -22- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) •線」 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 20 五、發明說明( 有約0.5%至約15%重量比之界面活性劑。 即可使用之組合物一般含有〇 1%至約1〇%,較佳〇 3%至約 5%,且最佳約〇·5%至約3%組合物重量比。適於稀釋之濃縮 組合物一般含有大於約5%重量比之界面活性劑。 存在於組合物中之界面活性劑含量與組合物中抗菌劑之 含量及種類’以及該界面活性劑之種類相關。測定界面活 性劑之含量’以使組合物水相中抗菌劑之飽和百分比係至 少約50%,較佳至少約75%,且最佳至少約%%。 在此具體貫例中,其中羥溶劑及增溶劑之存在係選擇性 者’界面活性劑之種類就提供連續水相中具有至少約5〇% 抗菌劑飽和百分比之組合物而言相當重要。如後文所說 明’可用於本發明此一具體實例中之界面活性劑包括陰離 子界面活性劑及所選之陽離子界面活性劑。含有相對高量 乙氧基化作用之非離子界面活性劑及陰離子界面活性劑並 不通用於此具體實例。含有超過2莫耳環氧乙烷之乙氧基化 界面活性劑對於抗菌劑具有強親和力,且在此具體實例中 會顯著減低抗菌劑之功效。 因此,在此具體實例中,該界面活性劑係選自下列類型 二界面活性劑· cvc!8垸基硫酸鹽、CrCi8脂肪酸鹽、具有j 或2莫耳乙氧基化之C8_CM烷基醚硫酸鹽、烷胺氧化 物A Cs cls:k基肌胺酸鹽、CfCu橫基乙酸鹽、C8_C18續基琥 =酸爲C8_C18烷基二苯基氧化物二磺酸鹽、(:8<:18烷基碳酸 8 18 α缔L〜酸鹽、甲酯續酸鹽、及其混合物。該 C8-C18垸基含有8至16個碳原子,且可為直鍵(如,十二燒基) (請先閱讀背面之注意事項3寫本頁)« . wherein X is sulfur or methylene, and the core and % are hydroxyl groups, and R 2 , R 2 , 2, R, 3, R 4 , R 4 , R 5 , and r 5 are each independently hydrogen or a halogen atom. Specific non-limiting examples of diphenyl compounds are hexachlorobenzene, tetrachlorobenzene, dichlorobenzene, 2,3-dihydroxy-5,5'-dichlorodiphenyl sulfide, 2,2, dihydroxy-3, 3,5,5,-tetrachlorodiphenyl sulfide, 2,2'-dihydroxy-3,5',5,5,6,6,'hexachlorodiphenyl sulfide, and 3,3,_ 2 Bromo 5,5, di- gas-2,2'-dihydroxydiphenylamine. Other diphenyl compounds are listed in WO 98/55096, which is incorporated herein by reference. 2 · Interface activity over ι| In addition to the antibacterial agent, the antibacterial composition also contains a surfactant. The interfacial active agent is present in a weight ratio of from about 1% to about 40%, and preferably from about 3% to about 2% by weight of the composition. In order to achieve all the advantages of the present invention, the antibacterial composition contains -22- the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) • Line” Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 1284020 A7 B7 20 V. Description of the invention (having from about 0.5% to about 15% by weight of the surfactant. The ready-to-use composition generally contains from 1% to about 1%, preferably from about 3% to about 5%, and Preferably, from about 5% to about 3% by weight of the composition. The concentrated composition suitable for dilution generally contains greater than about 5% by weight of surfactant. The amount of surfactant present in the composition is in the composition. The content and type of the antibacterial agent and the type of the surfactant are related. The content of the surfactant is determined such that the saturation percentage of the antibacterial agent in the aqueous phase of the composition is at least about 50%, preferably at least about 75%, and most Preferably, at least about %%. In this particular example, wherein the presence of a hydroxy solvent and a solubilizing agent is selected, the type of surfactant provides a composition having at least about 5% by weight of the antimicrobial agent in the continuous aqueous phase. It’s very important. As after The surfactants useful in this embodiment of the invention include anionic surfactants and selected cationic surfactants. Nonionic surfactants and anionic surfactants containing relatively high amounts of ethoxylation. Not specifically exemplified in this particular example. Ethoxylated surfactants containing more than 2 moles of ethylene oxide have a strong affinity for the antimicrobial agent, and in this particular example significantly reduce the efficacy of the antimicrobial agent. In an embodiment, the surfactant is selected from the group consisting of the following types of surfactants: cvc! 8 mercapto sulfate, CrCi8 fatty acid salt, C8_CM alkyl ether sulfate with j or 2 mole ethoxylation, alkylamine oxidation A Cs cls: k-based sarcosinate, CfCu transverse acetate, C8_C18 contiguous succinic acid = C8_C18 alkyl diphenyl oxide disulfonate, (: 8 <: 18 alkyl carbonate 8 18 α L-acid salt, methyl ester salt, and mixtures thereof. The C8-C18 thiol group has 8 to 16 carbon atoms and can be a direct bond (eg, 12-alkyl) (please read the back note first) Matter 3 write this page)

I I P 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 23 1284020 A7 B7 五 經濟部智慧財產局員工消費合作社印製 發明說明(21) 或支鏈(如,2 -乙基-己基)。該陰離子界面活性劑之陽離子 可為鹼金屬(較佳為鈉或鉀)、銨、CrC4烷基銨(單-、二-、 三-)、或(^-(^鏈烷醇銨(單-、二-、三-)。可使用鋰及鹼土 陽離子(如,鎂),但抗菌功效會降低。 可用於此具體實例中之具體界面活性劑包括,但不限 於,十二燒基硫酸鹽、辛基硫酸鹽、2 -乙基己基硫酸鹽、 氧化十二胺、癸基硫酸鹽、十三烷基硫酸鹽、可可酸鹽、 十二燒醯基肌胺酸鹽、十二燒基續基琥ίό酸鹽、直鏈C1Q二 苯基氧二磺酸鹽、十二烷基磺基琥珀酸鹽、十二烷基醚硫 酸鹽(1及2莫耳環氧乙烷)、十四烷基硫酸鹽、油酸鹽、硬 脂酸鹽、樹脂酸鹽、氧化可可胺、氧化癸胺、氧化十四 胺、蓖麻酸鹽、十六烷基硫酸鹽、及類似之界面活性劑。 界面活性劑之其他實例可見於’’CTFA Cosmetic Ingredient Handbook,’* J.M. Nikitakis, ed.? The Cosmetic, Toiletry and Fragrance Association,Inc.,Washington,D.C. (1988)(後文稱為 CTFA Handbook),p· 10-13, 42-46,及87-94,其併入本文作為參考文獻。 3 . 載體 此具體實例中之載體包含水。 4. 選擇性成分 本發明之抗菌組合物亦可含有熟習技藝者所熟知之選擇 性成分。舉例而言,該組合物可含有羥溶劑及/或增溶 劑。此等特定之選擇性成分及可存在於該組合物中之量於 後文討論。 此等組合物亦可含有其他選擇性成分,諸如,染劑及香 -24- ----.----------裝--- (請先閱讀背面之注意事項HI寫本頁) · · ·!線k 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( 22 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 味劑,其以足夠之量存在,以展現其目標功能,且不逆向 影響該組合物之抗菌功效。此等選擇性之成分一般係分別 以自0%至約5%組合物重量比,且總計自〇%至約2〇%組合物 重量比.存在。 選擇性成分之類型包括,但不限於,染劑、香味劑、pH 調節劑、增稠劑、黏性修飾劑、緩衝劑、泡沫安定劑、抗 氧化劑、泡沫增強劑、螯合劑、遮光劑、及熟習技藝者所 知之類似類型選擇性成分。 選擇性成分之具體類型包括作為泡沫增強劑及安定劑之 鏈烷醇醯胺;作為增稠劑之膠及聚合物;作為緩衝劑之無 機磷酸鹽、硫酸鹽、及碳酸鹽;作為螯合劑之EDTA及磷酸 鹽;以及作為pH調節劑之酸及驗。 較佳類型驗性pH調節劑之實例包括氨;單_、二_、及三_ 烷基胺,单-、二_、及三-鏈烷醇胺;鹼金屬及鹼土金屬氫 氧化物;以及其混合物。然而,鹼性PH調節劑之種類並不 受限制,且技藝中所知之任何驗性pH調節劑皆可使用。驗 性PH調節劑之具體非限制性實例包括氨;氫氧化納、鉀、 及鋰;單乙醇胺;Z乙胺;異丙醇胺、二乙醇胺;及三乙 醇胺。 較佳類型酸性pH調節劑之實例包括無機酸及多羧酸。垚 機酸之非限制性實例包括鹽酸、硝酸、鱗酸、及硫酸。多、 竣酸之非限制性實例包括檸檬酸、乙二醇酸、及乳酸。酸 性PH调即叙種類並不受限制,且技藝中所知之任何酸 pH碉節劑皆可單獨或結合使用。 ---1 —----------裝--- (請先閱讀背面之注意事項HI寫本頁) . · -25- :^張尺度適用中國 -n n n n - 1284020 A7 B7 五、發明說明(23) 對組合物提供增稠、泡沫增進、及泡沫安定作用之鏈燒 醇酿胺可為’但不限於’可可醯胺MEA、可可酿胺DEA、大 豆醯胺DEA、肉桂SS胺DEA、油醯胺MIPA、硬脂醯胺MEA、 肉豆蔻醯胺MEA、肉桂醯胺MEA、癸醯胺DEA、蓖麻醯胺 DEA、肉豆蔻醯胺DEA、硬脂醯胺DEA、油醯胺DEA、牛脂酿 胺DEA、肉桂醯胺MIPA、牛脂醯胺MEA、異硬脂醯胺DEA、 異硬脂醯胺MEA、及其混合物。 B · 含有i菌劑、界面活性劑、羥溶劑及/或增溶劑^ 抗菌組合物 在另一具體實例中,該抗菌組合物含有活性抗菌劑、界 面活性劑、以及羥溶劑及/或增溶劑。具體實例B之組合 物具有迅速之細菌滅殺作用,且本質上不限制組合物中界 面活性劑之種類。該溶劑及/或增溶劑可協助溶解該抗菌 劑,並減低抗菌劑進入界面活性劑微膠粒之親和力。因 此,不論該界面活性劑之種類為何,皆可達成連績水相中 抗菌劑至少25%之飽和度。 1 . 抗菌劑 在此本發明具體實例中所存在之抗菌劑含量及種類係如 上文A . 1所論。 此外,為在短暫之接觸時間,諸如,15至6〇秒中,達成目 標之細菌滅殺作用,當在室溫下測量時,該組合物之連續 水相含有之抗菌劑量係該抗菌劑在水中飽和濃度之至少約 25%,且較佳至少約50%,且更較佳至少約75%。為達成本 發明之全部優點’遠連績水相係為該抗菌劑約至1〇〇% -26- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) ----------------裝 (請先閱讀背面之注意事項H寫本頁) I tmme ^1· I ϋ a— ·! em— _ 經濟部智慧財產局員工消費合作社印製 1284020 A7 五、發明說明(24 經濟部智慧財產局員工消費合作社印製 飽和。 2. 界面活性劑 在此本發明具體實例中 A 2am 界面活性劑含量與上文 A · 2所揭7F又含里相同。炊… 、七如田 …、而由於趙落刮及/或增溶劑 〈存在,界面活性劑之種類並不如Α·2中般受限。 特定言之,羥溶劑及/或增溶劑(其如後文定義)之存在 可減低抗菌劑進入界面活性劑微膠粒之親和力。因此,不 論該界面活性劑之種類為何,該連續水相中皆厶有足量之 抗菌劑’以快速並有效滅殺廣泛種類之細菌。在t中# 溶劑及增溶劑之具體實例中,各種界面活性劑,諸如^ 氧基化之非離子界面活性劑’對於抗菌劑具有高親和力, 以致於該抗菌劑不可為快速之細菌減殺所獲。 、因,,在此具體實财,該界面活性射為陰離子界面 活性劑、陽離子界面活性劑、非離子界面活性劑、及界面 活t生劑之相容性混合物。該界面活性劑亦可為兩性界面活 性劑,其可根據組合物之pH值而具有陰離子或陽離子特 性。 因此,該等抗菌組合物可含有揭示於上文八.2中之陰離 ,界面活性劑,且更概略言之可包含任何陰離子界面:性 劑,其具有一疏水部分,諸如,包含約8至約30個碳原子之 碳鏈,且特別是約12至約20個碳原子者,且進一步具有一親 水邵分,諸如,硫酸鹽、磺酸鹽、碳酸鹽、磷酸鹽、或羧 酸鹽。通常,該疏水碳鏈係經醚化,諸如,與環氧乙烷或 環氧丙垸醚化,以產生特定之物理特性,諸如,增加水溶 -27- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項 »寫本頁: 裝 . 丨線」 1284020 A7 B7 五、發明說明() 解度或減少對於該陰離子界面活性劑之表面張力。 因此,適當之陰離子界面活性劑包括,但不限於,已知 屬於下列類型之化合物:烷基硫酸鹽、烷基醚硫酸鹽、烷 基醚磺酸鹽、烷基苯氧基聚氧乙烯乙醇之硫酸酯、α -烯烴 磺酸鹽、^ -烷氧基烷磺酸鹽、烷芳基磺酸鹽、烷基單甘油 酯硫酸鹽、烷基醚羧酸鹽、脂肪酸、磺基琥珀酸鹽、肌胺 酸鹽、oxtoxynol或nonoxynol磷酸鹽、牛橫酸鹽、脂肪牛續醢 胺、脂肪酸醯胺龙氧乙烯硫酸鹽、羥乙磺酸鹽、或其混合 物。其他之陰離子界面活性劑列於McCutcheon’s Emulsifiers and Detergents,1993 Annuals,(後文稱為 McCutcheon’s),McCutcheon Division, MC Publishing Co.,Glen Rock,NJ,pp. 263-266,其併入本文作為參考 文獻。諸多其他之陰離子界面活性劑,以及陰離子界面活 性劑之類型揭示於Laughlin et al.美國專利No. 3,929,678,其併入 本文作為參考文獻。 經濟部智慧財產局員工消費合作社印製 ----;----------裝—— (請先閱讀背面之注意事項Hi寫本頁) 線, 該等抗菌組合物亦可含有非離子界面活性劑。一般而 '言,非離子界面活性劑具有一疏水基團,諸如,長鏈烷基 或烷化芳基,以及一親水鏈,其包含足夠數目(亦即,1至 約30)之乙氧基及/或丙氧基。非離子界面活性劑之實例包 括乙氧基化之烷基酚、乙氧基化及丙氧基化之脂肪醇、甲 基葡萄糖之聚乙二醇醚、甘露糖醇之聚乙二醇醚、環氧乙 烷-環氧丙烷嵌段共聚物、脂肪(C8_C18)酸之乙氧基化酯、 環氧乙烷與長鏈胺或醯胺之縮合產物、及其混合物。 非離子界面活性劑之實例包括,但不限於,甲基葡萄糖 醚-10、PEG-20甲基葡萄糖二硬脂酸鹽、PEG-20甲基葡萄糖倍 -28- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 五、發明說明(26) 半硬脂故鹽、Cl 1_15键坑基酸-20、十7T坑基鍵-8、十六燒基 醚-12、dodoxynol-12、十二垸基醚-15、PEG-20蓖麻油、多乙氧 基醚20、十八燒基醚-20、聚氧乙晞-10十六垸基醚、聚氧乙 烯-10十八烷基醚、聚氧乙烯-20十六烷基醚、聚氧乙烯-ίο油 醚、聚氧乙烯-20油醚、乙氧基化壬基酚、乙氧基化辛基 酚、乙氧基化十二烷基酚、或乙氧基化脂肪(C6-C22)醇,包 括3至20個環氧乙烷部分、聚氧乙晞-20異十六烷基醚、聚氧 乙烯-23甘油十二酸鹽、聚氧乙烯-20甘油基硬脂酸鹽、PPG-10 甲基葡萄糖醚、PPG-20甲基葡萄糖醚、聚氧乙烯-20脫水山梨 糖醇單酯、聚氧乙烯-80蓖麻油、聚氧乙烯-15十三烷基醚、 聚氧乙烯-6十三垸基醚、十二垸基醚-2、十二垸基醚-3、十 二烷基醚-4、PEG-3蓖麻油、PEG600二油酸鹽、PEG400二油酸 鹽、及其混合物。 諸多其他之非離子界面活性劑皆揭示於McCutcheon’s Emulsifiers and Detergents, 1993 Annuals, published by McCutcheon Division, MC Publishing Co.,Glen Rock,NJ,pp· 1-246 and 266-272 ; CTFA International Cosmetic Ingredient Dictionary, Fourth Ed., Cosmetic, Toiletry and Fragrance Association,Inc·,Washington,D.C· (1988)(後文稱為 CTFA Dictionary),p. 1-651 ;及 CTFA Handbook,p. 86-94 ;其各併入本文作 為參考文獻。 除陰離子及非離子界面活性劑外,陽離子及兩性界面活 性劑亦可用於該等抗菌組合物中。陽離子界面活性劑包括 氧化胺,舉例而言。 兩性界面活性劑可廣泛描述為二級及三級胺之衍生物, -29- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) il--T----------裝—— (請先閱讀背面之注意事Amjc寫本頁) . •f 1284020 A7 B7 五、發明說明(27) 其具有直鏈或支鏈之脂族基團,且其中該等脂族取代基之 一含有自約8至18個碳原子,且至少一個脂族取代基含有一 陰離子水溶性基團,如,羧基、磺酸鹽、或硫酸鹽。屬於 此等敘述之化合物實例包括3 -(十二统基胺基)丙酸鈉、3 -(十二烷基胺基)-丙烷-1 -磺酸鈉、2 -(十二烷基胺基)乙基 硫酸鈉、2 -(二甲基胺基)乙基硫酸鈉、3 - ( N -羧甲基-十二 烷基胺基)-丙烷-1 -磺酸鈉、十八烷基亞胺基二乙酸二鈉、 1·叛甲基-2_十一燒基味。坐鈉 '及N,N -雙(2-¾基乙基)-2 -硫酸根合-3 -十二烷氧基丙胺鈉。 更特定言之,一類型包含肌胺酸鹽及牛磺酸鹽之兩性界 面活性劑具有結構通式 0I I P Ministry of Economics, Intellectual Property, Bureau of Employees, Consumers, and Consumers Co., Ltd. 23 1284020 A7 B7 V. Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, Printed Description (21) or branched (eg, 2-ethyl-hexyl). The cation of the anionic surfactant may be an alkali metal (preferably sodium or potassium), ammonium, CrC4 alkyl ammonium (mono-, di-, tri-), or (^-(^alkanol ammonium (single- , di-, tri-). Lithium and alkaline earth cations (eg, magnesium) may be used, but the antibacterial efficacy may be reduced. Specific surfactants that may be used in this specific example include, but are not limited to, taudecyl sulfate, Octyl sulfate, 2-ethylhexyl sulfate, dodecyl oxide, sulfhydryl sulfate, tridecyl sulfate, cocoate, dodecyl sarcosine, twelfth base Acrylate, linear C1Q diphenyl oxydisulfonate, dodecyl sulfosuccinate, lauryl ether sulfate (1 and 2 molar ethylene oxide), tetradecyl sulfate Salts, oleates, stearates, resinates, oxidized cocoamines, guanamines, tetradecylamines, ricinoleates, cetyl sulfates, and similar surfactants. Other examples can be found in ''CTFA Cosmetic Ingredient Handbook,'* JM Nikitakis, ed.? The Cosmetic, Toiletry and Fragrance Ass Ociation, Inc., Washington, DC (1988) (hereinafter referred to as CTFA Handbook), p. 10-13, 42-46, and 87-94, which is incorporated herein by reference. The carrier comprises water. 4. Optional Ingredients The antimicrobial compositions of the present invention may also contain optional ingredients well known to those skilled in the art. For example, the compositions may contain hydroxy solvents and/or solubilizing agents. The optional ingredients and the amounts which may be present in the compositions are discussed below. These compositions may also contain other optional ingredients such as dyes and fragrances 24-- ----. ----Install--- (Please read the note on the back HI to write this page) · · ·! Line k This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 , invention description (22 Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperatives, printed scented agents, which exist in sufficient quantities to demonstrate their intended function, and do not adversely affect the antibacterial efficacy of the composition. These selective ingredients are generally Respectively from 0% to about 5% by weight of the composition, and totaling from 〇% to about 2 〇% composition by weight ratio. The types of optional ingredients include, but are not limited to, dyes, fragrances, pH adjusters, thickeners, viscosity modifiers, buffers, foam stabilizers, antioxidants, foams Enhancers, chelating agents, opacifiers, and similar types of selective ingredients known to those skilled in the art. Specific types of optional ingredients include alkanolamine as a foam enhancer and stabilizer; gums as thickeners and Polymer; inorganic phosphate, sulfate, and carbonate as a buffer; EDTA and phosphate as a chelating agent; and acid as a pH adjuster. Examples of preferred types of illustrative pH adjusting agents include ammonia; mono-, di-, and tri-alkylamines, mono-, di-, and tri-alkanolamines; alkali metal and alkaline earth metal hydroxides; Its mixture. However, the type of alkaline pH adjusting agent is not limited, and any of the qualitative pH adjusting agents known in the art can be used. Specific non-limiting examples of the assay pH adjusting agent include ammonia; sodium, potassium, and lithium hydroxide; monoethanolamine; Z ethylamine; isopropanolamine, diethanolamine; and triethanolamine. Examples of preferred types of acidic pH adjusting agents include inorganic acids and polycarboxylic acids. Non-limiting examples of the acid include hydrochloric acid, nitric acid, scaly acid, and sulfuric acid. Non-limiting examples of poly, citric acid include citric acid, glycolic acid, and lactic acid. The acidity of the pH is not limited, and any acid pH chelating agent known in the art can be used alone or in combination. ---1 —----------装--- (Please read the note on the back HI to write this page) . · -25- :^ Zhang scale for China-nnnn - 1284020 A7 B7 DESCRIPTION OF THE INVENTION (23) The chain-smelting amine which provides thickening, foaming, and foaming stability to the composition may be 'but not limited to' cocoamine MEA, cocoa amine DEA, soybean decyl DEA, cinnamon SS Amine DEA, oleic acid MIPA, stearylamine MEA, myristyl MEA, cinnamylamine MEA, decyl DEA, castoramine DEA, myristyl DEA, stearylamine DEA, oil 醯Amine DEA, tallow amine DEA, cinnamylamine MIPA, tallow amine MEA, isostearylamine DEA, isostearylamine MEA, and mixtures thereof. B · Containing i bacteria, surfactant, hydroxy solvent and/or solubilizer ^ Antibacterial composition In another embodiment, the antibacterial composition contains an active antibacterial agent, a surfactant, and a hydroxy solvent and/or a solubilizing agent . The composition of Specific Example B has a rapid bacterial killing effect and does not substantially limit the type of surfactant in the composition. The solvent and/or solubilizer assists in dissolving the antimicrobial agent and reduces the affinity of the antimicrobial agent to enter the surfactant micelles. Therefore, regardless of the type of surfactant, a saturation of at least 25% of the antimicrobial agent in the aqueous phase can be achieved. 1. Antibacterial Agent The antibacterial agent content and type present in the specific examples of the present invention are as discussed in the above A.1. In addition, in order to achieve the target bacterial killing effect in a short contact time, such as 15 to 6 seconds, the continuous aqueous phase of the composition contains an antimicrobial dose when measured at room temperature. The saturated concentration of water is at least about 25%, and preferably at least about 50%, and more preferably at least about 75%. In order to achieve all the advantages of the present invention, the long-term performance of the aqueous phase is about 1% of the antibacterial agent. -26- This paper scale applies the Chinese National Standard (CNS) A4 specification (210 X 297 public) ---- ------------Installation (please read the note on the back first H write this page) I tmme ^1· I ϋ a- ·! em- _ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1284020 A7 V. INSTRUCTIONS (24 The Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, Printed Saturated. 2. Surfactant In this particular example of the invention, the content of A 2am surfactant is the same as that of A 2 The same. 炊..., 七如田..., and because of the presence of smear and/or solubilizer, the type of surfactant is not as limited as in Α2. In particular, hydroxy solvents and/or solubilizers ( Its presence as defined below reduces the affinity of the antimicrobial agent to enter the surfactant micelles. Therefore, regardless of the type of surfactant, there is a sufficient amount of antimicrobial agent in the continuous aqueous phase. Effectively kill a wide variety of bacteria. In the specific examples of #solvent and solubilizer in t, various circles A surfactant, such as an oxylated nonionic surfactant, has a high affinity for the antimicrobial agent, so that the antimicrobial agent cannot be obtained by rapid bacterial reduction. The shot is an anionic surfactant, a cationic surfactant, a nonionic surfactant, and a compatible mixture of interfacial active agents. The surfactant may also be an amphoteric surfactant, which may be based on the pH of the composition. And having anionic or cationic properties. Accordingly, the antimicrobial compositions may contain anionic, surfactants as disclosed in VIII.2 above, and more generally may comprise any anionic interface: a hydrophobic agent having a hydrophobic Part, such as a carbon chain comprising from about 8 to about 30 carbon atoms, and especially from about 12 to about 20 carbon atoms, and further having a hydrophilic moiety, such as sulfates, sulfonates, carbonates, Phosphate, or a carboxylate. Typically, the hydrophobic carbon chain is etherified, such as with ethylene oxide or glycidene, to produce specific physical properties, such as increased water solubility. Zhang scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) (Please read the notes on the back page » Write this page: Packing. 丨 line) 1284020 A7 B7 V. Description of invention () Solution or reduction for The surface tension of the anionic surfactant. Accordingly, suitable anionic surfactants include, but are not limited to, compounds of the following type: alkyl sulfates, alkyl ether sulfates, alkyl ether sulfonates, alkanes Sulphate of phenoxy polyoxyethylene ethanol, α-olefin sulfonate, ^-alkoxy alkane sulfonate, alkylaryl sulfonate, alkyl monoglyceride sulfate, alkyl ether carboxylate , fatty acid, sulfosuccinate, sarcosinate, oxtoxynol or nonoxynol phosphate, crotonate, fatty bovine decylamine, fatty acid guanamine, oxyethylene sulfonate, isethionate, or mixtures thereof. Other anionic surfactants are listed in McCutcheon's Emulsifiers and Detergents, 1993 Annuals, (hereinafter referred to as McCutcheon's), McCutcheon Division, MC Publishing Co., Glen Rock, NJ, pp. 263-266, incorporated herein by reference. . A variety of other anionic surfactants, as well as anionic surfactants, are disclosed in U.S. Patent No. 3,929,678 to Laughlin et al., which is incorporated herein by reference. Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff and Consumer Cooperatives -----;---------- Packing - (Please read the note on the back first, write this page) Line, these antibacterial compositions can also be Contains a nonionic surfactant. Generally, the nonionic surfactant has a hydrophobic group, such as a long chain alkyl or alkylated aryl group, and a hydrophilic chain comprising a sufficient number (i.e., from 1 to about 30) of ethoxy groups. And / or propoxy. Examples of nonionic surfactants include ethoxylated alkyl phenols, ethoxylated and propoxylated fatty alcohols, polyethylene glycol ethers of methyl glucose, polyethylene glycol ethers of mannitol, Ethylene oxide-propylene oxide block copolymer, ethoxylated ester of fatty (C8_C18) acid, condensation product of ethylene oxide with long chain amine or decylamine, and mixtures thereof. Examples of nonionic surfactants include, but are not limited to, methyl glucose ether-10, PEG-20 methyl glucose distearate, PEG-20 methyl glucose -28 - the paper scale applies to Chinese national standards ( CNS)A4 specification (210 X 297 mm) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1284020 A7 B7 V. Invention description (26) Semi-hard fat salt, Cl 1_15 key pit acid -20, 10 7T pit base Bond-8, hexadecyl ether-12, dodoxynol-12, dodecyl ether-15, PEG-20 castor oil, polysorbate 20, octadecyl ether-20, polyoxyethylene oxime - 10 hexyl decyl ether, polyoxyethylene-10 octadecyl ether, polyoxyethylene-20 hexadecyl ether, polyoxyethylene- ίο oil ether, polyoxyethylene-20 oleyl ether, ethoxylated cesium Phenol, ethoxylated octylphenol, ethoxylated dodecyl phenol, or ethoxylated fat (C6-C22) alcohol, including 3 to 20 ethylene oxide moieties, polyoxyethylene oxime - 20 isohexadecyl ether, polyoxyethylene-23 glyceryl dodecanoate, polyoxyethylene-20 glyceryl stearate, PPG-10 methyl glucose ether, PPG-20 methyl glucose ether, polyoxyethylene -20 dehydrated sorbose Alcohol monoester, polyoxyethylene-80 castor oil, polyoxyethylene-15 tridecyl ether, polyoxyethylene-6 tridecyl ether, dodecyl ether-2, dodecyl ether-3, Dodecyl ether-4, PEG-3 castor oil, PEG600 dioleate, PEG400 dioleate, and mixtures thereof. Many other nonionic surfactants are disclosed in McCutcheon's Emulsifiers and Detergents, 1993 Annuals, published by McCutcheon Division, MC Publishing Co., Glen Rock, NJ, pp. 1-246 and 266-272; CTFA International Cosmetic Ingredient Dictionary, Fourth Ed., Cosmetic, Toiletry and Fragrance Association, Inc., Washington, DC (1988) (hereinafter referred to as CTFA Dictionary), p. 1-651; and CTFA Handbook, p. 86-94; This article serves as a reference. In addition to anionic and nonionic surfactants, cationic and amphoteric surfactants can also be used in such antimicrobial compositions. Cationic surfactants include amine oxides, for example. Amphoteric surfactants can be widely described as derivatives of secondary and tertiary amines, -29- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) il--T------ ---- Installed - (Please read the note on the back first, Amjc write this page) . • f 1284020 A7 B7 V. Inventive Note (27) It has a linear or branched aliphatic group, and these One of the aliphatic substituents contains from about 8 to 18 carbon atoms, and at least one of the aliphatic substituents contains an anionic water-soluble group such as a carboxyl group, a sulfonate, or a sulfate. Examples of the compounds recited herein include sodium 3-(dodecylamino)propionate, sodium 3-(dodecylamino)-propane-1-sulfonate, and 2-(dodecylamino). Ethyl sulphate, sodium 2-(dimethylamino)ethyl sulfate, sodium 3-(N-carboxymethyl-dodecylamino)-propane-1 -sulfonate, octadecyl Disodium amide diacetate, 1 · renetropic methyl-2_ eleven burning base. Sodium 'and N,N-bis(2-3⁄4ylethyl)-2-sulphate-3-dodecyloxypropylamine sodium. More specifically, a type of amphoteric surfactant comprising sarcosinate and taurate has a structural formula 0

IIII

Ri-C-N-(CH2)n.YRi-C-N-(CH2)n.Y

I R2 其中Ri係Cu至C21烷基,R2係氫或CrC2烷基,Y係C02M或 SO3M,Μ係驗金屬,且η係數字1至3。 另一類型之兩性界面活性劑具有結構式 0 S03-Na+I R2 wherein Ri is Cu to C21 alkyl, R2 is hydrogen or CrC2 alkyl, Y is CO 2 M or SO 3 M, lanthanide is metal, and η is a number 1 to 3. Another type of amphoteric surfactant has the structural formula 0 S03-Na+

II III I

Ri-NHCCH2-CH-C02-Na+ 亦可使用下列類型之兩性界面活性劑: -30- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項ml寫本頁) -1 ---【----一—訂---J-----線- 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 五、發明說明( 28Ri-NHCCH2-CH-C02-Na+ can also be used with the following types of amphoteric surfactants: -30- This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) (please read the notes on the back first) Ml write this page) -1 ---[----一-订---J-----线- Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1284020 A7 B7 V. Invention description ( 28

〇II CH2C〇2_Na+〇II CH2C〇2_Na+

R1CNHCH2CH2NR1CNHCH2CH2N

CH2CH2OH 烷基兩性甘胺酸鹽 Ο CH2C02-Na+ R1CNHCH2CH2NCH2C02H ch2ch2oh 烷基兩性羧基甘胺酸鹽 〇 CH2CH2C02-Na+CH2CH2OH alkyl amphoteric glycinate Ο CH2C02-Na+ R1CNHCH2CH2NCH2C02H ch2ch2oh alkyl amphoteric carboxylglycine 〇 CH2CH2C02-Na+

RiCNHCH2CH2N I ch2ch2oh 烷基兩性丙酸鹽 CH2CH2C02_Na+ Η (請先閱讀背面之注意事 裝—— 寫本頁) ·RiCNHCH2CH2N I ch2ch2oh Alkyl amphopropionate CH2CH2C02_Na+ Η (Please read the note on the back first - write this page)

經濟部智慧財產局員工消費合作社印製 ricnhch2ch2nch2co2 CH2CH2OH 烷基兩性羧基丙酸鹽 -31 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) 1284020 A7 經濟部智慧財產局員工消費合作社印製 ____B7_;_ 99 五、發明說明() OHI O CH2CHCH2S03-Na+ II I ricnhch2ch2n ch2ch2oh 燒基兩性丙基橫酸鹽 o ch3 II I R1CNH(CH2)3N+-CH2C02- ch3 烷醯胺基丙基三甲銨乙内酯 〇 ch3 ohII I I R1CNH(CH2)3N+-CH2CHCH2S03- ch3 烷醯胺基丙基羥基磺酸三甲銨内酯(sultaine) 〇II RiNHCH2CH2C-0_Na+ 烷胺基丙酸鹽 (請先閱讀背面之注意事項ml寫本頁) 裝 ·. .Ί線· -32- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 ___B7___L___ 五、發明說明(3G) ch2ch2co2-Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed ricnhch2ch2nch2co2 CH2CH2OH alkyl amphocarboxypropionate-31 - This paper scale applies to China National Standard (CNS) A4 specification (210 297 297 mm) 1284020 A7 Ministry of Economic Affairs Intellectual Property Bureau staff consumption Co-operative printing ____B7_;_ 99 V. Invention description () OHI O CH2CHCH2S03-Na+ II I ricnhch2ch2n ch2ch2oh succinyl propyl sulphate o ch3 II I R1CNH(CH2)3N+-CH2C02- ch3 alkanoylpropyl Methylammonium lactone 〇ch3 ohII II R1CNH(CH2)3N+-CH2CHCH2S03-ch3 alkalamine propyl hydroxysulfonate sultaine 〇II RiNHCH2CH2C-0_Na+ alkylaminopropionate (please read the back first) Precautions ml write this page) Loading ·. .Ί线· -32- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 ___B7___L___ V. Invention description (3G) ch2ch2co2-

I ----Γ----------裝--- (請先閱讀背面之注意事項寫本頁)I ----Γ----------装--- (Please read the note on the back first to write this page)

RNHRNH

I ch2ch2co2h 烷基亞胺基丙酸鹽。 其他類型之兩性界面活性劑包括磷酸三甲铵内酯及亞填酸 三甲铵内醋(phosphitaines)。 經濟部智慧財產局員工消費合作社印製 可用於本發明兩性界面活性劑之具體非限制性實例包括 N -甲基牛磺酸椰子鈉、N -甲基牛磺酸油基鈉、N -甲基牛 磺酸高油酸鈉、N -甲基牛磺酸棕橺醯基鈉、可可二甲基羧 甲基三甲銨内酯、十二烷基二甲基羧乙基三甲銨内酯、十 六烷基二甲基羧甲基三甲銨内酯、十二烷基-雙- (2 -羥乙基) 羧甲基三甲銨内酯、油基二甲基-T -羧丙基三甲銨内酯、 十二烷基-雙- (2 -羥丙基)-羧乙基三甲銨内酯、可可醯胺基 二甲基丙基磺酸三甲銨内酯、十八烷基醯胺基二甲基丙基 磺酸三甲銨内酯、十二烷基醯胺基-雙·( 2 -羥乙基)丙基磺 酸三甲銨内酯、油醯胺PEG-2磺基琥珀酸二鈉、TEA油醯胺基 PEG-2磺基琥珀酸、油醯胺MEA磺基琥珀酸二鈉、油醯胺 MIPA磺基琥珀酸二鈉、萬麻醯胺MEA磺基琥珀酸二鈉、十 一烷醯胺MEA磺基琥珀酸二鈉、麥芽醯胺基MEA橫基琥珀酸 二鈉、異硬脂醯胺MEA磺基琥珀酸二鈉、可可兩性甘胺酸 鹽、可可兩性羧基甘胺酸鹽、十二烷基兩性甘胺酸鹽、十 二烷基兩性羧基甘胺酸鹽、辛基兩性羧基甘胺酸鹽、可可 兩性丙酸鹽、可可兩性羧基丙酸鹽、十二烷基兩性羧基丙 -33- _____ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) 1284020 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(31) 酸鹽、辛基兩性瘦基丙酸鹽、二經基乙基牛脂甘胺酸鹽、 3 -羥丙基磷酸三甲銨内酯可可醯胺基二鈉、3_羥丙基磷酸 二甲备*内酉旨十一坑基十四規基酿胺基二納、甘胺g盛基麟故 三甲銨内酯十二烷基十四烷基醯胺基二鈉、3 -羥丙基磷酸 三甲按内酯十二燒基十四燒基醯胺基瘦基二鈉、亞磷酸三 甲銨内酯可可醯胺基丙基單鈉、亞磷酸三甲銨内酯十二烷 基十四烷基醯胺基丙基單鈉、及其混合物。 3 . 載體 此具體貫例中之載體包含水。 4. 選擇性成分 於上文Α·4所論及之選擇性成分亦可以相同之量及相同 之目的,用於本發明之此一具體實例中。 5 · 輕溶劑及增溶劑 本發明之此一具體實例包含〇%至約25%重量比之羥溶 劑,以及0%至約30%重量比之增溶劑,其中該抗菌組合物 含有羥溶劑及增溶劑中之至少一者。較佳之具體實例同時 含有經溶劑及增溶劑兩者。 較佳之具體實例含有約2%至約20%重量比之羥溶劑,及 /或約2%至約25%重量比之增溶劑。最佳之具體實例含有 約5%至約15%重量比之羥溶劑,及/或約5%至約20%重量 比之增溶劑。 如本文所定義者’ 1¾彙「經溶劑」係一種水可溶性之有 機化合物,其含有1至6個,且一般係1至3個羥基。詞彙 「羥溶劑」因此涵括水可溶性之醇、二醇、三醇、及多元 -34- (請先閱讀背面之注意事寫本頁) 裝 · ·!線· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 32 五、發明說明( 醇。羥溶劑之具體實例包括,但不限於,甲醇、乙醇、異 丙醇、正-丁醇、正-丙醇、乙二醇、丙二醇、甘油、二乙 二醇、二丙二醇、三丙二醇、己二醇、丁二醇、1,2,6 -己 三醇、甘露糖醇、pEG_4、及類似之含羥基化合物。 增溶劑係一種化合物,其具有增進其他化合物水可溶性 之能力。本發明所用之增溶劑缺乏界面活性劑特性,且一 般係短鏈烷芳基磺酸鹽。增溶劑之具體實例包括,但不限 於’異丙基苯磺酸鈉、異丙基苯磺酸銨、二甲苯磺酸銨、 甲苯橫酸鉀、甲苯磺酸鈉、二曱苯磺酸鉀、甲苯磺酸、及 二甲苯續酸。其他可用之增溶劑包括聚莕磺酸鈉、聚苯乙 晞% fee納、甲基菩橫酸鈉、及琥珀酸二鈉。 C. 免直劑、以及蕤溶劑及/或增浚劑之抗茼紐厶 物 在又另一具體實例中,該抗菌組合物含有活性抗菌劑、 以及羥溶劑及/或增溶劑。具體實例c之組合物具有迅速 ^細菌滅殺作用,且亦在本質上不限制組合物中界面活性 劑《種類。1¾溶劑及//或增溶劑可協助溶解該抗菌劑。因 此,即使在無界面活性劑存在之情形下,亦可達成連續水 相中抗菌劑至少25%之飽和度。 1 . 抗菌劍 在此本發明具體實例中所存在、 τ尸/Γ仔在 < 抗囷劑含量及種類係如 上文A . 1所論。 似具體實例B,為在短暫之接觸時間,諸如,15 至60秒中’達成目標之細菌滅殺作用,當在室溫下測量 本紙張尺度適用中國國¥標準— i;----------裝 i — (請先閱讀背面之注意事寫本頁) $ · 經濟部智慧財產局員工消費合作社印製 -35- 1284020 Α7I ch2ch2co2h alkyliminopropionate. Other types of amphoteric surfactants include trimethylammonium lactone and phosphinines. Specific non-limiting examples of the amphoteric surfactants that can be used in the present invention include the N-methyl taurine coconut sodium, the N-methyl taurine oil sodium, the N-methyl group. Taurine sodium oleate, sodium N-methyltaurate, sodium cocodimethyl carboxymethyltrimethylammonium lactone, lauryl dimethyl carboxyethyl trimethyl ammonium lactone, sixteen Alkyldimethylcarboxymethyltrimethylammonium lactone, dodecyl-bis-(2-hydroxyethyl)carboxymethyltrimethylammonium lactone, oleyl dimethyl-T-carboxypropyltrimethylammonium lactone , dodecyl-bis-(2-hydroxypropyl)-carboxyethyltrimethylammonium lactone, cocoguanamine dimethyl propyl sulfonic acid trimethylammonium lactone, octadecyl decyl dimethyl dimethyl Trimethylammonium propyl sulfonate, trimethylammonium lactadide-bis(2-hydroxyethyl)propyl sulfonate, disodium oleic acid PEG-2 sulfosuccinate, TEA oil Amidoxime PEG-2 sulfosuccinic acid, oily amine MEA sulfosuccinate disodium, oily amine MIPA sulfosuccinate disodium, valeramine MEA sulfosuccinate disodium, undecyl decylamine MEA sulfosuccinate disodium, malt Amino-based MEA succinic acid disodium succinate, isostearyl guanamine MEA sulfosuccinate disodium, cocoa amphoteric glycinate, cocoa amphoteric carboxylate, dodecyl ampholactic acid, twelve Alkyl amphocarboxyglycinate, octyl amphocarboxyglycolate, cocoa amphoteric propionate, cocoa amphocarboxypropionate, dodecyl amphocarboxyl-33- _____ This paper scale applies to Chinese national standards ( CNS)A4 specification (210 X 297 public) 1284020 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 5, invention description (31) acid salt, octyl amphoteric acid propionate, di-vinyl ethyl tallow Amine, 3-hydroxypropylphosphoric acid trimethylammonium lactone cocoaguanamine disodium, 3-hydroxypropyl phosphate dimethyl methoxide * 酉 十一 11 11 11 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 g Shengjilin, such as trimethylammonium lactone, dodecyltetradecylguanidinium disodium, 3-hydroxypropylphosphoric acid, trimethyl lactone, dodecyl group, tetradecyl amide, guanylamine, bisphosphonate, trimethyl phosphite Ammonium lactone cocoamidopropyl monosodium, trimethylammonium phosphite lauryl dodecyl decyl guanidinopropyl And mixtures thereof. 3. Carrier The carrier in this specific example contains water. 4. Selective Ingredients The optional ingredients discussed in the above paragraph 4 may also be used in this particular embodiment of the invention for the same amount and for the same purpose. 5 · Light Solvent and Solubilizer One embodiment of the present invention comprises from about 5% to about 25% by weight of a hydroxy solvent, and from 0% to about 30% by weight of a solubilizing agent, wherein the antimicrobial composition contains a hydroxy solvent and increases At least one of the solvents. Preferred embodiments include both a solvent and a solubilizer. Preferred embodiments contain from about 2% to about 20% by weight of the hydroxy solvent, and/or from about 2% to about 25% by weight of the solubilizer. The most preferred embodiment contains from about 5% to about 15% by weight of the hydroxy solvent, and/or from about 5% to about 20% by weight of the solubilizer. A "solvent" as defined herein is a water-soluble organic compound containing from 1 to 6, and typically from 1 to 3 hydroxyl groups. The vocabulary "hydroxyl solvent" thus includes water-soluble alcohols, glycols, triols, and poly-34- (please read the note on the back of this page). ··! Line · This paper scale applies to Chinese national standards ( CNS) A4 size (210 X 297 mm) 1284020 A7 B7 32 V. Description of the invention (Alcohol. Specific examples of hydroxy solvents include, but are not limited to, methanol, ethanol, isopropanol, n-butanol, n-propanol , ethylene glycol, propylene glycol, glycerin, diethylene glycol, dipropylene glycol, tripropylene glycol, hexanediol, butanediol, 1,2,6-hexanetriol, mannitol, pEG_4, and the like A solubilizer is a compound which has the ability to enhance the water solubility of other compounds. The solubilizer used in the present invention lacks surfactant properties and is generally a short-chain alkaryl sulfonate. Specific examples of solubilizer include, but not Limited to 'sodium cumene sulfonate, ammonium cumene sulfonate, ammonium xylene sulfonate, potassium traversate, sodium toluene sulfonate, potassium diphenyl sulfonate, toluene sulfonic acid, and xylene Other available solubilizers include sodium polysulfonate, poly Phenylacetate%, sodium methyl sulphate, and disodium succinate. C. Straightening agent, and antimony and/or anti-caries agent. In yet another embodiment, The antibacterial composition contains an active antibacterial agent, and a hydroxy solvent and/or a solubilizing agent. The composition of the specific example c has a rapid bacterial killing effect, and also does not substantially limit the surfactant in the composition. // or a solubilizing agent can assist in dissolving the antibacterial agent. Therefore, even in the absence of a surfactant, a saturation of at least 25% of the antibacterial agent in the continuous aqueous phase can be achieved. The presence of τ 尸 / Γ 在 & & & & & & & & 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷 囷Bactericidal killing effect, when measuring the paper scale at room temperature, applicable to China's national standard - i;---------- loaded i - (please read the note on the back first to write this page) $ · Economy Ministry of Intellectual Property Bureau employee consumption cooperative printing -35-1284020 Α7

五、發明說明(33 ) 攻、、且6物之連續水相含有之抗菌劑量係該抗菌劑在水 中飽和濃度之至少約25%,且較佳至少約娜,且更較佳至 y約75% »為達成本發明之全部優點,該連續水相係為該 抗菌劑約95%至1〇〇%飽和。 2 · 界面活性劍 界面活性劑在此具體實例中係一種選擇性成分。然而, f存在時’在此本發明具體實例中所存在之界面活性劑含 置係0% 土約1〇〇/。重量t匕,較佳係〇%至約5%重量比。為達成 f發月之王部優點,該界面活性劑係以〇〇/〇至約重量比之 量存在由於每/谷劑及/或增溶劑之存在,此具體實例中 界面活丨生剑之種類係與B · 2中揭示之界面活性劑相同。 3 · _載體— 此具體實例中之載體包含水。 4. 、\上文A · 4所淪及之選擇性成分亦可以相同之量及相同 之目的’用於本發明之此一具體實例中。 5 · 及增溶劑 ;文B · $所娜及之技溶劑及增溶劑亦可以相同之目的用 2 t發Μ <此_具體實例中。然而’此_具體實例中經溶 =及/或增溶劑之含量可較上文β·5所揭示者高,因額外 田、羧/谷別及/或增溶劑可能是在無界面活性劑存在之情 形下欲穩定該抗菌劑所必需者。 因此,在具體實例C中,該組合物可包含〇%至約6〇%重量 比又羥溶劑,以及〇%至約4〇%重量比之增溶劑。然而,該 _ -36- 二張尺 規格(21。χ 297 ~---- --------------裝--- (請先閱讀背面之注意事寫本頁) 訂- 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 34 五、發明說明( 組合物含有羥溶劑及增溶劑中之至少一者。較佳之具體實 例含有約2°/。至約20%重量比之羥溶劑,及/或約2%至約 25%重量比之增溶赞’]。鬲度較佳之具體實例含有約5%至約 15/〇重量比之無泛劑’及/或約5%至約2〇%重量比之增溶 劑。最佳之具體實例同時含有羥溶劑及增溶劑兩者。 D . 盒-有抗菌劑、消兔^二凝膠劑之抗菌組合物 在另一具體貫例中,該抗菌組合物含有活性抗菌劑、消 毒醇、及凝膠劑。具體實例D之組合物具有迅速之細菌減 殺作用。具體實例D之組合物係絕佳之手部消毒劑。 1 · 抗菌劍 在此本發明具體實例中所存在之抗菌劑種類係如上、 Α· 1所論。在此具體實例中,該抗菌劑係以約〇〇5〇/。至2 5%,且較佳約0.1%至約4%組合物重量比之量存在。^、约 本發明之全部優點,該抗菌劑係以約〇25〇/。至約2%組二達成 量比之量存在。 物重 2. 載體 本組合物之載體包含水。 3 . 消毒醇 本發明之之抗菌組合物含有約1%至約4〇0/。重量比之一 醇。較佳之具體實例含有約2%至約%%重量 ’肖毒 i比 < 消毒醇 最佳之具體實例含有約5%至約3〇%重量比之消毒醇。 ° 如本文所定義,詞彙「消毒醇」係一種水可溶性之合 其含有1至6個碳原子。消毒醇包括,但不限 前上醇, a ,甲醇、 醇、丙醇、及異丙醇。 己 -37· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事 寫本頁} 經濟部智慧財產局員工消費合作社印製 351284020 Α7 Β7 五、發明說明( 4. 凝膠劑 本發明之之抗菌組合物含有約0 〇1%至約5〇/〇重量比, -£L較 佳約0.10%至約3%重量比之凝膠劑。為達成本發明之全部優 點’該等抗菌組合物含有約〇 25%至約2.5%重量比 > 〜咖 劑。該等抗菌組合物一般含有足夠量之凝膠劑,以使組人 物成為黏稠液體、凝膠、或半固體,其可輕易施用並搓揉 至皮膚上。熟習技藝者明暸應納入組合物中之凝膠劑類刑 及含量,以提供目標之組合物黏度或稠度。 土 在此處及後文中,詞彙「凝膠劑」係指可增進以水為基 礎之組合物之黏度之化合物,或可將以水為基礎之組合物 轉化為凝膠之化合物。因此,凝膠劑可為有機性質者,例 如,天然膠或合成聚合物,或可為無機性質者。 如前所述,本發明之組合物不含界面活性劑。界面活性 5^1並不 足為要加入本發明之抗菌組合物中,但可以ογ二 約0·5%重量比之量存在,因界面活性劑可能存在於市售形 式之凝膠劑中,以協助使該凝膠劑分散於水中。界面活性 劑亦可以添加物或其他組合物成分副產物之形式存在。 界面活性劑係自本組合物中略去,以協助避免微勝粒之 形成’微膠粒會溶解活性抗菌化合物並減低其功效。同 樣,較佳之凝膠劑係特別不會形成微膠粒者,且不與該活 性抗菌劑複合或結合者,或不以其他方式逆向影響該抗菌 货1J之抗菌特性者。不論該凝膠劑之種類為何,凝膠劑及其 他組合物成分之含量係經選擇,以在室溫下測量時,使抗 菌劑係以至少25%飽和度之含量存在。 -38- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----r----------裝--- ί請先閱讀背面之注意事寫本頁) I. 經濟部智慧財產局員工消費合作社印製 1284020 A75. Description of the Invention (33) The antibacterial dose of the continuous aqueous phase of the attack, and the six substances is at least about 25% of the saturated concentration of the antibacterial agent in water, and preferably at least about Na, and more preferably about y is about 75. % » To achieve the full advantage of the present invention, the continuous aqueous phase is about 95% to 1% saturated with the antimicrobial agent. 2 · Interface Active Sword The surfactant is an optional component in this specific example. However, when f is present, the surfactant present in the specific examples of the invention herein is about 0% soil. The weight t匕 is preferably from 〇% to about 5% by weight. In order to achieve the advantages of the king of the month, the surfactant is present in an amount of 〇〇/〇 to about by weight due to the presence of each/valley and/or solubilizing agent. The type is the same as the surfactant disclosed in B. 2. 3 · _ carrier - The carrier in this specific example contains water. 4. The optional components of the above-mentioned A · 4 may also be used in the same embodiment of the invention for the same amount and the same purpose. 5 · and solubilizer; text B · $ 娜 到 and the technical solvent and solubilizer can also be used for the same purpose 2 t Μ < this _ specific examples. However, the content of the dissolved and/or solubilizing agent in the specific example may be higher than that disclosed in the above-mentioned β·5, since the additional field, the carboxyl group/valley and/or the solubilizing agent may be present in the absence of the surfactant. In the case where it is necessary to stabilize the antibacterial agent. Thus, in a specific example C, the composition may comprise from about 5% to about 6% by weight of a hydroxy solvent, and from about 〇% to about 4% by weight of a solubilizer. However, the _-36- two-foot size specification (21. χ 297 ~----------------- installed--- (please read the note on the back first to write this page ) - Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 1284020 A7 B7 34 V. Description of the Invention (The composition contains at least one of a hydroxyl solvent and a solubilizer. Preferred embodiments include about 2 ° / to about 20% The weight ratio of the hydroxy solvent, and/or the solubilization of about 2% to about 25% by weight. The preferred embodiment of the oxime contains from about 5% to about 15% by weight of the non-ubiquitent agent' and/or a solubilizing agent in a weight ratio of from about 5% to about 2% by weight. The most preferred embodiment contains both a hydroxy solvent and a solubilizing agent. D. Box - an antibacterial composition having an antibacterial agent, a rabbit and a second gelling agent in another In a specific example, the antibacterial composition contains an active antibacterial agent, a disinfecting alcohol, and a gelling agent. The composition of the specific example D has a rapid bacterial killing effect. The composition of the specific example D is an excellent hand disinfectant. 1 · Antibacterial Sword The type of antibacterial agent present in the specific examples of the present invention is as described above, in the case of Α·1. In this specific example, the antibacterial agent is about 〇〇5〇/. to 25%, and preferably from about 0.1% to about 4% by weight of the composition. ^, about the full advantage of the present invention, the antimicrobial agent is about 25 〇 /. Approximately 2% of the two ingredients are present in an amount. Weight 2. Carrier The carrier of the present composition comprises water. 3. Disinfecting alcohol The antibacterial composition of the present invention contains from about 1% to about 4% by weight. Preferably, the specific example contains from about 2% to about % by weight of the weight of the mixture. The preferred embodiment of the disinfecting alcohol contains from about 5% to about 3% by weight of the disinfecting alcohol. The term "disinfecting alcohol" is a water-soluble mixture containing from 1 to 6 carbon atoms. The disinfecting alcohol includes, but is not limited to, pre-alcohol, a, methanol, alcohol, propanol, and isopropanol. This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) (please read the note on the back to write this page) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 351284020 Α7 Β7 V. Invention Description (4 Gels The antimicrobial compositions of the present invention comprise from about 0% to about 1% by weight, preferably from about 0.10%. A gelling agent of about 3% by weight. To achieve all of the advantages of the present invention, the antimicrobial compositions comprise from about 25% to about 2.5% by weight of a coffee agent. The antimicrobial compositions generally contain a sufficient amount. a gelling agent to make a group of people a viscous liquid, gel, or semi-solid that can be easily applied and applied to the skin. Those skilled in the art will recognize the gelation and levels of gels that should be included in the composition to provide The viscosity or consistency of the target composition. Here and in the following, the term "gel" refers to a compound that enhances the viscosity of a water-based composition, or can convert a water-based composition into a compound of the gel. Thus, the gelling agent can be of an organic nature, such as a natural gum or a synthetic polymer, or can be inorganic in nature. As stated previously, the compositions of the present invention are free of surfactants. The interface activity of 5 ^ 1 is not sufficient to be added to the antibacterial composition of the present invention, but may be present in an amount of about 5% by weight of the gamma, since the surfactant may be present in a commercially available form of the gel, Helps disperse the gel in water. The surfactant may also be present in the form of additives or by-products of other composition ingredients. The surfactant is omitted from the present composition to help avoid the formation of micro-particles. The micelles dissolve the active antimicrobial compound and reduce its efficacy. Also, a preferred gelling agent is particularly one which does not form a micelle, and which does not compound or combine with the active antimicrobial agent, or which does not adversely affect the antibacterial properties of the antimicrobial product 1J. Regardless of the type of gelling agent, the amount of gelling agent and other component ingredients is selected such that the antimicrobial agent is present at a level of at least 25% saturation when measured at room temperature. -38- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----r----------Install--- 请Please read the note on the back first This page) I. Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1284020 A7

下列凝膠劑之非限制性實例可用於本發明中 之,下列之化合物,包括有機及盔 " .,、、, 機及…、機者,皆主要藉使該细 e物 < 水性部分增稠或凝集而作用: 阿拉伯膠、丙烯酸鹽/十二烷基醚_2〇異二 物、瓊脂、藻酸銨、藻酸、丙烯酸銨共聚物 化銨、硫酸銨、支鏈澱粉、attapulgite、膨潤土 酸鈣、藻酸鈣、角叉菜膠鈣、氣化鈣、辛醇 劑910、聚羧乙烯製劑934、聚羧乙烯製劑934pNon-limiting examples of the following gels can be used in the present invention, and the following compounds, including organic and helmets, and the like, mainly rely on the fine substance <aqueous part Thickening or agglutination: Acacia, acrylate/dodecyl ether 2 bismuth, agar, ammonium alginate, alginic acid, ammonium acrylate ammonium, ammonium sulfate, amylopectin, attapulgite, bentonite Calcium acid, calcium alginate, calcium carrageenan, calcium carbonate, octanol 910, carboxyvinyl preparation 934, carboxyvinyl preparation 934p

劑_、聚羧乙埽製劑94卜羧甲基羥乙基纖維素::口 丙基瓜耳膠、角叉菜膠、纖維素、纖維素膠、⑽邮醇’ 鯨蠟醇、玉米澱粉、達瑪樹脂、糊精、二亞芊基甘露 醇、伸乙基二氫化牛脂醯胺、伸乙基二油醯胺、伸乙基 硬脂醯胺、明膠、瓜耳膠、瓜耳膠羥丙基氯化―咖、 輝石、透明質酸、水合矽石、羥丁基甲基纖維素、羥乙 ’”滅’准素 &乙基乙基纖維素、輕乙基硬脂醯胺-mipa、輕I 經濟部智慧財產局員工消費合作社印製 烯酸鹽共5 蕩酸铵、I C9-15 醇、香' 聚羧乙烯禽 聚羧乙烯_, carboxy acetamidine formulation 94 carboxymethyl hydroxyethyl cellulose:: mouth guar guar, carrageenan, cellulose, cellulose gum, (10) ketol cetyl alcohol, corn starch, Dama resin, dextrin, dimercapto mannitol, ethyl dihydrogenated tallowamine, ethyl dioleamide, ethyl stearylamine, gelatin, guar gum, guar hydroxypropyl Chlorinated - gamma, pyroxene, hyaluronic acid, hydrated vermiculite, hydroxybutyl methylcellulose, hydroxyethyl '" 灭' primed & ethyl ethyl cellulose, light ethyl stearylamine - mipa, light I Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperatives Printed olefinic acid 5 ammonium sulphate, I C9-15 alcohol, fragrant 'Polycarboxylated poultry carboxy

基纖維素、羥丙基瓜耳膠、羥丙基甲基纖維素、異鯨4 醇、異硬脂醇、刺梧桐樹膠、海草灰、肉桂醇、刺槐」 膠、矽酸鋁鎂、矽酸鎂、三矽酸鎂、甲氧基pEG_2〇/十二大 基乙二醇共聚物、甲基纖維素、微晶纖維素、蒙脫土、戸 旦蔻醇、燕麥粉、油醇、棕櫚仁油、果膠、PEG-2M、PEC 5M、聚丙烯酸、聚乙烯醇、藻酸鉀、聚丙烯酸鋁鉀、角又 菜膠卸、氯化鉀、硫酸鉀、馬铃薯澱粉、丙二醇藻酸鹽、 丙缔酸納/乙烯醇共聚物、羧甲基葡聚糖鈉、角叉菜膠 納、纖維素硫酸鈉、氯化鈉、聚甲基丙烯酸鈉、矽鋁酸 -39- 本紙張尺度適用中國國豕標準(CNS)A4規格⑵◦ χ撕公爱) 1284020 A7 B7 五、發明說明( 鈉、硫酸鈉、硬脂鏘膨潤土、硬脂鏘水輝石、硬脂醇、牛 脂醇' TEA·鹽酸化物、黃蓍膠、十三醇、三甲胺硬酸銘 鎂、小麥粉、小麥澱粉、黃原膠、及其混合物。 下列凝膠劑之其他非限制性實例係主要藉使該组合物之 非水性部分增稠而作用: 松香醇、丙晞油酸、山荼酸鋁、二硬脂酸鋁、異硬脂酸 /肉桂酸/標搁酸或硬脂酸鋁、異硬脂酸/肉豆惹酸銘、 異硬脂酸/棕櫚酸鋁、異硬脂酸/硬脂酸鋁、羊毛酸鋁、 肉豆蔻酸/棕搁酸鋁、硬脂酸鋁、硬脂酸鋁、三硬脂酸 鋁、蜂蠟、山荼醯胺、山茶醇、丁二烯/丙烯腈共聚物、X C29_70酸、山茶酸鈣、硬脂酸鈣、小燭樹蠟、巴西棕櫚蠟、 純地蠟、膽固醇、膽留婦基羥硬脂酸酯、椰子醇、沽巴樹 脂、二甘油基硬脂酸酯蘋果酸鹽、二經松香醇、二甲基十 二胺油酸酯、十二雙酸/ cetearyl醇/乙二醇共聚物、芥醯 胺、乙基纖維素、甘油基三乙醯基羥基硬脂酸酯、甘油基 三乙醯基蓖麻油酸酯、乙二醇二山荼酸酯、乙二醇二辛酸 醋、乙二醇二硬脂酸酯、己二醇二硬脂酸酯、氫化以七缔 烴聚合物、氫化蓖麻油、氫化棉籽油、氫化豬油、氫化緋 油、氫化棕搁仁油甘油酯、氫化棕櫚仁油、氫化棕搁油、 氩化聚異丁烯、氫化大豆油、氫化牛脂醯胺、氫化牛脂甘 油酯、氫化植物甘油酯、氫化植物甘油酯、氫化植物油、 經丙基纖維素、異丁烯/異戊二烯共聚物、異蠟基硬脂醯 基硬脂酸酯、日本蠟、蘆薈蠟、羊毛脂醇、月桂醯胺、甲 基脫氫松香酸酯、甲基氫化松脂酸酯、甲基松脂酸酯、甲 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -1-------------裝--- (請先閱讀背面之注意事寫本頁) LSJ· · 經濟部智慧財產局員工消費合作社印製 1284020 A7 χ^--—-^-—_ 五、發明說明(38 ) 基苯乙婦/乙埽基甲苯共聚物、微晶蠟、褐煤酸蠟、褐煤 蠟、肉豆蔻基二十醇、肉豆蔻基十八醇、十八烯/馬來酐 共聚物、辛基十二烷基硬脂醯基硬脂酸酯、油醯胺、油硬 脂、小冠巴西棕蠟、氧化聚乙烯、地蠟、棕搁仁醇、石 蠟、五赤蘚基氫化松脂酸酯、五赤蘚基松脂酸酯、五赤蘚 基四山茶酸酯、五赤蘚基四辛酸酯、五赤蘚基四油酸酯、 五赤蘚基四硬脂酸酯、鄰苯二甲酸酐/甘油/縮水甘油基 、 癸酸酯共聚物、鄰苯二甲酸//三苯六甲酸/乙二醇共聚 物、氷丁烯、聚丁烯對苯二酸酯、聚二戊烯、聚乙烯、聚 兴丁烯、聚異戊二烯、聚乙烯丁醛、聚乙婦肉桂酸酯、丙 二醇二辛酸酯、丙二醇二可可酸酯、丙二醇二異壬酸酯、 丙二醇二肉桂酸酯、丙二醇二壬酸酯、丙二醇二硬脂酸 酯、丙二醇二十一酸酯、pyp/十六碳缔共聚物、米糠蠟、 PVP/二十唆烯共聚物、硬脂鏘膨潤土、硬脂鑌水輝石、硬 醯胺、硬脂醯胺DEA-二硬脂酸酯、硬脂醯胺DIBA-硬脂酸 酯、硬脂醯胺MEA-硬脂酸酯、硬脂酮、硬脂醇、硬脂基芥 酿胺、硬脂基硬脂酸酯、硬脂基硬脂醯基硬脂酸酯、合成 蜂蠟、合成蠟、三羥基硬脂精、三異壬精、三異硬脂精、 二異壬精、三異硬脂精、三異硬脂基三亞油酸酯、三肉桂 精、三亞油酸、三亞油精、三肉豆蔻精、三油精、三棕櫚 精、二硬脂精、肉桂酸鋅、肉豆蔻酸鋅、新癸酸鋅、松脂 酸鋅、硬脂酸鋅、及其混合物。 5 · 選擇性成分 a .多經溶劑 •41 - 本紙張尺度適用^國國家標準(CNS)A4規格(210 X 297公爱) ---- ---------------裝--- (請先閱讀背面之注意事寫本頁) 訂. 經濟部智慧財產局員工消費合作社印製 391284020 A7 經濟部智慧財產局員工消費合作社印製 五、發明說明( 多無溶劑’如存在時,係 货、、々αΐ/。至約50% ,且較佳約5% 至約遞組合物重量比之量存在。為達成本發明之全部優 點’该多㈣劑係以約腦至約篇組合物重量比之量存 在。不同於消毒醇,多輕溶劑對於本發明組合物之抗菌功 效僅有微量之貢獻,如其有貢獻時。 如本文所定義,詞彙「多羥溶劑」係-種水可溶性有機 化口物其s有2至6個,且一般係2至3個巍基。詞囊「水 可溶性」意謂該多經溶劑在坑下具有每獅克水至少〇」克 ^ 合片]之水,谷解度。多羥溶劑之水溶解度並無上限, 如,該多羥溶劑與水可在所有比例下皆為可溶。 凋彙夕羚落劑」因此涵括水可溶性二醇、三醇、及多 元醇。多羥溶劑之具體實例包括,但不限於,乙二醇、丙 一醇甘油、一乙二醇、二丙二醇、三丙二醇、己二醇、 丁一醇丨,2,6 -己二醇、甘露糖醇、peg-4、及類似之多岁莖 基化合物。 b .增溶劑 增备制’如存在時,係以約〇 1%至約3〇%,且較佳約〇 5% 至力25 /〇組&物重量比之量存在。為達成本發明之全部優 點’該多輕溶劑係以約1%至約2〇%組合物重量比之量存 在 ▲等増洛劑之種類係於上文B · 5中論述,且其以相同 之目的用於此一本發明之具體實例。 c.其他選擇性成分 於上文Α·4所論及之其他選擇性成分亦可以相同之量及 相同之目的,用於本發明之此一具體實例中。 42- 本紙張尺度適用中國國家標準(CNS)A4規格(心χ 297公爱) .—•IV----------裝--- (請先閱讀背面之注意事寫本頁) Η-Τ· 線. 1284020 A7 B7 五、發明說明( 可用於此具體實例之其他選擇性成分包括皮膚條理劑。 皮膚條理劑之實例包括軟化劑,諸如,絲壤基肉豆蔻酸 醋、甘油基二油酸酯、異丙基肉豆蔻酸酯、羊毛脂、甲基 肉桂酸醋、PPG-9肉桂酸酯、大豆硬脂基、辛基棕櫚酸酯、 及PPG-5羊毛酸醋’舉例而言。該皮膚條理劑亦可為溼潤 劑’例如’葡糖胺及吡哆素,舉例而言。亦可使用包含性 皮膚條理劑’例如’羊毛酸紹玉米油、methic〇n、椰子油、 硬脂基硬脂酸酯、苯基三methic〇n、三肉豆蔻精、橄欖油、 及合成壤。除外熟習技藝者所知之各種皮膚條理劑(單獨或 結合使用),亦可使用各類型皮膚條理劑之組合。各種皮膚 條理劑之非限制性之實例包括蘆薈、膽固醇、胱胺酸、角 蛋白、印磷脂、蛋黃、甘胺酸、PPCM2、視黃醇、水揚酸、 乳清酸、植物油、及可溶性動物膠原蛋白。皮膚條理劑可 單獨使用’或結合皮膚保護劑,諸如,凡士林、可可脂、 鋅膏、及高嶺土,舉例而言。亦可單獨使用皮膚保護劑。 皮膚條理劑及皮膚保護劑之其他實例可見於,,CTFA c〇smeticCellulose, hydroxypropyl guar, hydroxypropyl methylcellulose, whale 4 alcohol, isostearyl alcohol, karaya gum, seaweed ash, cinnamyl alcohol, hedgehog" gum, aluminum magnesium niobate, tannic acid Magnesium, magnesium tricaprate, methoxy pEG 2 〇 / dodecaethylene glycol copolymer, methyl cellulose, microcrystalline cellulose, montmorillonite, decyl sterol, oat flour, oleyl alcohol, palm kernel Oil, pectin, PEG-2M, PEC 5M, polyacrylic acid, polyvinyl alcohol, potassium alginate, aluminum polyaluminum silicate, keratin, potassium chloride, potassium sulfate, potato starch, propylene glycol alginate , sodium propionate/vinyl alcohol copolymer, sodium carboxymethyl dextran, carrageenan, sodium cellulose sulfate, sodium chloride, sodium polymethacrylate, yttrium aluminate-39- China National Standard (CNS) A4 Specification (2) χ χ 公 Public Love) 1284020 A7 B7 V. Description of Invention (Sodium, Sodium Sulfate, Stearic Acid Bentonite, Stearin, Hectorite, Stearyl Alcohol, Tallow Alcohol) TEA·HCl Compound, tragacanth, tridecyl alcohol, trimethylamine hard acid magnesium, wheat flour, wheat starch, xanthan gum, and mixtures thereof. Other non-limiting examples of agents function primarily by thickening the non-aqueous portion of the composition: rosin alcohol, propionate oleic acid, aluminum behenate, aluminum distearate, isostearic acid/cinnamic acid/ Standard acid or aluminum stearate, isostearic acid / myristic acid, isostearic acid / aluminum palmitate, isostearic acid / aluminum stearate, aluminum lanolate, myristic acid / palmitic acid Aluminum, aluminum stearate, aluminum stearate, aluminum tristearate, beeswax, behenamide, camelliaol, butadiene/acrylonitrile copolymer, X C29_70 acid, calcium catechin, calcium stearate, Candelilla wax, carnauba wax, pure wax, cholesterol, biliary hydroxystearate, coconut alcohol, samarium resin, diglyceryl stearate malate, rosinol, dimethyl Dodecyl oleate, dodecanoic acid / cetearyl alcohol / ethylene glycol copolymer, mannosamine, ethyl cellulose, glyceryl triethylene hydroxy stearate, glyceryl triethyl hydrazide Sesame oleate, ethylene glycol dibehenate, ethylene glycol dioctanoate, ethylene glycol distearate, hexanediol distearate, hydrogenated to seven hydrocarbon polymers, Hydrogenated castor oil, hydrogenated cottonseed oil, hydrogenated lard, hydrogenated eucalyptus oil, hydrogenated palm kernel oil glyceride, hydrogenated palm kernel oil, hydrogenated palm oil, argonized polyisobutylene, hydrogenated soybean oil, hydrogenated tallow amine, hydrogenated tallow Glycerides, hydrogenated vegetable glycerides, hydrogenated vegetable glycerides, hydrogenated vegetable oils, propyl cellulose, isobutylene/isoprene copolymers, iso-p-stearone stearates, Japanese waxes, aloe waxes, wool Aliphatic alcohol, laurylamine, methyl dehydroabietic acid ester, methyl hydrogenated abietic acid ester, methyl rosinate, and a paper grade applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -1 -------------装--- (Please read the note on the back to write this page) LSJ· · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1284020 A7 χ^---- ^--_ V. Description of invention (38) Benzene/Ethylene-toluene copolymer, microcrystalline wax, montanic acid wax, montan wax, myristyl eicosanol, myristyl stearyl alcohol, 18 Alkene/maleic anhydride copolymer, octyl lauryl stearate stearate, oleylamine, oil stearin, Crown Brazilian palm wax, oxidized polyethylene, ceresin, palmitol, paraffin, pentaerythritol hydrogenated rosinate, pentaerythritol rosinate, pentaerythritol tetracyanate, pentaerythritol Octanoate, pentaerythritol tetraoleate, pentaerythritol tetrastearate, phthalic anhydride/glycerol/glycidyl, phthalate copolymer, phthalic acid//triphenylbenzene Formic acid/ethylene glycol copolymer, ice butylene, polybutylene terephthalate, polydipentene, polyethylene, polybutene, polyisoprene, polyvinyl butyral, polyethyl cinnamic acid Ester, propylene glycol dicaprylate, propylene glycol dicocoate, propylene glycol diisodecanoate, propylene glycol dicinnamate, propylene glycol dicaprate, propylene glycol distearate, propylene glycol heptaester, pyp/ten Hexacarbon-based copolymer, rice bran wax, PVP/cetene copolymer, stearin bentonite, stearin, hectorite, hard decylamine, stearylamine DEA-distearate, stearylamine DIBA - stearate, stearylamine MEA-stearate, stearyl ketone, stearyl alcohol, stearyl stearylamine, stearyl stearate, stearyl Lipidyl stearate, synthetic beeswax, synthetic wax, trihydroxystearin, triisoxanthine, triisostearyl, diisonon, triisostearyl, triisostearyl trilinoleic acid Ester, tri-cinnamon, tri-linoleic acid, tri-alkali, tri-myristyl, triolein, tripalmitin, distearyl, zinc cinnamate, zinc myristate, zinc neodecanoate, zinc rosinate, Zinc stearate, and mixtures thereof. 5 · Selective ingredients a. Multi-solvent • 41 - This paper scale applies to National Standard (CNS) A4 (210 X 297 public) ---- ------------- --装--- (Please read the note on the back to write this page) Set. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 391284020 A7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 5, invention description (more solvent-free 'If present, the product, 々αΐ/. to about 50%, and preferably from about 5% to the weight of the composition of the composition, is present. To achieve all of the advantages of the present invention, the multi-(four) agent is about The weight ratio of the brain to the composition of the composition is present. Unlike the disinfecting alcohol, the multi-light solvent has only a minor contribution to the antibacterial efficacy of the composition of the invention, as it contributes. As defined herein, the term "polyhydroxyl solvent" a water-soluble organically synthesized mouth having 2 to 6 s and generally 2 to 3 sulfhydryl groups. The term "water-soluble" means that the solvent is at least 每 每 水 under the pit.克^合片] The water, the degree of solution. There is no upper limit to the solubility of water in a polyhydroxy solvent. For example, the polyhydroxy solvent and water can be used in the It is soluble in proportion. The stagnation of the sacred antelope thus covers water-soluble diols, triols, and polyols. Specific examples of polyhydric solvents include, but are not limited to, ethylene glycol, glycerol , monoethylene glycol, dipropylene glycol, tripropylene glycol, hexanediol, butyl decoxide, 2,6-hexanediol, mannitol, peg-4, and similar years old stem-based compounds. The addition system, if present, is present in an amount of from about 1% to about 3%, and preferably from about 5% to about 25 parts by weight of the group & weight ratio. To achieve all of the advantages of the present invention' The multi-light solvent is present in an amount by weight of from about 1% to about 2% by weight of the composition. The type of the emollient agent is as discussed in B. 5 above, and is used for the same purpose for the same purpose. Specific examples. c. Other optional ingredients Other optional ingredients discussed in the above paragraph 4 may also be used in the same amount and the same purpose for this specific example of the present invention. China National Standard (CNS) A4 specification (heart 297 public).—•IV----------装--- (Please read the note on the back first) Page) Η-Τ· 线. 1284020 A7 B7 V. INSTRUCTIONS (Other optional ingredients that may be used in this specific example include skin conditioning agents. Examples of skin conditioning agents include softening agents such as silky soil based myristic acid vinegar, Glyceryl dioleate, isopropyl myristate, lanolin, methyl cinnamic acid vinegar, PPG-9 cinnamate, soy stearyl, octyl palmitate, and PPG-5 wool vinegar For example, the skin treatment agent may also be a humectant such as 'glucosamine and pyridoxine. For example, an inclusive skin preparation agent such as 'lanolinic acid corn oil, methic〇n, coconut may also be used. Oil, stearyl stearate, phenyl trimethic, n-myristyl, olive oil, and synthetic soil. Combinations of various types of skin conditioning agents can also be used, in addition to the various skin conditioning agents known to those skilled in the art, either alone or in combination. Non-limiting examples of various skin conditioning agents include aloe vera, cholesterol, cystine, keratin, phospholipid, egg yolk, glycine, PPCM2, retinol, salicylic acid, whey acid, vegetable oil, and soluble animals. Collagen. The skin conditioning agent can be used alone or in combination with a skin protectant such as petrolatum, cocoa butter, zinc paste, and kaolin, for example. Skin protectants can also be used alone. Other examples of skin conditioners and skin protectants can be found in CTFA c〇smetic

Ingredient Handbook/ J.M. Nikitakis, ed., The Cosmetic, Toiletry and Fragrance Association,lnc.,Washington,D c (1988)(後文稱為 CTFA Handb〇〇k),p 79-85,其併入本文作為參考文獻。 本發明包含活性抗菌劑、消毒醇、及增溶劑之抗菌組合 物具有快速之細菌滅殺作用。該醇及增溶劑可協助溶解該 抗菌劑。因此,即使在無界面活性劑存在之情形下,亦可 達成組合物中抗菌劑至少25%之飽和度。 本發明之抗菌組合物並不依賴低pH或高pH來提供細菌族 - — III — — — —--I —Ml · I I (請先閱讀背面之注意事項寫本頁) 訂- 經濟部智慧財產局員工消費合作社印製 -43-Ingredient Handbook/JM Nikitakis, ed., The Cosmetic, Toiletry and Fragrance Association, lnc., Washington, Dc (1988) (hereinafter referred to as CTFA Handb〇〇k), p 79-85, which is incorporated herein by reference. literature. The antibacterial composition of the present invention comprising an active antibacterial agent, a disinfecting alcohol, and a solubilizing agent has a rapid bacterial killing action. The alcohol and solubilizer assist in dissolving the antimicrobial agent. Thus, at least 25% saturation of the antimicrobial agent in the composition can be achieved even in the absence of surfactant. The antibacterial composition of the present invention does not rely on low pH or high pH to provide the bacterial family - III - - - - I - Ml · II (please read the note on the back to write this page) Bureau employee consumption cooperative printed -43-

1284020 A7 B7 五、發明說明(41) _ 群之快速減少。本發明之抗菌組合物可具有約4至約9之PH 值,但在此pH範圍之兩極端部分,該等組合物可刺激皮膚 或傷害其他由該組合物接觸之表面。因此’本發明之抗菌 組合物較佳具有約5至約8之pH值,且更佳係約6至約8。為 達成本發明之全部優點,該等抗菌組合物具有約6·5至約7·5 之pH值。此外’本發明之抗菌組合物亦不依賴南^度之消 毒醇。 為說明本發明抗菌組合物所提供之新穎及非預期結果, 製備下列之實例及比較實例,並測定該等組合物控制格藍 氏陽性及格藍氏陰性細菌之能力。列於下列各實例中之重 量百分比代表組合物中各成分之實際,或活性重量。該等 組合物係藉由混合諸等成分而製備,如熟習技藝者所明瞭 者,且如下所述。 使用下列材料作為實例中之成分。各成分之來源,及其 縮寫,皆摘述於下: a ) 燒基(直鏈)二苯基氧二續酸鹽,Pilot Chemical Co·,Santa Fe· Springs,CA,CALFAX 101-45 (活性=45.4% ), b )燒基聚葡糖(APG),Henkel Corp·,Hoboken,NJ,PLANTAREN 2000N UP (活性=55.53% ), c) 續酸 a -婦烴(AOS),Stepan Chemical Co·,Northfield,IL, BIOTERGE AS-40 (活性=38.80% ), d) 十二烷基硫酸銨(ALS),Henkel Corp.,STANDAPOL A (活 性= 28.3%),1284020 A7 B7 V. INSTRUCTIONS (41) _ Rapid reduction of groups. The antimicrobial compositions of the present invention may have a pH of from about 4 to about 9, but at both extremes of the pH range, the compositions may irritate the skin or otherwise damage other surfaces that are contacted by the composition. Thus, the antibacterial composition of the present invention preferably has a pH of from about 5 to about 8, and more preferably from about 6 to about 8. To achieve the full advantage of the present invention, the antimicrobial compositions have a pH of from about 6.5 to about 7.5. Further, the antibacterial composition of the present invention is also independent of the anti-toxic alcohol of the south. To illustrate the novel and unexpected results provided by the antimicrobial compositions of the present invention, the following examples and comparative examples were prepared and tested for their ability to control Gram-positive and Gram-negative bacteria. The weight percentages listed in the following examples represent the actual, or active, weight of each component of the composition. These compositions are prepared by mixing the ingredients, as will be apparent to those skilled in the art, and as described below. The following materials were used as ingredients in the examples. The source of each component, and its abbreviations, are summarized below: a) Alkyl (linear) diphenyloxy dicarboxylate, Pilot Chemical Co., Santa Fe. Springs, CA, CALFAX 101-45 (Active =45.4%), b) alkyl polyglucose (APG), Henkel Corp., Hoboken, NJ, PLANTAREN 2000N UP (activity = 55.53%), c) continued acid a-hydrocarbon (AOS), Stepan Chemical Co· , Northfield, IL, BIOTERGE AS-40 (activity = 38.80%), d) ammonium lauryl sulfate (ALS), Henkel Corp., STANDAPOL A (activity = 28.3%),

e) 二甲苯磺酸銨(AXS),Stepan Chemical Co·,STEPANATE AXS -44- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------^ (請先閱讀背面之注意事寫本頁) --^—訂----·---- 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 五、發明說明() (活性=40% ), f) 可可醯胺丙基三甲銨乙内酯(CAPB),McIntyre Group, Ltd·, Chicago, IL,MACKAM 35-HP (估計 30% 活性三甲銨乙内 酯), g )二丙二醇(DPG),Dow Chemical Co·,Midland,MI, h ) 十二燒基醚橫基琥拍酸二納(DSLScct),McIntyre Group, Ltd·,MACKANATE EL (活性=33.8%), i )十二燒基績基琥始酸二納(DSLrylScct),McIntyre Group, Ltd.,MACKANATE LO (活性估計=40%), j ) DMDM 乙内酿(DMDM),McIntyre Group,Ltd.,MACKSTAT DM (大約55%活性), k) DowFax 增溶劑溶液(DFX),Dow Chemical Co.,DowFax Hydrotrope Solution (苯,1,1 ’ -氧雙-,第二-己基衍生物,續酸 化鈉鹽)(活性估計=45.7% ), l) 甘油(GLY),Henkel/Emery,Cincinnati,OH,Emery 916 Glycerine (99.7% CP/USP), m) 異丙醇(IP A),Fisher Scientific,Pittsburgh,PA,2-Propanol,HPLC Grade A 451-4, n) 氧化十二胺(LAO),McIntyre Group,Ltd·,MACKAMINE L〇 (活性= 30.55%), o) 液態香精(PF), p )十二烷基硫酸鋰(LLS),Henkel,TEXAPON LLS (活性 = 28.8%),e) Ammonium xylene sulfonate (AXS), Stepan Chemical Co., STEPANATE AXS -44- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ---------- ----^ (Please read the note on the back to write this page) --^—Book--------- Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1284020 A7 B7 V. Invention description () (activity = 40%), f) cocoamidopropyl betaine (CAPB), McIntyre Group, Ltd., Chicago, IL, MACKAM 35-HP (estimated 30% active betaine), g Dipropylene glycol (DPG), Dow Chemical Co., Midland, MI, h) Dodecyl ether, succinic acid, sodium sulphate (DSLScct), McIntyre Group, Ltd., MACKANATE EL (activity = 33.8%), i ) 12 烧 基 基 基 基 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (approximately 55% active), k) DowFax solubilizer solution (DFX), Dow Chemical Co., DowFax Hydrotrope Solution (benzene, 1,1 '-oxybis-, second-hexyl derivative, acidification) Salt) (activity estimate = 45.7%), l) glycerol (GLY), Henkel/Emery, Cincinnati, OH, Emery 916 Glycerine (99.7% CP/USP), m) isopropanol (IP A), Fisher Scientific, Pittsburgh ,PA,2-Propanol,HPLC Grade A 451-4, n) Oxidized dodecylamine (LAO), McIntyre Group, Ltd., MACKAMINE L〇 (activity = 30.55%), o) Liquid essence (PF), p ) Lithium lauryl sulfate (LLS), Henkel, TEXAPON LLS (activity = 28.8%),

q)十二烷基硫酸鎂(MLS),Stepan Chemical Co.,STEPANOL -45- 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) ---I----------裝 (請先閱讀背面之注意事寫本頁) --^--訂----.---- 經濟部智慧財產局員工消費合作社印製 1284020 A7 — B7 五、發明說明() . MG(活性= 28.3%), r )磺酸甲酯(MES),Stepan Chemical Co·,ALPHA-STEP ML-40 (甲基-2 -磺基月桂酸鉀及2 -磺基月桂酸二鉀)(活性 = 36.47%), s) 單乙醇胺(MEA),Dow Chemical Co., t) 十二烷基硫酸單乙醇胺(MEALS),Albright & Wilson, Cumbria,England,EMPICOL LQ 33/F (活性=33% ), u) 辛基酚乙氧化物,9-10 莫耳 EO (TX100),Union Carbide, TRITON-X-100, v) PEQ-6ME,聚乙二醇 300 甲基醚,自 Dow Chemical Co., Midland,MI,以 MPEG 350取得(活性=估計 100% ), w) Poloxymer 338 (F108) ,BASF,Wyandotte,MI,PLURONIC F108 (活性=估計100% ), x )可可酸鉀(KCO),McIntyre Group,Ltd·,MACKADET 40-K (活 性= 38.4%), y) 月桂酸鉀(KL),自肉桂酸(Sigma,#L-4250,活性= 99.8%) 及氫氧化鉀製備, z) 油酸鉀(KO),Norman,Fox & Co.,Vemon,CA,NORFOX KO (活性=約80% ), aa)丙二醇(PG) ,Dow Chemical Co·, USP Grade (活性 = 99.96%), bb) 2 -乙基己基硫酸鈉(S2EHS),Henkel, SULFOTEX OA (活 性= 39.68% ), cc) CirC18硫酸鈉(SC12-18S),Henkel,TEXAPON ZHC needles -46· 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) ---------------裝--- (請先閱讀背面之注意事寫本頁) 訂: 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 44 五、發明說明() (活性=90.95% ), dd)可可兩性乙酸鈉(SCA),McIntyre Group,Ltd·,MACKAM IC-90(活性=約32%), ee)異丙基苯磺酸鈉(SCS),Stepan Chemical Co·,STEPANATE SCS (活性= 44.6%), ff)癸基硫酸鈉(SDecS),Henkel,SULFOTEX 110 (活性 = 30.80%), gg)十二燒醯基肌胺酸納(SLSarc),Hampshire Chemical Co., Lexington, MA,HAMPOSYL L-30 Type 724 (活性=29.9% ), hh) 十二烷基醚硫酸鈉,1莫耳EO (SLES-1),Henkel, STANDAPOL ES-1 (活性=25.40% ), ii) 十二烷基醚硫酸鈉,2莫耳EO (SLES-2),Henkel, STANDAPOL ES-2 (活性=25.71% ), jj) 肉桂基硫酸鈉/十二烷基硫酸鈉(SLS/SDS),BDH Biochemical,BHD Ltd” Poole,England (活性=99.0% ), kk)十二燒基續基乙酸納(SLSA),Stepan Chemical Co., LANTHANOL LAL (活性=72.65% ), 11)辛基硫酸鈉(SOS),Henkel,STANDAPOL LF (活性 = 32.90%), mm) NEODOX 23-4之鈉鹽(NDX23-4),Shell Chemical Co·,衍生 自NEODOX 23-4,其為具有一 194分子量鏈、4莫耳E〇、及一 羧酸基之化合物(活性=32.90% ), nn)十三烷基硫酸鈉(SC 13S) ,Rhodia,Parsippany,NJ, RHODAPON TDS (活性=24.65% ), -47- 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) (請先閱讀背面之注意事寫本頁) 裝 訂: 經濟部智慧財產局員工消費合作社印製 1284020 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(45) 00)二甲苯磺酸鈉(SXS),Stepan Chemical Co.,STEPANATE SXS (活性=40-42% ), pp)三氯生(TCS),IRGASAN DP-300,Ciba Specialty Chemicals Corp·,Greensboro, NC (對於戶斤用批次之GC分析=99.8-99.9%活性 TCS ; mp = 56.0-58.0 C·), qq)十二烷基硫酸三乙醇胺(TEALS),Henkel,STANDAPOL T (活性= 40.1%), rr)三丙二醇(TPG),Dow Chemical Co·,Tripropylene Glycol (活 性= 99.96% ), ss)對-氯-間-二甲苯酚(PCMX),NIPACIDE PX-R,Nipa Inc·, Wilmington,Delaware (約 100% 活性), tt) 甘油基聚甲基丙烯酸酯及丙二醇(LUBRAGEL DV), Intemation Speciality Products, Wayne, New Jersey (約 46% 活,除), uu) CARBOPOL ULTREZ 10 ( ULTREZ 10),交聯聚丙烯酸,BF Goodrich Specialty Chemicals,Cleveland,Ohio (約 98% 活性), w) 二異丙胺,Air Products and Chemicals, Allentown, Pennsylvania (約100%活性), ww) LAPONITE XLG (石夕酸鍰經,合成綠土),Southern Clay Products,Gonzales,Texas (約 99% 活性), xx) CELQUAT CS230M (Polyquatemium 10),National Starch and Chemical Company,Bridgewater,New Jersey (約 92% 活,f生), yy)聚丙二醇-9 ( PPG-9),Polyglycol P425, Dow Chemical Company, Midland,Michigan (約 100% 活性), zz)乙醇(Denatured Ethyl Alcohol 40B),Gold Shield, Hayward, -48- 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) --------------裝--- (請先閱讀背面之注意事寫本頁) 訂_ · 1284020 A7 B7 五、發明說明( 46q) Magnesium Sulfate Magnesium Sulfate (MLS), Stepan Chemical Co., STEPANOL -45- This paper scale applies to China National Standard (CNS) A4 specification (210 x 297 mm) ---I------ ----Install (please read the note on the back to write this page) --^--Book----.---- Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1284020 A7 — B7 V. Invention Description () . MG (activity = 28.3%), r) methyl sulfonate (MES), Stepan Chemical Co., ALPHA-STEP ML-40 (potassium methyl 2-sulfolaurate and 2-sulfolauric acid) Dipotassium) (activity = 36.47%), s) monoethanolamine (MEA), Dow Chemical Co., t) dodecyl sulfate monoethanolamine (MEALS), Albright & Wilson, Cumbria, England, EMPICOL LQ 33/F (activity = 33%), u) octylphenol ethoxylate, 9-10 Mo EO (TX100), Union Carbide, TRITON-X-100, v) PEQ-6ME, polyethylene glycol 300 methyl ether, From Dow Chemical Co., Midland, MI, obtained with MPEG 350 (activity = estimated 100%), w) Poloxymer 338 (F108), BASF, Wyandotte, MI, PLURONIC F108 (activity = estimated 100%), x) cocoa Potassium (KCO), McIntyre Group, Lt d·, MACKADET 40-K (activity = 38.4%), y) potassium laurate (KL), prepared from cinnamic acid (Sigma, #L-4250, activity = 99.8%) and potassium hydroxide, z) potassium oleate (KO), Norman, Fox & Co., Vemon, CA, NORFOX KO (activity = about 80%), aa) propylene glycol (PG), Dow Chemical Co., USP Grade (activity = 99.96%), bb) 2 -ethylhexyl sulfate (S2EHS), Henkel, SULFOTEX OA (activity = 39.68%), cc) CirC18 sodium sulfate (SC12-18S), Henkel, TEXAPON ZHC needles -46· This paper scale applies to the Chinese National Standard (CNS) A4 size (210 x 297 mm) --------------- Pack--- (Please read the note on the back first to write this page) Order: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative Printed 1284020 A7 B7 44 V. INSTRUCTIONS () (activity = 90.95%), dd) sodium cocoamphoacetate (SCA), McIntyre Group, Ltd., MACKAM IC-90 (activity = about 32%), ee) Sodium propylbenzenesulfonate (SCS), Stepan Chemical Co., STEPANATE SCS (activity = 44.6%), ff) sodium decyl sulfate (SDecS), Henkel, SULFOTEX 110 (activity = 30.80%), gg) Thioglycolic acid sodium (SLSa Rc), Hampshire Chemical Co., Lexington, MA, HAMPOSYL L-30 Type 724 (activity = 29.9%), hh) sodium lauryl ether sulfate, 1 mole EO (SLES-1), Henkel, STANDAPOL ES- 1 (activity = 25.40%), ii) sodium lauryl ether sulfate, 2 mol EO (SLES-2), Henkel, STANDAPOL ES-2 (activity = 25.71%), jj) sodium cinnamate/12 Sodium Alkyl Sulfate (SLS/SDS), BDH Biochemical, BHD Ltd” Poole, England (activity = 99.0%), kk) Sodium decyl thioacetate (SLSA), Stepan Chemical Co., LANTHANOL LAL (activity = 72.65%), 11) sodium octyl sulfate (SOS), Henkel, STANDAPOL LF (activity = 32.90%), mm) sodium salt of NEODOX 23-4 (NDX23-4), Shell Chemical Co., derived from NEODOX 23- 4, which is a compound having a molecular weight chain of 194, 4 moles of E〇, and a monocarboxylic acid group (activity = 32.90%), nn) sodium tridecyl sulfate (SC 13S), Rhodia, Parsippany, NJ, RHODAPON TDS (activity = 24.65%), -47- This paper size is applicable to China National Standard (CNS) A4 specification (210 297 297 mm) (please read the note on the back to write this page) Binding: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Invention description (45) 00) Sodium xylene sulfonate (SXS), Stepan Chemical Co., STEPANATE SXS (activity = 40 -42%), pp) Triclosan (TCS), IRGASAN DP-300, Ciba Specialty Chemicals Corp., Greensboro, NC (GC analysis for batches of households = 99.8-99.9% active TCS; mp = 56.0- 58.0 C·), qq) triethanolamine lauryl sulfate (TEALS), Henkel, STANDAPOL T (activity = 40.1%), rr) tripropylene glycol (TPG), Dow Chemical Co., Tripropylene Glycol (activity = 99.96%) , ss) p-chloro-m-xylenol (PCMX), NIPACIDE PX-R, Nipa Inc., Wilmington, Delaware (about 100% active), tt) Glyceryl polymethacrylate and propylene glycol (LUBRAGEL DV) , Intemation Speciality Products, Wayne, New Jersey (about 46% live, except), uu) CARBOPOL ULTREZ 10 ( ULTREZ 10), cross-linked polyacrylic acid, BF Goodrich Specialty Chemicals, Cleveland, Ohio (about 98% active), w) Diisopropylamine, Air Products and Chemicals, Allentow n, Pennsylvania (about 100% active), ww) LAPONITE XLG (Astragalus sinensis, synthetic smectite), Southern Clay Products, Gonzales, Texas (about 99% active), xx) CELQUAT CS230M (Polyquatemium 10), National Starch and Chemical Company, Bridgewater, New Jersey (about 92% live, f), yy) polypropylene glycol-9 (PGG-9), Polyglycol P425, Dow Chemical Company, Midland, Michigan (about 100% active), zz) Ethanol (Denatured Ethyl Alcohol 40B), Gold Shield, Hayward, -48- This paper scale applies to China National Standard (CNS) A4 specification (210 x 297 mm) -------------- --- (Please read the note on the back to write this page) Order _ · 1284020 A7 B7 V. Description of invention ( 46

California,(約 ι〇〇% 活性), aaa)水-除非另外指明,水係如下 通過CormngAG-3蒸水器蒸餾—次, 衔.使去離子水(DI 使用下列之方法製備並試驗該等實例. a)測定抗菌產物之快速滅菌 滅. 物之活性係以限時滅殺法測量,成奴)活性:抗菌组名 抗菌試驗组合物下之經挑戰微生物=函數測定暴露灰 其使小份之稀釋組合物與試驗細菌之::族:此試,中: 溫度下,接觸指定之時間期。在咳時門 在彳曰疋之 組合物,因而中止該组合物之抗菌活』期二和試驗 族群之減少百分比或對數減少。一般而士原始細囷 熟習技藝者所知者。 D,限時滅殺法係 由自。侧之任何濃度試驗。所用濃度之選擇係 舉例而 Γ而週當之濃度可由熟習技藝者輕易測定。 :。’黏性樣本通常係以5G%稀釋試驗,而非黏性於 本置於裝配磁性擾拌棒之無菌250 1〇〇^ : ’且如需要,以無菌去離子水將樣本體積加至 :。所有之試驗皆以三重試驗進行,結合結果,並報 告平均之對數減少。 根接觸時間期之選擇亦由研究者判斷。可選擇任何接觸時 二。、一般之接觸時間係自15秒至5分鐘不等,其中3〇秒及^ 刀4里係典型之接觸時間。接觸溫度亦可為任何溫度,一般 係室溫,或約攝氏25度。 、'菌心浮液,或試驗接種物,係在任何適當固體培養某 (請先閱讀背面之注意事寫本頁) 裝 • 1· i_i ϋ --II 訂----;· Ί·線. -49- I 1 I» 1 - 本紙張尺度義(eNS)A4g^ 0 X 297公釐) 1284020 A7 B7 五、發明說明(47 ) (如,瓊脂)上使細菌培養物生長而製備。再以無菌生理食 鹽水將細菌族群自瓊脂上洗出,並將該細菌懸浮液之族群 調整至每毫升約108菌落形成單元(cfli/ml)。 下表列出用於下列試驗中之細菌培養物,並包括細菌之 名稱、ATCC (美國典型培養物保存中心American Type Culture Collection)辨識編號、以及用於後文中之微生物名稱縮窝。 微生物名稱 ATCC# 縮寫 金黃葡萄球菌 6538 S. aureus Escherichia coli 大腸择菌 11229 E. coli 肺炎克雷伯氏桿菌 10031 K. pnenm. c/zo/eram/b 霍亂沙門氏样菌 10708 S. choler. 又•係格藍氏陽性細菌,而£*· co//、AT. 、及X c/20/er.係 格藍氏陰性細菌。 將含有試驗組合物之燒杯置於水浴中(如欲使用穩定之溫 度),或置於磁性攪拌器上(如欲使用實驗室室溫)。再以1.0 毫升之試驗細菌懸浮液接種樣本。使接種物與試驗組合物 共同攪拌預定之接觸時間。在接觸時間終了時,將1.0毫升 之試驗組合物/細菌混合物轉移至9.0毫升之胰化蛋白腺-組 胺酸 Tween 中和溶液(Tryptone-Histidine-Tween Neutralizer Solution) ( THT)中。再進行可數範圍内之十倍數稀釋。不同微 生物之稀釋數可各有不同。以三重試驗,將選擇之稀釋物 -50- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --J- I--I---— II · I I (請先閱讀背面之注意事寫本頁) 訂: 經濟部智慧財產局員工消費合作社印製 1284020 A7 發明說明( 千板培養於TSA+培養盤上(TSA+係含有㈣脂及多乙氧基 & - 8〇《Trypticase Soy蜗。再培養該等培養盤25±2小時計 數菌落取得存活數目’在計算減少百分比或對數減少。控 制組計數(控制组數目)係如前述進行實驗流程,惟使用τηί 取代試驗组合物而载。以標準之微生物學方法,分別將 對控制组數目及樣本之培養盤計數轉化為cfWmj。 對數減少係使用下式計算 對數減少=l〇g1〇(控制組 數目)-l〇glQ(試驗樣本存活數目) ---------------裝 (請先閱讀背面之注意事寫本頁) 經濟部智慧財產局員工消費合作社印製 下表係細菌族群之減少百分比與對數減少之相關性 %減少 對數減少 90 1 99 2 99.9 3 99.99 4 99.999 5 b ) TCS飽和水溶液之製備:在一個4升燒瓶中配備一 3吁之 磁性攪拌棒,並裝入約3.5克(g)之TCS及3升(L)之水。再將 4燒瓶置於水浴中,揽掉,並加熱(4〇_45。〇)至少8小時。自 51 - .紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ---"—訂----,---- 1284020 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(49) 水浴中取出含有所得TCS/水懸浮液之燒瓶,並使該溫懸浮 液通過裝備Whatman #40 ( 5·5公分)滤紙之Coors #32-H资Buchner漏 斗過濾。該過濾組合係連結於一 2升之真空過濾瓶上,以批 次進行過濾。再將濾液轉移製另一 4升燒瓶中,並予以冷 卻。一般而言,在於室溫下貯存該濾液數天後,會形成細 針狀之TCS晶體。 就部分之限時滅殺實驗而言,在用於實驗中前,其在室 溫下再次過濾該TCS溶液。就其他限時滅殺實驗而言,其使 少量之TCS晶體留在試驗容器中,以在溫度發生變化時確保 飽和。其假設存在於限時滅殺試驗容器中之TCS晶體不會影 響試驗結果,應晶體TCS並不可作用於細菌(亦即,其並未 溶解)。 為測定水溶液中TCS之濃度,以HPLC分析過濾之樣本(以 三重試驗進行)。用於過滤溶液之裝置係Whatman AUTO VIAL®,具有0.45 /zm PTFE膜及玻璃微纖維預濾器,cat No. AV125UORG。使用線性回歸線相符(Microsoft EXCEL®軟體)’ 對包括於相同HPLC試驗中之TCS/IPA標準物,計算TCS濃度。 c )製備TCS水溶液/界面活性劑組合物:在法國方形瓶 中,加入含有各種濃度介面活性劑及0.3%重量比TCS之溶 液。攪拌混合物並加熱(35-40°C )數個小時,直到TCS溶解為 止。使用由可變式變壓器控制之加熱燈進行加熱,並以數 位式溫度劑監測溶液之溫度。之後,中止攪拌,將TCS種晶 (約1毫克)加入溶液中,並將該混合物置於約20°c下。幾天 後,可在溶液容器之底部觀察到晶體,其中已超過TCS之最 -52- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----·----------裝--- (請先閱讀背面之注意事寫本頁) II訂· --線- 1284020 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(5G) . 大溶解度。 幾乎完全溶解該0.3% TCS所需之界面活性劑大約濃度係藉 由使用實驗設計而測定,其中一系列試驗樣本中之界面活 性劑之濃度係藉除以二而序列減少,直到觀察到界面活性 劑中TCS之大約飽和點為止。再將濃度差異(飽和對恰好溶 解)減半,直到測定出TCS飽和之接近終點為止。TCS/界面 活性劑組合物之飽和點可以小規模(15至100毫升)之樣本有 效估計,但需要約600-800克樣本,以取得可靠之終結果。因 此,使用小規模樣本來建立最初之範圍,再以較大規模之 樣本測定終濃度。 d )製備含有TCS及溶劑或溶劑/增溶劑組合之組合物:首 先將TCS溶於組合物中所用之溶劑中。再將水加入該TCS/ 溶劑組合物中,再加入約1毫克之TCS種晶,並將所得之混 合物置於約20 °C下以進行結晶。在含有溶劑、增溶劑、及 界面活性劑之組合物中,如上所述將TCS溶解於溶劑中,再 將增溶劑及界面活性劑加入該TCS/溶劑組合物中。之後, 以水將所得之混合物稀釋至批次總體積。如需要,亦進行 pH值之調整。在室溫下攪捽該混合物約1小時,加入種晶 TCS,再如上靜置混合物並進行結晶。亦如上述測定TCS飽 和點(亦即,將界面活性劑濃度減半)。類似上述測定最大 添加濃度之方法已述於文獻中。舉例而言,P.H. Elworthy et al., "Solubilization by surface-active agents and its applicatin in chemistry and biological sciences,” Chapman and Hall, Ltd.,London,pp. 62-65 (1968)即描 述藉由觀察混合物之濁度而測定接近飽和之濃度。係著以 -53- (請先閱讀背面之注意事 寫本頁) 裝 1ϋ ϋ fl·— I a— mmmf I .ϋ n ϋ« · 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 __ B7 — 五、發明說明(51 ) 自裝備光束聚焦附件之小型手電筒產生之高強度光,由直 角觀察樣本而使用類似之技術(亦即,MINI MAGLITE® AA, MAG Instruments,Califormia,USA)。亦將此一方法用於非常接近 飽和之溶液,以增進對於在容器底部形成之少量晶體之觀 察。 表2摘述對諸等TCS/水組合物進行之限時滅殺試驗結 果。兩系列之結果,I及II,說明諸等TCS/水組合物中%飽 和之效應,亦即,在特定試驗系列中,%飽和之減少會同 時造成限時滅殺功效之減低。 (請先閲讀背面之注意事寫本頁) 經濟部智慧財產局員工消費合作社印製 54 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(52 ) =: — 1 50%飽和 100%飽和 10%飽和 50%飽和 100%飽和 樣本 4.9x1 Ο*6 9/)xl〇-6 6.7x108 3.9xl〇-7 9.3xlO·7 TCS (克/毫升) (以 HPLC) 0.24 3.93 0.03/15S 0.03/I5S .. 1.07/15s 1分鐘/ 或t S. aureus 對數減少 0.02 >3.91 5分鐘 0.26 0.06/I5S 0.I3/15S 0.44/l5s 1分鐘/ 或t E. coli 0.08 = >4.06 5分鍾 0.35 2.85 0/15s 0.21715s 0.32/I5s 1分鐘/ 或t $ 2 3 ·〇 二 2.76 >4.00 5分鐘 2.15 1分鐘/ 或t S. chol. 5分嫂 >2!赛兮TCS/矢贫吟蓥蛉FM令务痒據米 (請先閱讀背面之注意事 寫本頁) -丨裝 一-口,·. 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 _ __B7_;__ 五、發明說明(53 ) 比較表2及3中之數據顯示,在TCS濃度極低時(亦即,5至 10 ppm),限時滅殺之功效較含有較高含量1^^之樣本為低。 舉例而言,表2含有0.93 ppm TCS之樣本在15秒後對抗大腸桿 菌具有0.44之對數減少值,而表3含有484 !)pm TCS之樣本在15 秒後對抗相同微生物具有4.13之對數減少值。此種效應在較 短接觸時間期時更為明顯。另一在較複雜組合物中之實例 述於表3之樣本中,亦即,50 ppm TCS (估計)/ 10% PG/ 5% SXS對(448 ppm TCS (估計)/ 20% PG/ 10% SXS)。具有較高 TCS 濃度之樣本顯示在1分鐘後具有至少1 log較高之細菌減少作 用。表3之數據亦顯示在與大約相同之TCS濃度使用不同溶 劑/增溶劑之功效差異。 (請先閱讀背面之注意事^^|$寫本頁) 經濟部智慧財產局員工消費合作社印製 56 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(气 經濟部智慧財產局員工消費合作社印製 〇 ON V-ϋ ο ο 1385 oc VC 603 723 510 484 n3 11()(估計) o 112(估計) (ppm) TCS 表3-溶劑及/或增溶劑系統中之TCS 5%SXS 5%SXS 75.00%PG 50.00%PG 50.00%PG 47.52%PG 45.05%PG 44.20%PG 42.53%PG 41.86%PG 40.01%PG 23.85%PG 17%IPA I7%IPA 溶劑/ 增溶劑 1.20/15 0.15/15 >4.49/15 >5.17/30 >4.69/15 >3.46/15 >5.17/30 >3.46/15 4.79丨)/302) S. auerus 0.33 >4.43 2.35 0.13 >4.49 >5.17 >4.69 >3.46 >5.17 >3.46 >5.17 >4.39 0.42 >4.42 1分鎊 0.35/15 0.25/15 4.45/15 4.42/30 4.21/15 >4.38/15 4.47/30 4.13/15 4.29/30 E. coli -0.15 0.96 0.26 >4.65 >4.67 >4.65 >4.38 >4.67 >4.38 >4.67 2.37 -0.24 >3.56 1分鐘 --I-------------Ί (請先閱讀背面之注意事寫本頁) ·. 57 « 公 97 2 X 10 2 y^\ 格 規 4 )A 5) N (C 準 標 家 國 一國 中 用 適 度 尺 張 紙 本 1284020 A7 B7 55 五、發明說明( 經濟部智慧財產局員工消費合作社印製 〇 LA s ο 1 Ο ^-Λ 4·“ —τ- ο ΟΟ Ό ο I Η η 0Q > 1 \ W iB家 ~U Η η CO 〇 〇 〇 CO X 00 二 α -σ Ο ο CO X C/D ο -α Ο D; CO η 00 Ξ -ο Ο D; 00 Ω S CO X CO Ξ S 00 X 00 -D Ο 00 X 00 NJ Ο i 00 X GO in 〇η Ω 〇δ ψίτ a\ 〇 S UJ 〇 V UJ •ΟΝ UJ OJ Ο ο ο V -fc. 二 & Ο 2 p 〇 V LO ΟΝ ο S ο ν〇 ο S LO 丄 NJ ο V ό s UJ 2 〇 ΓΟ σ\ V 全 UJ Ο •to UJ 〇 Γ5 〇 V ο Ό CN •Ό Ο ο LO LO OC ·: V ό ο g 5β (請先閱讀背面之注意事 裝—— 寫本頁) . 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7California, (approximately 〇〇% active), aaa) water - unless otherwise indicated, the water is distilled as follows via a CormngAG-3 water purifier - the deionized water (DI is prepared and tested using the following method) Examples. a) Determination of the rapid sterilization of antibacterial products. The activity of the substance is measured by the method of time-limited killing, and the activity of the slave is: the antimicrobial group under the antibacterial test composition, the challenged microorganisms = the function of measuring the exposed ash, which makes the small part Dilution composition and test bacteria:: Family: This test, medium: At temperature, contact for a specified period of time. At the time of coughing, the composition of the sputum is stopped, thereby suspending the antibacterial activity of the composition and reducing the percentage or logarithm of the test population. The general syllabus is familiar to those skilled in the art. D, the time-limited killing method is from. Any concentration test on the side. The choice of concentration used is for example and the concentration can be easily determined by a skilled artisan. :. The viscous sample is usually diluted at 5G%, rather than being viscous in the sterile 250 1〇〇^:' and the sample volume is added to sterile deionized water if necessary. All trials were performed in a triple trial, combining the results and reporting an average log reduction. The choice of root contact time period is also judged by the investigator. You can choose any contact time. The general contact time varies from 15 seconds to 5 minutes, of which 3 sec and ^ 4 are typical contact times. The contact temperature can also be any temperature, typically room temperature, or about 25 degrees Celsius. , 'bacterial heart floating liquid, or test inoculum, is in any suitable solid culture (please read the note on the back to write this page) installed • 1· i_i ϋ --II order----;· Ί· line. -49- I 1 I» 1 - Paper size scale (eNS) A4g^ 0 X 297 mm) 1284020 A7 B7 V. Inventive Note (47) (eg, agar) Prepared by growing a bacterial culture. The bacterial population was washed out of the agar with sterile physiological saline, and the population of the bacterial suspension was adjusted to about 108 colony forming units per ml (cfli/ml). The following table lists the bacterial cultures used in the following tests, including the name of the bacteria, the ATCC (American Type Culture Collection) identification number, and the microbial name dimples used hereinafter. Microbiological name ATCC# Abbreviation Staphylococcus aureus 6538 S. aureus Escherichia coli Escherichia coli 11229 E. coli Klebsiella pneumoniae 10031 K. pnenm. c/zo/eram/b cholera-salmonella 10708 S. choler. • Gram-positive bacteria, while £*· co//, AT., and X c/20/er. are Gram-negative bacteria. Place the beaker containing the test composition in a water bath (if a stable temperature is desired) or on a magnetic stirrer (if laboratory temperature is desired). The sample was inoculated with 1.0 ml of the test bacterial suspension. The inoculum is stirred with the test composition for a predetermined contact time. At the end of the contact time, 1.0 ml of the test composition/bacterial mixture was transferred to 9.0 ml of Tryptone-Histidine-Tween Neutralizer Solution (THT). A ten-fold dilution in the countable range is then performed. The dilution of different microorganisms can vary. In the triple test, the selected dilution -50 - the paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) --J-I--I---- II · II (please read first Note on the back of this page) Order: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1284020 A7 Description of the invention (Thousands of plates cultured on TSA + culture plate (TSA+ contains (four) fat and polyethoxy & - 8〇" Trypticase Soy. Re-culture the plates for 25 ± 2 hours to count colonies to obtain the number of survivors' in the calculation of reduction percentage or log reduction. Control group count (number of control groups) is the experimental procedure as described above, but using τηί instead of the test composition In the standard microbiological method, the number of control groups and the plate count of the sample were converted to cfWmj. The log reduction was calculated by the following formula: l〇g1〇 (number of control groups)-l〇glQ ( The number of test samples survived) --------------- Install (please read the note on the back first to write this page) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed the following table is the reduction of bacterial population Percentage and log reduction Reduction of logarithm % 90 1 99 2 99.9 3 99.99 4 99.999 5 b ) Preparation of TCS saturated aqueous solution: equipped with a 3 magnetic stir bar in a 4 liter flask and loaded with about 3.5 g (g) of TCS and 3 liters (L) of water. Place the 4 flask in a water bath, remove it, and heat (4 〇 _45. 〇) for at least 8 hours. From 51 - . The paper scale applies to the Chinese National Standard (CNS) A4 specification ( 210 X 297 mm) ---"-book----,---- 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Invention description (49) Take out the water containing TCS/water The flask was suspended and the warm suspension was filtered through a Coors #32-H Buchner funnel equipped with Whatman #40 (5·5 cm) filter paper. The filter assembly was attached to a 2 liter vacuum filter bottle to The batch is filtered. The filtrate is transferred to another 4 liter flask and cooled. Generally, after storing the filtrate for several days at room temperature, fine needle-like TCS crystals are formed. For the killing experiment, the TCS solution was again filtered at room temperature before being used in the experiment. For other time-limited killing experiments, it leaves a small amount of TCS crystals in the test vessel to ensure saturation when the temperature changes. It is assumed that the TCS crystals present in the time-limited killing test vessel will not affect the test results, and should be crystal TCS does not act on bacteria (ie, it does not dissolve). To determine the concentration of TCS in aqueous solution, the filtered sample was analyzed by HPLC (in a triple test). The device used to filter the solution is Whatman AUTO VIAL® with 0.45 /zm PTFE membrane and glass microfiber prefilter, cat No. AV125UORG. The TCS concentration was calculated using a linear regression line match (Microsoft EXCEL® Software)' for the TCS/IPA standards included in the same HPLC assay. c) Preparation of TCS aqueous solution/surfactant composition: In a French square bottle, a solution containing various concentrations of surfactant and 0.3% by weight of TCS was added. The mixture was stirred and heated (35-40 ° C) for several hours until the TCS dissolved. The heating was carried out using a heating lamp controlled by a variable transformer, and the temperature of the solution was monitored with a digital temperature agent. Thereafter, the stirring was stopped, TCS seed crystals (about 1 mg) were added to the solution, and the mixture was placed at about 20 °C. After a few days, crystals can be observed at the bottom of the solution container, which has exceeded the TCS's most -52- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) -------- -------装--- (Please read the note on the back to write this page) II set · -- Line - 1284020 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 5, invention description (5G) . Large solubility. The approximate concentration of surfactant required to dissolve the 0.3% TCS almost completely was determined by using an experimental design in which the concentration of the surfactant in a series of test samples was reduced by two, until the interface activity was observed. The approximate saturation point of TCS in the agent. The concentration difference (saturation pair just dissolved) was then halved until the end of the TCS saturation was determined. TCS/Interface The saturation point of the active agent composition can be effectively estimated for small scale (15 to 100 ml) samples, but requires approximately 600-800 g samples for reliable end results. Therefore, a small sample is used to establish the initial range, and the final concentration is determined on a larger sample. d) preparing a composition comprising a combination of TCS and a solvent or solvent/solubilizing agent: the TCS is first dissolved in a solvent used in the composition. Water was added to the TCS/solvent composition, about 1 mg of TCS seed crystals were added, and the resulting mixture was placed at about 20 ° C for crystallization. In a composition comprising a solvent, a solubilizing agent, and a surfactant, the TCS is dissolved in a solvent as described above, and a solubilizing agent and a surfactant are added to the TCS/solvent composition. Thereafter, the resulting mixture was diluted with water to the total volume of the batch. Adjust the pH as needed. The mixture was stirred at room temperature for about 1 hour, seed crystal TCS was added, and the mixture was allowed to stand still as above and crystallized. The TCS saturation point was also measured as described above (i.e., the surfactant concentration was halved). A method similar to the above determination of the maximum added concentration has been described in the literature. For example, PH Elworthy et al., "Solubilization by surface-active agents and its applicatin in chemistry and biological sciences," Chapman and Hall, Ltd., London, pp. 62-65 (1968) is described by observation Determine the concentration close to saturation by the turbidity of the mixture. Use -53- (please read this page on the back) 1ϋ ϋ fl·— I a — mmmf I .ϋ n ϋ« · This paper size applies China National Standard (CNS) A4 Specification (210 X 297 mm) 1284020 A7 __ B7 — V. Invention Description (51) High-intensity light generated by a small flashlight equipped with a beam focusing attachment, using a similar technique for observing samples at right angles (i.e., MINI MAGLITE® AA, MAG Instruments, Califormia, USA). This method was also used for solutions that are very close to saturation to enhance the observation of a small amount of crystals formed at the bottom of the vessel. Table 2 summarizes the The results of the time-limited killing test conducted by the TCS/water composition. The results of the two series, I and II, illustrate the effect of % saturation in the TCS/water compositions, ie, in a particular test series, % The reduction will also reduce the effectiveness of time-limited killing. (Please read the note on the back to write this page.) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print 54 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 V. Description of Invention (52) =: — 1 50% Saturated 100% Saturated 10% Saturated 50% Saturated 100% Saturated Sample 4.9x1 Ο*6 9/)xl〇-6 6.7x108 3.9xl〇-7 9.3xlO·7 TCS (g/ml) (by HPLC) 0.24 3.93 0.03/15S 0.03/I5S .. 1.07/15s 1 minute / or t S. aureus logarithm Decrease 0.02 >3.91 5 minutes 0.26 0.06/I5S 0.I3/15S 0.44/l5s 1 minute / or t E. coli 0.08 = >4.06 5 minutes 0.35 2.85 0/15s 0.21715s 0.32/I5s 1 minute / or t $ 2 3 ·〇二 2.76 >4.00 5 minutes 2.15 1 minute / or t S. chol. 5 minutes 嫂>2! Celluloid TCS/Yaga 吟蓥蛉 FM itch itching according to rice (please read the back note first) Write this page) - Armored one-mouth, ·. This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 _ __B7_;__ V. INSTRUCTIONS (53) The data in Tables 2 and 3 show that when the TCS concentration is extremely low (ie, 5 to 10 ppm), the effect of time-limited killing is higher than that of 1 The sample of ^^ is low. For example, the sample of Table 2 containing 0.93 ppm TCS has a logarithmic reduction of 0.44 against E. coli after 15 seconds, while the sample of Table 3 containing 484 !) pm TCS has a logarithmic reduction of 4.13 against the same microorganism after 15 seconds. . This effect is more pronounced during shorter contact periods. Another example in a more complex composition is described in the sample in Table 3, ie 50 ppm TCS (estimated) / 10% PG / 5% SXS pair (448 ppm TCS (estimated) / 20% PG / 10%) SXS). Samples with higher TCS concentrations showed a bacterial reduction of at least 1 log higher after 1 minute. The data in Table 3 also shows the difference in efficacy between different solvents/solubilizers used at approximately the same TCS concentration. (Please read the note on the back first ^^|$write this page) Ministry of Economic Affairs Intellectual Property Bureau employees consumption cooperatives print 56 paper scale applicable to China National Standard (CNS) A4 specifications (210 X 297 mm) 1284020 A7 B7 Five , invention description (Ministry of Economy, Intellectual Property Bureau, employee consumption cooperative printing 〇 ON V-ϋ ο ο 1385 oc VC 603 723 510 484 n3 11 () (estimated) o 112 (estimated) (ppm) TCS Table 3 - Solvent and / or TCS in the solubilizer system 5% SXS 5% SXS 75.00% PG 50.00% PG 50.00% PG 47.52% PG 45.05% PG 44.20% PG 42.53% PG 41.86% PG 40.01% PG 23.85% PG 17% IPA I7% IPA Solvent / solubilizer 1.20/15 0.15/15 >4.49/15 >5.17/30 >4.69/15 >3.46/15 >5.17/30 >3.46/15 4.79丨)/302) S. auerus 0.33 >4.43 2.35 0.13 >4.49 >5.17 >4.69 >3.46 >5.17 >3.46 >5.17 >4.39 0.42 >4.42 1 cent £ 0.35/15 0.25/15 4.45/15 4.42/30 4.21/ 15 >4.38/15 4.47/30 4.13/15 4.29/30 E. coli -0.15 0.96 0.26 >4.65 >4.67 >4.65 >4.38 >4.67 >4.38 >4.67 2.37 -0.24 >3.56 1 Minutes--I-------------Ί (please first Read the note on the back page. · 57 « 公 97 2 X 10 2 y^\ 格 4 4 4 4 4 4 Illustrated by the Ministry of Economic Affairs, Intellectual Property Office, Employees' Consumption Cooperatives, 〇LA s ο 1 Ο ^-Λ 4·“ —τ- ο ΟΟ Ό ο I Η η 0Q > 1 \ W iB 家~U Η η CO 〇〇 〇CO X 00 二α -σ Ο ο CO XC/D ο -α Ο D; CO η 00 Ξ -ο Ο D; 00 Ω S CO X CO Ξ S 00 X 00 -D Ο 00 X 00 NJ Ο i 00 X GO in 〇η Ω 〇δ ψίτ a\ 〇S UJ 〇V UJ •ΟΝ UJ OJ Ο ο ο V -fc. 二& Ο 2 p 〇V LO ΟΝ ο S ο ν〇ο S LO 丄NJ ο V s s UJ 2 〇ΓΟ σ\ V All UJ Ο • to UJ 〇Γ5 〇V ο Ό CN •Ό Ο ο LO LO OC ·: V ό ο g 5β (Please read the note on the back first - write this page The paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7

經濟部智慧財產局員工Ministry of Economic Affairs Intellectual Property Office staff

〇 ON UJ o 二 oo g LO UJ I ro 1 4»U O a-U UJ a· 逢 ί Η on CO La cn CO | I。 s s 1 a a NJ o La £ § o 6 0\ Ui O 2 o 1 ro UJ a 2 f s£ $5V 逢\ 〇〇 s 己 Ui is-) Cn KJ\ •ro ON o hO s 1 UJ to u> o 1 UJ •CN Cs - k> vC P. bo v〇 V g 1 ro ON v〇 to SJ i v〇 三 ·: 〇\ o i ro La ro LO s Ό c: LO \ NJ Ni UJ UJ ·: UJ ί vC (請先閱讀背面之注意事 — II · n I Ί I i J— I 抑5J·寫本頁) 1284020 A7 B7 五、發明說明(Θ ) 一)冶犛寡: 經濟部智慧財產局員工消費合作社印製 〇 S i ο 1 «»w ο 4«U ° oc i α·“ I ㈠ η 00 Ό 〇 i CO X in Ξ La σ Ο ο 00 X 00 5 G 03 Q ο ο ίΠ η GO 5 00 X CO 5 w CO X .CO § 0 1 CO X 03 K> o -a 〇 o CO X GO 00 La 00 Q 窆\ 〇 ο V ο o NJ K) Cj o LO NJ UJ o -¾ § ο. LO ν〇 V Ξ o L〇 V 么 to Ο UJ CN UJ ο V Ξ & ο o to o UJ uj o ?〇 ο 1 •ο V V UJ •CN oo -60- --------------裝---(請先閱讀背面之注意事寫本頁) . 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) 1284020 A7 _ __B7_:___ 五、發明說明(% ) 許多本發明之組合物皆含有界面活性劑,其潛在性可減 低抗菌劑之功效。下列之實例顯示由本發明組合物達成之 意外助益。 實例1 在此實例中,其將本發明之組合物與三種市售可得之抗 菌清潔組合物,在限時滅殺試驗中,使用5分鐘之接觸時間 而進行比較。本發明之組合物(產品A)係一飽和溶液,其 在1.5%肉桂基硫酸鈉(SLS)水溶液中,含有0.3%三氯生。該 等三種具有未知之三氯生濃度之市售可得抗菌清潔組合物 係 Jergens Antibacterial (JA) Hand Soap,Andrew Jergens Inc.之產品; Clean and Smooth (CS),Benckiser之產品;及 Soft Soap (SSp),Colgate Palmolive之產品 〇 (請先閱讀背面之注意事 寫本頁) 經濟部智慧財產局員工消費合作社印製 6 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( 59, 一):丨:缽筠斧ilMiJi赛; 2)dnk:=^s>^:iL 〕):% 麥 f 私逛 TCS>:4/&.多 7MSDt ~^^π、νΛ。 A JA CS SS1) Β 0. 3 1. unk. Unk. (請先閱讀背面之注意事 %麥^〕) 100 ullk· ullk. cllk. 寫本頁) 裝 S. aureus V4.47 2.4100 N80 1.62 E. coli 〉4·41 0 20 0.00 000〇 ON UJ o Two oo g LO UJ I ro 1 4»U O a-U UJ a· Everyday Η on CO La cn CO | I. Ss 1 aa NJ o La £ § o 6 0\ Ui O 2 o 1 ro UJ a 2 fs £ $5V 逢 \ 〇〇s Ui is-) Cn KJ\ •ro ON o hO s 1 UJ to u> o 1 UJ •CN Cs - k> vC P. bo v〇V g 1 ro ON v〇to SJ iv〇三·: 〇\ oi ro La ro LO s Ό c: LO \ NJ Ni UJ UJ ·: UJ ί vC (Please read the note on the back first - II · n I Ί I i J - I 5 5J · write this page) 1284020 A7 B7 V. Invention Description (Θ) a) 牦 牦 :: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative Printed 〇S i ο 1 «»w ο 4«U ° oc i α·“ I (一) η 00 Ό 〇i CO X in Ξ La σ Ο ο 00 X 00 5 G 03 Q ο ο ίΠ η GO 5 00 X CO 5 w CO X .CO § 0 1 CO X 03 K> o -a 〇o CO X GO 00 La 00 Q 窆\ 〇ο V ο o NJ K) Cj o LO NJ UJ o -3⁄4 § ο. LO ν 〇V Ξ o L〇V 到to Ο UJ CN UJ ο V Ξ & ο o to o UJ uj o ?〇ο 1 •ο VV UJ •CN oo -60- ----------- ---Install---(Please read the note on the back first to write this page). This paper scale applies to China National Standard (CNS) A4 specification (210 χ 297 mm) 1284020 A7 _ __B7_:___ V. Description of the Invention (%) Many of the compositions of the present invention contain a surfactant which potentially reduces the efficacy of the antimicrobial agent. The following examples show the accidents achieved by the compositions of the present invention. Example 1 In this example, a composition of the invention was compared to three commercially available antimicrobial cleaning compositions in a time-limited killing test using a contact time of 5 minutes. (Product A) is a saturated solution containing 0.3% triclosan in 1.5% aqueous sodium cinnamate (SLS) solution. These three commercially available antibacterial cleaning compositions with unknown triclosan concentrations Department of Jergens Antibacterial (JA) Hand Soap, Andrew Jergens Inc.; Clean and Smooth (CS), Benckiser products; and Soft Soap (SSp), Colgate Palmolive products (please read the note on the back) ) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 6 paper scales applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (59, ): Shu: ax ilMiJi game bowl Jun; 2) dnk: = ^ s > ^: iL]): f% Wheat private shopping TCS >: 4 / &. plurality 7MSDt ~ ^^ π, νΛ. A JA CS SS1) Β 0. 3 1. unk. Unk. (Please read the note on the back first%) ^ 100 ullk· ullk. cllk. Write this page) Install S. aureus V4.47 2.4100 N80 1.62 E . coli 〉4·41 0 20 0.00 000

l·___III 1 I I 0.20 經濟部智慧財產局員工消費合作社印製 K. pneum. 〉436 01100 0.10 s. Choi. 么.67 62- 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) 1284020 A7 B7 五、發明說明(6G ) '實例m明本發明组合物相較於目前可得之市 合物在細菌族群之對數減少方面所提供之意外二固、 此,在SLS中含有三氣生之水性組合物在麵飽和時,二 提供較孩等三種試驗市售"σ顯著較高之抗菌功效 格藍氏陽性及格藍氏陰性微生物,該兩種微生物皆: 費者造成顯著之健康威脅。 ^ 實例2 此一實例名本發明組合物之抗菌活性係由活性抗菌劑造 成’而非界面活性劑。製備試驗組合物及A_2。組合物Ad 係含有0·3%二氯生,i 35%十二烷基硫酸銨,並以水平衡之 溶液。組合物A-丨係100%三氯生飽和。組合物A-2係「安慰 d」’亦即’ 1.35%十二垸基硫酸铵之水溶液,不含活性抗 菌劑。 11 — J111 11111 ^ --- (請先閱讀背面之注意事寫本頁) · .線! 經濟部智慧財產局員工消費合作社印製 63- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 經濟部智慧財產局員工消費合作社印製 A7 _B7 五、發明說明(61 ) > ΓΟ > 〇 〇 : 〇 w 〇 〇 V V •ON y: 2 Γ5 ξ Λ· 〇 L/i Ο 〇 V 公 Uj VO $ 2 1 〇 〇 LO y: -64- (請先閱讀背面之注意事 寫本頁) -—裝 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284〇2〇 五、 發明說明( 經濟部智慧財產局員工消費合作社印製 本發明之組合物A-丨明顯提供優良、範圍廣泛之抗菌活 眭而安慰劑」組合物A-2則僅具有極有限之活性範圍。 組合物A-2對抗格藍氏陰性微生物具有特別差之功效。格藍 氏陰性微生物之控制係消#者特別重視者,因此等微^ 可造成顯著之健康威脅。組合物Μ優良之廣泛範圍抗菌活 性明顯顯示,該抗菌活性毫無疑問係由連續水相中存在之 抗菌劑造成。 在此實例中,其使用溶劑(亦即,丙二醇(PG))將三氯生 溶解於水性載體中。並未有增溶劑或界面活性劑之存在。 組合物A-3含有0.0872%重量比之三氣生,47 5%PG水溶液,並 以水平衡。組合物A-3係100%三氯生飽和,且係本發明之組 合物。試驗組合物A-4係「安慰劑」,由47.5%重量比之?〇構 成’並以水平衡。&一實例說明在組合物中包含選擇性羥 落劑之額外優點。特定言之,觀察到先前實例中在1及$分 鐘接觸時間所展現之優良廣泛範圍活性可在羥溶劑 2 情形下,以30秒之接觸時間達成。此一實例進一步說明, 本發明組合物 < 抗菌活性毫無疑問係由抗菌劑之存在造 成。 。 I I J I I I----— II --- (請先閱讀背面之注意事寫本頁) · -65- 1284020 A7 B7 63 五、發明說明() .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(64) 實例4 此一實例說明,本發明之組合物儘管僅含相對低濃度之 消毒醇,其可提供可接受之消毒功效。實例B-1、B-3、及B-5 含有0.15%重量比之三氯生,100%飽和。實例B-2、B-4、及B-6係比較性實例,其含有0%三氯生。 (請先閱讀背面之注意事寫本頁) 經濟部智慧財產局員工消費合作社印製 -67- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五 明說 明發 5 6 經濟部智慧財產局員工消費合作社印製 l· 抽 奈· C η d rn N ο 3 小 Ο1 SM W 〇 〇 〇 •S ο UJ 1 1 U) OQ Ο σ 1 ΓΖιΓ ν^γ rr ·〇 〇 〇 ο •UJ 1 1 LO 〇〇 •ο ο ο 03 ro 〇 〇 〇 S Ο Uj OO fO οο ’〇 ο 七 C3 P 〇 〇 ο οο •ο ο ο CD •k 〇 〇 〇 S ο •UJ ο b I 1 ο 二 σ ·〇 〇 〇 ο Uj XX ο •Ο 1 1 ο ο ψ σ\ --------------^---(請先閱讀背面之注意事寫本頁) 訂·- 68 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) l284〇2〇 A7 五、發明說明( 66 下表摘述15秒之限時滅殺結果l·___III 1 II 0.20 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed K. pneum. 〉 436 01100 0.10 s. Choi. 么.67 62- This paper scale applies to China National Standard (CNS) A4 specification (210 χ 297 gong) PCT) 1284020 A7 B7 V. INSTRUCTIONS (6G) 'Examples show that the composition of the present invention provides an unexpected second solid in comparison with the currently available product in the logarithmic reduction of the bacterial population, and this is contained in the SLS. When the water-repellent composition of the three gas is saturated in the surface, the two products are available in three trials, such as children, and have a significantly higher antibacterial efficacy, such as Gram-positive and Gram-negative microorganisms, both of which are: Health threats. ^ EXAMPLE 2 This example shows that the antibacterial activity of the compositions of the present invention is made up of active antibacterial agents rather than surfactants. The test composition and A_2 were prepared. Composition Ad is a solution containing 0.3% diclosan, i 35% ammonium lauryl sulfate, and equilibrated with water. Composition A-lanthanide was saturated with 100% triclosan. Composition A-2 is a "soothing d", i.e., an aqueous solution of 1.35% ammonium decyl sulfate, which does not contain an active antibacterial agent. 11 — J111 11111 ^ --- (Please read the note on the back first to write this page) · . Ministry of Economic Affairs, Intellectual Property Bureau, Staff and Consumer Cooperatives Printed 63- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 _B7 V. Invention Description (61 > ΓΟ > 〇〇: 〇w 〇〇VV •ON y: 2 Γ5 ξ Λ· 〇L/i Ο 〇V Male Uj VO $ 2 1 〇〇LO y: -64- (Please read the back Note the matter on this page) - The size of the paper is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1284〇2〇5, invention description (The Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed the invention Composition A-丨 clearly provides an excellent, wide range of antimicrobial activity while placebo" Composition A-2 has only a very limited range of activity. Composition A-2 has a particularly poor efficacy against Gram-negative microorganisms. The control system of Gram-negative microorganisms is particularly important, so that micro-cause can cause significant health threats. The antibacterial activity of the composition is excellent in a wide range of antibacterial activity, and the antibacterial activity is undoubtedly in the continuous aqueous phase. In the present example, it uses a solvent (i.e., propylene glycol (PG)) to dissolve triclosan in an aqueous carrier. There is no solubilizer or surfactant present. Composition A-3 Containing 0.0872% by weight of tri-aerobic, 475% PG aqueous solution, and equilibrated with water. Composition A-3 is 100% triclosan saturated and is a composition of the present invention. Test composition A-4 is " "Placebo" consists of 47.5% by weight of 〇 and is equilibrated with water. & An example illustrates the additional advantage of including a selective hydroxyl-dropping agent in the composition. In particular, it was observed in the previous example at 1 and The excellent range of activity exhibited by the $min contact time can be achieved in the case of hydroxy solvent 2 with a contact time of 30 seconds. This example further illustrates that the composition of the present invention < antibacterial activity is undoubtedly the presence of an antibacterial agent Caused by: IIJII I----- II --- (Please read the note on the back to write this page) · -65- 1284020 A7 B7 63 V. Invention description () . This paper scale applies to Chinese national standards (CNS ) A4 size (210 X 297 mm) 1284020 A7 B7 V. DESCRIPTION OF THE INVENTION (64) Example 4 This example demonstrates that the compositions of the present invention provide acceptable disinfecting efficacy despite the relatively low concentration of disinfecting alcohol. Examples B-1, B-3, and B-5 contain 0.15% by weight of triclosan, 100% saturated. Examples B-2, B-4, and B-6 are comparative examples containing 0% triclosan. (Please read the note on the back first to write this page) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -67- This paper scale applies China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 5 5 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed l· 奈 na · C η d rn N ο 3 小Ο 1 SM W 〇〇〇•S ο UJ 1 1 U) OQ Ο σ 1 ΓΖιΓ ν^γ rr · 〇〇〇ο • UJ 1 1 LO 〇〇•ο ο ο 03 ro 〇〇〇S Ο Uj OO fO οο '〇ο Seven C3 P 〇〇ο οο •ο ο ο CD •k 〇〇〇S ο •UJ ο b I 1 ο 二σ ·〇〇〇ο Uj XX ο •Ο 1 1 ο ο ψ σ\ --------------^---(Please read the notes on the back first Write this page) Order ·- 68 The paper size is applicable to China National Standard (CNS) A4 specification (210 297 297 mm) l284〇2〇A7 V. Invention description (66 The following table summarizes the results of the 15 second limit killing

(請先閱讀背面之注意事 寫本頁) 裝 經濟部智慧財產局員工消費合作社印製 此等結果顯示達成可接受之消毒功效 A , 甚至是在具有齡供 含量之消毒醇及其他多羥溶劑存在知 ^ 呀$下0同時,本私 明之組合物因為活性成分三氯生之非揮發性質而可提供: 續,抗菌功效’而目前市面上之組合物則無法提供持續之 抗菌活性。 特定言之’實例B-3至Β·6說明’本發明组合物之快速抗菌 活性主要係由抗菌劑(如,三氯生)造成,而非消毒醇。此 與先前技藝之揭示内容相反。舉例而言,組合物β_3僅含有 28%之乙醇,但其具有優良之抗菌活性對抗金黃葡萄球菌 及大腸桿菌。先前技藝之教示係依賴高醇濃度(亦即, > 40% )而達成快速、範圍廣泛之抗菌活性。 實例5 69-本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) !284〇2〇 Α7 Β7 五 、發明說明( 67 此一實例說明界面活性劑之種3½ i . 、 ^ 硬類對於組合物抗菌活性之 作用。摘述於下之試驗社吴得7 您w禾你以各種不同之組合物進行, 其含有陰離子界面活性劑或代表性之陽離子、险離 離子、兩性、及非離子界面活性劑^此實例組4 飽和百分比係至少約90%。 ---- --------—裝 i I (請先閱讀背面之注意事寫本頁) 訂:(Please read the note on the back to write this page.) Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Cooperatives, etc. These results show that acceptable disinfection A is achieved, even in disinfectant alcohols and other polyhydric solvents with age content. At the same time, the composition of the present invention can be provided because of the non-volatile nature of the active ingredient triclosan: continued, antibacterial effect' while the currently available compositions do not provide sustained antibacterial activity. Specifically, 'Examples B-3 to 6' indicate that the rapid antibacterial activity of the composition of the present invention is mainly caused by an antibacterial agent (e.g., triclosan) rather than a disinfecting alcohol. This is contrary to the disclosure of the prior art. For example, the composition β_3 contains only 28% ethanol, but it has excellent antibacterial activity against Staphylococcus aureus and Escherichia coli. The teachings of the prior art rely on high alcohol concentrations (i.e., > 40%) to achieve a rapid, wide range of antimicrobial activity. Example 5 69- The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) !284〇2〇Α7 Β7 5. Inventive Note (67 This example shows the species of surfactant 31⁄2 i . , ^ The effect of hard on the antibacterial activity of the composition. It is described in the following test society. Wu De 7 You are using a variety of different compositions, which contain anionic surfactants or representative cations, dangerous ions, bisexual, And non-ionic surfactants ^ This example group 4 saturation percentage is at least about 90%. ---- -------- - Install i I (please read the note on the back first to write this page) Order:

經濟部智慧財產局員工消費合作社印製 -70- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(68 經濟部智慧財產局員工消費合作社印製Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed -70- This paper scale applies China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (68 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative print system

眷 i 〇 •LO Η η 00 〇 Η 〇 Li η 00 ο •LO Q 〇 •UJ § 〇 U) Η Q 〇 U) η CO Ο •UJ ί ο 00 Ο •LO ί Ω 〇 •UJ Η η CO 〇 LO Η 〇 LO Η η CO in · r K 邑+ 二 ΙΟ 2 '〇 S $ -€ 恶 C: n o Ρ Ln s # 笄 H6 2 2 + W 涔 cl ^ 8 ^ pt * r l· > Ο isj ^ m ^ i ν w D 〇 q - Z2 L·^ 系 Ο 恭 >C S袋 JL· l· G § \ l· 0^ )φ 十 十 ? + 十 + + 4. 4- -μ + + 1 + 4- Μ + + f 4- 十 V.。 •S? 2 ^ ί 〇 〇 + 〇 〇 丄 + ί i .-L f + -L + 十 + + 丰 〇 ^ : 今S 71 .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) - — III---- — II - I · I I 1 l· I J— I » — — —— — 1. (請先閱讀背面之注意事寫本頁) 1284020 經濟部智慧財產局員工消費合作社印製 A7 __B7 五、發明說明(69)眷i LO•LO Η η 00 〇Η 〇Li η 00 ο •LO Q 〇•UJ § 〇U) Η Q 〇U) η CO Ο •UJ ί ο 00 Ο •LO ί Ω 〇•UJ Η η CO 〇 LO Η 〇LO Η η CO in · r K 邑+ 二ΙΟ 2 '〇S $ -€ 恶C: no Ρ Ln s # 笄H6 2 2 + W 涔cl ^ 8 ^ pt * rl· > Ο isj ^ m ^ i ν w D 〇q - Z2 L·^ System 恭 > CS bag JL· l· G § \ l· 0^ ) φ Ten? + Ten + + 4. 4- -μ + + 1 + 4- Μ + + f 4- ten V. • S? 2 ^ ί 〇〇+ 〇〇丄+ ί i .-L f + -L + ten + + Feng 〇 ^ : Today S 71 . This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 ))) — III---- — II - I · II 1 l· IJ — I » — — — — 1. (Please read the note on the back first to write this page) 1284020 Ministry of Economic Affairs Intellectual Property Office staff consumption Cooperatives printed A7 __B7 V. Invention description (69)

\ S' \ \ 尝 巻 •7^ 楽Γ hi 〇 Η ο L〇 ί η GO 〇 U> 3 Q 〇 UJ Q 〇 •UJ Η 〇 Uj η in ο •Ui 〇 U> 〇 Η 〇 •LO ί •UJ § η CO 〇 f〇 多b SI ΰ ο 土 ϊ 一 丄 1 l· 荈 一 C0 ; 0 ^ ISJ 〇 κ> 00 一 〇 S ft 4 S ^ w爿 .和 W 雖 一 00 io Q ^ ο t ^ NJ — 2 cn h 5黑 w漭 ί κ ο ^ §7 ? i η 一 s “ r ^ U δ· 系 l· 沴 Eg 9 η -&.— ^ 〇 jaV 苎 l· P l· — > -f w l· C^ a 命 >Φ ο 十 〇 ο + ΐ + 主 τ .1 ? Ο y〇 冷2 ^ ζ ο 〇 〇 〇 〇 ο O ο ο 二内 今S 72 ---------------裝--- (請先閱讀背面之注意事寫本頁)\ S' \ \ 试巻•7^ 楽Γ hi 〇Η ο L〇ί η GO 〇U> 3 Q 〇UJ Q 〇•UJ Η 〇Uj η in ο •Ui 〇U> 〇Η LO•LO ί • UJ § η CO 〇f〇多b SI ΰ ο 土ϊ一丄1 l·荈一C0 ; 0 ^ ISJ 〇κ> 00 一〇S ft 4 S ^ w爿. and W although 00 io Q ^ ο ^ NJ — 2 cn h 5 black w漭ί κ ο ^ §7 ? i η a s “ r ^ U δ·系 l· 沴Eg 9 η -&.— ^ 〇jaV 苎l· P l· — &gt ; -fwl· C^ a fat > Φ ο 十〇ο + ΐ + main τ .1 Ο y 〇 cold 2 ^ ζ ο 〇〇〇〇ο O ο ο 二内今 S 72 ------ ---------Install --- (Please read the note on the back first to write this page)

I 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( 經濟部智慧財產局員工消費合作社印製 hmI This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (Ministry of Commerce, Intellectual Property Bureau, Staff Consumption Cooperative, Printed hm

++ί. >3.99 ί-Γ>2.99 土- >1.99 - V0.99 0 〈SVC .桊 \ .乐 〇 Lj η 00 〇 Uj ί 〇 Lj S go o^ ν〇 s卜 〇 ^ 一荈 Id bo 备 U4 Σ> 漭 l· ♦ 〇 十 Ο沁 兮i yS?S Ο 〇 〇 今S (請先閱讀背面之注意事 寫本頁) 裝 -tr°J. -本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020++ί. >3.99 ί-Γ>2.99 土- >1.99 - V0.99 0 〈SVC .桊\ .乐〇Lj η 00 〇Uj ί 〇Lj S go o^ ν〇s卜〇^ 一荈Id bo Prepare U4 Σ> 漭l· ♦ 〇十Ο沁兮i yS?S Ο 〇〇 Today S (please read the note on the back first) Page -tr°J. -This paper scale applies to Chinese national standards (CNS) A4 size (210 X 297 mm) 1284020

71 五 、發明說明( 經 濟 部 智 慧 財 產 局 員 工 消 費 合 社 印 製 摘述於上之結果說明,意外的,當抗菌劑在組合物中之 飽和百分比南時,亦即,至少5〇%,抗菌劑及陰離子界面 活性劑形成鬲度有效之抗菌組合物。此外,亦觀察到,在 同源系列之界面活性劑中,功效可各有不同(亦即,在燒基 4酸那同源系列中,十二烷基硯酸納及辛烷基硫酸鈉可產 生高效之調配物)。陽離子之功效亦相當無法預期(亦即, 十二烷基硫酸納、銨、及三乙醇銨可提供高效調配物,而 十二垸基硫酸鐘及鎂則否)。 下表摘述界面活性劑種類對於組合物抗菌活性之作用。 此只例何生貫例5所提供之數據。該表包括對於各種組合 7進仃义試驗結果,該等組合物含有陰離子界面活性劑或 是代表性實例,包含陽離+、陰離子/非離子、兩性、及 非離子界面活性劑。 :該等結果說明’各種陰離子界面活性劑皆可形成高度有 =疋系統。與高活性(亦即,同時對於格藍氏陽性(金黃葡 苟球菌)及格藍氏陰性(大腸桿菌)細菌兩者具有高對數減少 作用)相關之界面活性劑包括十二烷基硫酸鈉、辛基硫酸 鈉、2-乙基己基硫酸納、及氧化十二胺。然而,含有氧化 十二胺之組合物之高活性亦可能得古 ^ j牝你王要由孩界面活性劑造 成0 系列I (十二烷基硫酸鹽)說明由 J田險離子造成疋功效作用。 十二烷基硫酸鈉具有最高之功效, 时 刀双 而知'、早乙醇銨、及三 乙醇銨則具有低功效。因十-餘A 丁一从基硫鉍鉀在室溫下之低溶 -74- i張尺度適用中_家標準(CNS)A4規格⑽X 297公f (請先閱讀背面之注意事 寫本頁) 裝 訂·· -7.線- 1284020 A7 _ __ B7 ' -------—-:------ 五、發明說明(72 ) 解度,並未對其進行試驗。 系列I (十二烷基硫酸鹽)及系列η (其他烷基碌峻蹄)之比 較顯示,同源系列中(亦即,正-烷基硫酸鈉)各有不同之功 效。十二烷基硫酸鈉及辛基硫酸鈉可產高效之铜配物,支 鏈界面活性劑2 -乙基己基硫酸鈉亦然。 系列III (垸基羧酸鹽)建議,TCS/羧酸鹽組合物對抗格藍 氏陰性細菌並不具有高度活性,但對抗格藍氏陽性細菌則 具有可接受之活性。 系列IV (含ΕΟ之界面活性劑)則確認界面活性劑中之環氧 乙烷(ΕΟ)傾向於使TCS失活之觀察。SLES-1及SLES_2對抗金黃 葡萄球菌之活性係由此等陰離子/非離子界面活性劑之陰 離子(「似十二烷基硫酸鹽」之特徵)造成。 系列V (其他各種界面活性劑)之結果顯示,此等組合物具 有中至低活性,除外氧化十二胺。LA〇之高活性部分係由該 界面活性劑因其似陽離子特性而單獨造成。系列v之其餘 界面活性劑/TCS組合物則顯示不同之活性對抗金黃葡萄球 菌(格藍氏陽性)及極少之活性對抗大腸桿菌(格益氏陰 性)。 (請先閱讀背面之注意事 裝— 寫本頁) Ί線. 經濟部智慧財產局員工消費合作社印製71 V. INSTRUCTIONS INSTRUCTIONS (The Ministry of Economic Affairs, Intellectual Property Office, Staff Consumers Co., Ltd., printed on the results of the above description, unexpectedly, when the percentage of saturation of the antibacterial agent in the composition is south, that is, at least 5%, antibacterial The agent and the anionic surfactant form an effective antibacterial composition. In addition, it has also been observed that in the homologous series of surfactants, the efficacy may be different (i.e., in the homologous series of the alkyl 4-acid) , sodium dodecyl decanoate and sodium octyl sulfate can produce highly effective formulations. The effect of cations is also quite unpredictable (ie, sodium, ammonium, and triethanolammonium dodecyl sulfate provide efficient blending) And the effect of the surfactant type on the antibacterial activity of the composition. The following is an example of the data provided in Example 5. The table includes various combinations. 7Into the results of the test, the compositions contain anionic surfactants or representative examples, including cationic +, anionic / nonionic, amphoteric, and nonionic surfactants. 'A variety of anionic surfactants can form a highly 疋 system. High activity (ie, simultaneous high log reduction for both Gram-positive (G. aureus) and Gram-negative (E. coli) bacteria Related surfactants include sodium lauryl sulfate, sodium octyl sulfate, sodium 2-ethylhexyl sulfate, and oxidized dodecylamine. However, the high activity of the composition containing oxidized dodecylamine may also be ^ j牝Your king wants to be caused by the surfactant of the child. Series 0 I (dodecyl sulfate) indicates the effect of sputum caused by J Tianzheng. Sodium dodecyl sulfate has the highest efficacy. ', early ethanol ammonium, and triethanolammonium have low efficacy. Because ten-to-A A-one from the base thiopurine potassium at room temperature, low solubility -74-i sheet scale is applicable _ home standard (CNS) A4 specifications (10) X 297 gong f (please read the note on the back to write this page) Binding·· -7. Line - 1284020 A7 _ __ B7 ' ---------:------ V. Description of invention (72) The degree of resolution has not been tested. Series I (dodecyl sulfate) and series η (other alkanes A comparison of the hoofs shows that the homologous series (ie, n-alkyl sodium sulfate) have different effects. Sodium dodecyl sulfate and sodium octyl sulfate can produce high-efficiency copper ligands, and branches The surfactant 2-ethylhexyl sulfate is also the same. The series III (mercaptocarboxylate) suggests that the TCS/carboxylate composition is not highly active against the Gram-negative bacteria, but against the Gram-positive bacteria. It has acceptable activity. Series IV (tantalum-containing surfactant) confirms that ethylene oxide (ΕΟ) in the surfactant tends to inactivate TCS. SLES-1 and SLES_2 against Staphylococcus aureus The active system is thus caused by an anion of an anionic/nonionic surfactant ("dot-dodecyl sulfate"). The results for Series V (other various surfactants) show that these compositions have moderate to low activity, with the exception of oxidized dodecylamine. The highly active portion of LA is caused by the surfactant alone due to its cationic nature. The remainder of the series v surfactant/TCS compositions showed different activities against Staphylococcus aureus (Glan's positive) and very little activity against E. coli (German's negative). (Please read the note on the back first - write this page) Ί线. Printed by the Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative

1284020 A7B71284020 A7B7

73 /V 經濟部智慧財產局員工消費合作社印製 眷 5^ % % % τ 蔡 δ JS\ *^β 1 •2 5 | 2 1 00 •S _ 00 1 d S S s 2 1 Q S S Q 2 1 CO 2 Q _ Q 2 1 ? •s 5 ·: S 〇 ro to 1 to ο" Sd ν〇 lyi to m VC NJ 和 ο "55 K) § Ky\ >52 1/» ί | lyi ί ? he S Kj\ ί 系 Ο 漭 W UJ % % > 5 u» i 彩 1 U) LA 游 1 ON 彝 w Os Ϊ 彩 S i NJ S NJ S U) •NJ ! •UJ Ο έ ν〇 έ Ό UJ -¾ έ I 5 2 έ Ό ί \〇 • i Γ° UJ ui NJ ivj v〇 's - v〇 ! i〇 - jo υί> i〇 - is \ 〇 二 ο LU is 一;? ^ S 1 ! VC Μ UJ \ 1 V V \ S S S \j\ 1 Q S 〇〇 s CO ij ί ·: VC Cj g NJ % as i CTs 运§ mrnmt V w (請先閱讀背面之注咅j事項 寫本頁) ------I - 76 2 1284020 A7 B7 五、發明說明(, 經濟部智慧財產局員工消費合作社印製73 /V Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 眷 5^ % % % τ Cai δ JS\ *^β 1 •2 5 | 2 1 00 •S _ 00 1 d SS s 2 1 QSSQ 2 1 CO 2 Q _ Q 2 1 ? •s 5 ·: S ro to 1 to ο" Sd ν〇lyi to m VC NJ and ο "55 K) § Ky\ >52 1/» ί | lyi ί ? he S Kj\ Ο System 漭W UJ % % > 5 u» i 彩 1 U) LA 游 1 ON 彝w Os Ϊ 彩 S i NJ S NJ SU) •NJ ! •UJ Ο έ ν〇έ Ό UJ -3⁄4 έ I 5 2 έ Ό ί \〇• i Γ° UJ ui NJ ivj v〇's - v〇! i〇- jo υί> i〇- is \ 〇二ο LU is one;? ^ S 1 ! VC Μ UJ \ 1 VV \ SSS \j\ 1 QS 〇〇s CO ij ί ·: VC Cj g NJ % as i CTs § mrnmt V w (please read the note on the back) Page) ------I - 76 2 1284020 A7 B7 V. Invention Description (Printed by the Consumers' Cooperative of the Intellectual Property Office of the Ministry of Economic Affairs

-τίτ 5? \ 屮—4 \ \ < 1 1 呤 CTJ 〇 〇 •LO η 00 Ο LO Η Ω 〇 •LO 〇 U> Η Q 〇 X 〇_ vb ys X ο NJ •Ο 1 •k σ X NJ LO 土 ϋ + 荈 NJ 〇 cT m Ο r S ί: \ l· .漭 〇 ο cn Ο r cn GO 1 V—/ ο 5; δ ρ v〇 0 •么 Ό 乂 *NJ ·&· \/ Xx K V Lo v〇 L〇 v〇 ο υ-> δ •么 CN ό ν〇 〇 3 o δ o •為 CN-τίτ 5? \ 屮—4 \ \ < 1 1 呤CTJ 〇〇•LO η 00 Ο LO Η Ω 〇•LO 〇U> Η Q 〇X 〇_ vb ys X ο NJ •Ο 1 •k σ X NJ LO ϋ + 荈 NJ 〇 cT m Ο r S ί: \ l· .漭〇ο cn Ο r cn GO 1 V—/ ο 5; δ ρ v〇0 • Ό 乂 N*NJ ·&· \ / Xx KV Lo v〇L〇v〇ο υ-> δ • 么 CN ό ν〇〇3 o δ o • for CN

Ξ!荈和焱SMCT穿Ξ!荈 and 焱SMCT wear

5 6 5^ 卜· Η η 00 % Zj ^ Ο Ώ 一 g 冷S W € S (請先閱讀背面之注意事 寫本頁) ---^--^---Γ — 訂----i---- -77- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(乃) 經濟部智慧財產局員工消費合作社印製 详 — \ ΤΪ3 — — 尝 < 1 1 伞· TSS 十 & Η 〇 ί η in ο UJ 2 ri 00 o H 00 Η Ρ Π u> 00 g 〇 Uj on \^J Ά •OJ o 0Q ο L〇 2 d ο U) δ ο UJ 2 d o n 00 o Uj Q ^ % NJ Ο Di il a -δ 桊 Ο1 Ίγ □g > S η > Eg 9 η 公一 〇 κ 苎 l· l· z ft is O NJ 〇 -€ s ΓΠ — A 拉 Ο L〇 l· Μ Σ> 涔 l· 00 〇 C: 1 1 卜 * 5· l· 00 r 00 ο :3 \ 1 l· 濟 s Ίλ Sk Ώ3 e c: 京 p\ ί 漭 > o C; > 〇 ρ ο ο ·: <b ο v〇 s ρ ό s NJ 一 〇 Z V 2 % 2 LO ν〇 u> oo UJ '5 b\ 0C ro VC LO ·§ -u O % Ui Cj V ro \/ •NJ Ο ^ ^ i ~ ^ 今S ο ο I S 0 to 1 p ό 3: P 〇〇 δ Μ LO O •ro oo δ LO LO 〇 O f〇 p s ό s 〇 LO ON δ Ui oo C5 s δ Ξ; A •i > O Xx i: V 么 ON LO V 么 CS LO Cs -78- ---------------裝--- (請先閱讀背面之注意事寫本頁) 一5J. 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) 1284020 A7 B7 五、發明說明(76) 實例7 此一實例說明界面活性劑組合物(亦即,不含羥溶劑及增 溶劑之組合物)中TCSi %飽和之作用。摘述於下表之數據 說明TCSi %飽和對於TCS/界面活性劑/水組合物中TCS功 效之作用。該表之兩部份(亦即,TCS/ALS組合物對抗大腸桿 菌及TCS/SOS組合物對抗金黃葡萄球菌)顯示,隨著%飽和之 減少,抗菌活性亦有顯著之減少。同時,100%飽和之樣本 (0.15%TCS/0.67%ALS)及(0.15%TCS/4.0%SOS)具有接近含 0.3% TCS 之100%飽和樣本之抗菌活性。在此等兩實例中,此等功效 明顯可在該界面活性劑並未顯示強安慰劑滅殺作用之微生 物上得見。 (請先閱讀背面之注意事寫本頁) 經濟部智慧財產局員工消費合作社印製 -79- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(775 6 5^ 卜· Η η 00 % Zj ^ Ο Ώ a g cold SW € S (please read the note on the back first) ---^--^---Γ — order----i ---- -77- The paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (Yes) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing details - \ ΤΪ3 — — Taste < 1 1 Umbrella TSS Ten & Η 〇 η in ο UJ 2 ri 00 o H 00 Η Ρ Π u> 00 g 〇Uj on \^J Ά •OJ o 0Q ο L〇2 d ο U) δ ο UJ 2 don 00 o Uj Q ^ % NJ Ο Di il a -δ 桊Ο1 Ίγ □g > S η > Eg 9 η 公一〇κ 苎l· l· z ft is O NJ 〇- € s ΓΠ — A 拉Ο L〇l· Μ Σ> 涔l· 00 〇C: 1 1 卜* 5· l· 00 r 00 ο :3 \ 1 l· 济 s Ίλ Sk Ώ3 ec: 京 p\ ί漭> o C; > 〇ρ ο ο ·: <b ο v〇s ρ ό s NJ 一〇ZV 2 % 2 LO ν〇u> oo UJ '5 b\ 0C ro VC LO ·§ -u O % Ui Cj V ro \/ •NJ Ο ^ ^ i ~ ^ Today S ο ο IS 0 to 1 p ό 3: P 〇〇δ Μ LO O •ro oo δ LO LO 〇O f〇p s ό s 〇LO ON δ Ui oo C5 s δ Ξ; A •i > O Xx i: V y ON LO V s CS LO Cs -78- --------------- Pack--- (Please read the note on the back to write this page) 1 5J. This paper scale applies to China National Standard (CNS) A4 specification (210 297 297 mm) 1284020 A7 B7 V. Invention Description (76) Example 7 This example illustrates the effect of TCSi% saturation in a surfactant composition (i.e., a composition that does not contain a hydroxy solvent and a solubilizing agent). The data summarized in the table below illustrates the effect of TCSi % saturation on TCS efficacy in TCS/surfactant/water compositions. Two parts of the table (i.e., the TCS/ALS composition against E. coli and the TCS/SOS composition against Staphylococcus aureus) showed a significant reduction in antibacterial activity as % saturation decreased. At the same time, 100% saturated samples (0.15% TCS/0.67% ALS) and (0.15% TCS/4.0% SOS) have antibacterial activity close to 100% saturated samples containing 0.3% TCS. In these two examples, these effects are clearly visible on microbes where the surfactant does not exhibit a strong placebo killing effect. (Please read the note on the back first to write this page) Printed by the Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative-79- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (77

Tns%/%#> S0/100 0.27/90 0.21/70 0.15/50 0.15/100 0/0 0.30/100 0 27/90 021/70 0.15/50 0.15/100 0/0 0.30/100 0.27/90 0.21/70 0.1 0.15/100 4oo%sos 5.751 5.75%sosTns%/%#> S0/100 0.27/90 0.21/70 0.15/50 0.15/100 0/0 0.30/100 0 27/90 021/70 0.15/50 0.15/100 0/0 0.30/100 0.27/90 0.21/70 0.1 0.15/100 4oo%sos 5.751 5.75% sos

5.750/OSOS5.750/OSOS

5.75%SOS5.75% SOS

L60%SLSL60%SLS

oocoyosLSoocoyosLS

.60%SLS.60% SLS

.60%SLS.60% SLS

•60%SLS• 60% SLS

60%SLS60% SLS

.35%ALS.35% ALS

0.67%>LS0.67%>LS

.35%>LS.35%>LS

.35%ALS.35% ALS

• 35%ALS• 35% ALS

.35%ALS.35% ALS

初穿并、一 i#J ----------------裝--- (請先閱讀背面之注意事寫本頁) 2·9§.20 •096/M3 1.59/1.82 2.59/3.04 3.39/3.04 V3.94/V3.94 >3.s/>3.94 >3.94/>3.94 V3.94/V3.94 V3.94/V3.94 v—3.94 V3.97/V3.97 V3.97/V3.97 〉3.97/〉3.97 >3.97/〉3.97 〉3.97/〉3.97 〉3.97/〉3.97 PO2/SS (30S/1 泠恭) )^J·. 1.51/2.96 3.17/>4.46 4.13/V4.46 4.04/X.46 产 36/>4.46 产 36/4.36 0.07/002First wear and one, i#J ---------------- loaded--- (please read the note on the back to write this page) 2·9§.20 •096/M3 1.59/1.82 2.59/3.04 3.39/3.04 V3.94/V3.94 >3.s/>3.94 >3.94/>3.94 V3.94/V3.94 V3.94/V3.94 v-3.94 V3 .97/V3.97 V3.97/V3.97 〉3.97/〉3.97 >3.97/〉3.97 〉3.97/〉3.97 〉3.97/〉3.97 PO2/SS (30S/1 泠恭) )^J·. 1.51 /2.96 3.17/>4.46 4.13/V4.46 4.04/X.46 Production 36/>4.46 Production 36/4.36 0.07/002

U0/3.S 0.09/1.17 0.37/1.54 0.61/2.89 1.39/3.95 E. coli (30S/1冷爸 經濟部智慧財產局員工消費合作社印製 〉4.44/&gt;4.44 V444/V4.44 &gt;4.44/v4.44 〉4.44/&gt;4.44 〉4.i/3.98 -80- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) K. Imeum. (30S/1 冷恭) 1284020 A7 B7 五、發明說明(7δ) 經濟部智慧財產局員工消費合作社印制衣 ri 〇 δ € 00 〇 00 % 逢 s 麥 i Co 〇 i fO UJ 〇 CO 二 s 今B 爸$ ?卜 » — ο S. 爸· Vt V ο ^ % 、、与 Vs •么 ---—-------------^--(請先閱讀背面之注意事寫本頁) --^1 訂----·---- -81 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 79 此 五、發明說明( 實例8 此一實例說日月可作為手部清潔劑之—種 一實例進-步說明-本發明之具體實例,1中二二:。 有以重量計〇·3%之三氯生、〇5%之十二烷基硫酸銨、2〇%之 丙二醇、及10%之二甲苯磺酸鈉,並以水平衡。合物Α-6含 有以重量計0.1%之三氣生、〇125%之二甲苯磺酸銨、20%之 丙二醇、及10%之二甲苯磺酸鈉,並以水平衡。組合物Α-5 及Α·6係100%之二氯生飽和。組合物α_7係「安慰劑」,其含 有以重量計0.5%之十二烷基硫酸銨、2〇%之丙二醇、及1〇% 之二甲苯橫酸鈉,並以水平衡。 1 JI— -裝 i — (請先閲讀背面之注拳寫本頁) ·. 經濟部智慧財產局員工消費合作社印製 -82- ^紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) 1284020 經濟部智慧財產局員工消費合作社印製 A7 __B7 80 五、發明說明() &gt; &gt; 6s &gt; λΙλ 穿 〇 b p 〇 1“ 2 〇 o : o UJ k) NJ - •s V *2 y: 3 5 S LO 卜· 粦 OJ Lo ON V V ’么 $ g o LO bo to UJ La 5 UJ •Ό •to CN i&gt;5 ----------------- (請先閱讀背面之注意事寫本頁) I - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 Α7 Β7 五、發明說明(81 此一實例說明本發明之兩項重要特徵。第一,相較於抗 菌劑在組合物中之飽和百分比而言,三氯生,或其他抗菌 浏之絶對含量較不重要。舉例而言,相較於組合物A_5 (含 有0.3%之三氯生),組合物A_6(含有〇1%之三氯生)至少係相 同有效。重要之特徵係在於兩種組合物皆為之三氯生 飽和。第二,實例5亦明顯顯示,活性抗菌劑係造成絕佳範 圍廣泛抗菌活性之原因。本發明之組合物A_5及A_6明顯較不 含活性抗菌劑之「安慰劑」組合物A-7有較佳之表現。 實例9 此一實例說明羥溶劑及增溶劑可使在其他情形下不具活 性之界面活性劑及抗菌劑組合物產生活性。在下表中,所 有之百分比皆係重量比,且所有組合物皆係以水平衡。組 合物B含有1.35%之十二烷基硫酸銨(ALS)及0.3%之三氯生 (TCS)。組合物C含有1.35%ALS及0.0%TCS。組合物D含有 0.25% ALS、14.4% DPG、10.0% SXS、及 0.3% TCS,且組合物 E 含 有 0.25% ALS、14.4% DPG、10.0% SXS、及 0·0% TCS。化合物 F 含 有2.5%之烷基聚葡糖(APG™)及0·3% TCS。化合物G含有 0.3% APG、14.4%之二丙二醇(DPG)、10%之二甲苯磺酸鈉 (SXS)、及 0.3% TCS。化合物 Η 含有 0.3% APG、14.4% DPG、 10% SXS、及0.0% TCS。組合物I含有1.25%之可可兩性乙酸鈉 (SCA)及 0.3%TCS。組合物 J 含有 0.25%SCA、14.4%DPG、 10.0% SXS、及 0.3% TCS。組合物 K 含有 0.25% SCA、14.4% DPG、 10.0% SXS、及0.0% TCS。组合物L含有1.75%之可可醯胺丙基 三曱銨乙内酯(CAPB)及0.3% TCS。組合物Μ含有0.25% CAPB、 -84- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事 寫本頁) 經濟部智慧財產局員工消費合作社印製 1284020 A7 — __B7___ 五、發明說明(δ2) 14.4% DPG、 10.0% SXS、及.0.3% TCS。組合物 N 含有 0.25% CAPB、14.4% DPG、10.0% SXS、及 0·0% TCS。組合物 0 含 有 4% 之 octoxynol_9 ( TRITON Χ-100ΤΜ,ΤΧ100)。組合物 Ρ 含有 0.75% ΤΧ100、14.4% DPG、10.0% SXS、及 0.3% TCS。組合物 Q 含 有1.25%之十二烷基醚硫酸鈉(1 EO,SLES-1)及0.3% TCS。組合 物 R 含有 0.25% SLES-卜 14.4% DPG、10.0% SXS、及 0.3% TCS。 • 1 1 IU ϋ ϋ 1 n I ϋ ϋ n I · ϋ ·ϋ n I I 1_1 · ϋ a— ·ϋ Ί— ι ·ϋ - (請先閱讀背面之注意事寫本頁) 經濟部智慧財產局員工消費合作社印製 5 8 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( S3, 經濟部智慧財產局員工消費合作社印製 一 C TJ ΓΏ σ n CO 〇 '〇 2 ο •LO ο S UJ •o 〇 •LO •O 〇 Uj l·、 〇 •NJ GO η &gt; •為 σ ρ 〇 00 X 00 ο NJ on 〇 &gt; •為 σ ρ ο ο 00 X 00 Μ 00 η &gt; ο Lj &gt; -ο ρ •二 •σ &quot;0 ρ •ο CO X GO ο •UJ S -d ρ 么 α Π3 ρ ο ο CO K) &gt; o 〇 to &gt; Ξ 〇 p 5 〇 GO &gt;&lt; CO o *NJ &gt; •么 a υ p o § CO □ &gt; ·: L/i &gt; 拉. 〇 丄 ο 丄 ο Ο 上 ο 丄 o 上 o 厶 ο o 丄 〇 ν〇 〇 &quot;〇〇 σ\ 〇 be oc V 么 UJ VC Uj VO ρ &lt;b 3 S V as ν〇 CN ν〇 VO •LO '— ·: V LO g LO •g V LO v〇 V UJ VC V UJ v〇 岑 VO Ό i&gt;3 c§ 玄i ro Ό Ο *s V ό ρ V ν〇 Ο 么 Ln .〇 La OC V bv VC V Sx bv v〇 V ro •二 vC V* 公 oo V •UJ OO 么 Uj oc ό •i CD •LO V〇 UJ •v〇 §s ----.-----------(請先閱讀背面之注意事寫本頁) ·- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( 84 經濟部智慧財產局員工消費合作社印製 7〇 Ο -3 Ο 2 X 广 •e 〇 •UJ Ο S ο ㊁ .〇 Ui o U&gt; W • ^ 〇 N) 00 r cn CO 1 Ξ σ -α ρ ρ ο GO X 00 CO r m CO 1 么 X ο •Ξ α ρ 5 ο 00 X 00 么 X '〇 ο *fO n &gt; *·Ό CD •么 a p •o o GO X! 00 o io n &gt; -a C3 σ &quot;T3 p o 00 X 0Q n &gt; &quot;O Cd ο 上 ο 上 Ο 丄 ο l o 〇 上 o ν〇 •NJ V •ΟΝ ο -CX •ΟΝ ν〇 Ό Lj s V UJ g LO V UJ v〇 % UJ VC V UJ UJ O a ^ i 玄1 念_ % 、十 % 弟 V α\ % 么 CN Ό Ο 〇〇 V •ΟΝ V* 么 ΟΝ ν〇 90 V 'lo oc LO OC ό o 6 g o Ui VC UJ Ό C/3 〜· 87 .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ---1----------裝---^--^(請先閱讀背面之注意事寫本頁) ϋ an 一一、 ϋ ·ϋ Ί§ I βϋ - 1284020 A7 五、發明說明( 摘述於上表之限時滅殺試驗結果非常意外的顯示,使用 ㈣劑及增溶劑可使單獨僅具有低至中功效之界面活性劑 / TCS組合產生南抗菌活性(亦即,比較組合物F對G ; I對 J ’ L對Μ ’及Q對R〈功效)。經溶劑及增溶劑亦可使活性 組合物在更短之接觸時間内產生更高之活性(亦即,比較組 口物Β對D )。特別思外者係觀察到巍溶劑及增溶劑可使甚 至是含有非離子界面活性劑(亦即,〇—〇1-9)之組合物產 生對抗大腸桿菌之活性(比較組合物〇對p )。此一結果係音 外者,因為已知多乙氣甚π &gt; w 心 、 ^虱暴化之界面活性劑可使酚抗菌劑失 活。 實例10 此一實例說明%飽和在含有羥溶劑及增溶劑之組人物 之重要性。如在界面活性劑/TCS組合物中所觀臾到; 菌劑在組合物連績水相中之相對%飽和亦大量:塑八,抗 溶劑及增溶劑之組合物之抗菌活性。如摘 心θ含有羥 _ 、於下之f 士要# 示,此種對於抗菌活性之影響就格藍氏陰 ^ 伯氏桿菌而言特別明顯。 -围肺炎克雷 - --- (請先閱讀背面之注意事寫本頁) 1^1 線! 經濟部智慧財產局員工消費合作社印製 -88- 表紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(S6) 經濟部智慧財產局員工消費合作社印製 N ·&lt; X &lt; C Η ζΛ P b 〇 UJ 〇 UJ 〇 •UJ 〇 〇 s 2 2 ·〇 〇 g o o ο ο ro &gt; 2 § § &gt; &gt; &gt; &gt; &gt; &gt; &gt; NJ La Κ) to s: •ξ 〇 α σ La o 〇 o α •么 σ P 〇 〇 p s s *Τ3 ρ ·〇 ρ 5 ·〇 〇 〇 ρ ·〇 〇 O 5 ο ο ο C/D 00 〇 r^s o 京 O ο X OQ X 00 泛 X m 00 X 00 00 00 X CO .cn X 00 〇 Λ X Λ l mmm o ώ Η (λ ι •Μ» -89 - (請先閱讀背面之注意事 寫本頁) i裝 訂·- .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 經濟部智慧財產局員工消費合作社印製 A7 __B7 五、發明說明(87)U0/3.S 0.09/1.17 0.37/1.54 0.61/2.89 1.39/3.95 E. coli (30S/1 Cold Daddy Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed>4.44/&gt;4.44 V444/V4.44 &gt;4.44 /v4.44 〉4.44/&gt;4.44 〉4.i/3.98 -80- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) K. Imeum. (30S/1 寒恭) 1284020 A7 B7 V. Invention Description (7δ) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed clothing ri 〇δ € 00 〇00 % Every s Mai i Co 〇i fO UJ 〇CO 2 s Today B Daddy $ 卜 » — ο S. Dad · Vt V ο ^ %, and Vs • What-----------------^--(Please read the note on the back first to write this page) --^ 1 订--------- -81 - This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 79 This five, invention description (Example 8) This example says the sun and the moon It can be used as a hand cleaner - an example of the step-by-step description - a specific example of the invention, 1 in the second two: There are 3% by weight of triclosan, 〇 5% Ammonium dodecyl sulfate, 2% propylene glycol, and 10% sodium xylene sulfonate, and equilibrated with water. Α-6 contains 0.1% by weight of tris, 〇 125% xylene Ammonium sulfonate, 20% propylene glycol, and 10% sodium xylene sulfonate, and equilibrated with water. Compositions Α-5 and Α6 are 100% dichlorosodium saturated. Composition α_7 is a "placebo" It contains 0.5% by weight of ammonium lauryl sulfate, 2% by weight of propylene glycol, and 1% by weight of sodium xylene xylate, and is equilibrated with water. 1 JI---i- (please read the back first) The note is written on this page. ·. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed -82- ^ Paper scale applies China National Standard (CNS) A4 specification (210 X 297 public) 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative Print A7 __B7 80 V. Invention description () &gt;&gt; 6s &gt; λΙλ 〇 bp 〇1“ 2 〇o : o UJ k) NJ - •s V *2 y: 3 5 S LO 卜·粦OJ Lo ON VV 'What $ go LO bo to UJ La 5 UJ •Ό •to CN i&gt;5 ----------------- (Please read the note on the back first to write this page ) I - the paper size is suitable China National Standard (CNS) A4 size (210 X 297 mm) 1284020 Α7 Β7 V. invention is described in (81 this Example illustrates two important features of the present invention. First, the absolute content of triclosan, or other antibacterials, is less important than the percentage of saturation of the antibacterial agent in the composition. For example, composition A_6 (containing 1% triclosan) is at least as effective as composition A_5 (containing 0.3% triclosan). An important feature is that both compositions are triclosan saturated. Second, Example 5 also clearly shows that active antimicrobial agents are responsible for the excellent range of broad antimicrobial activity. The compositions A_5 and A_6 of the present invention are significantly better than the "placebo" composition A-7 which does not contain an active antibacterial agent. EXAMPLE 9 This example illustrates that a hydroxy solvent and a solubilizing agent can render surfactants and antimicrobial compositions that are otherwise inactive in other situations active. In the table below, all percentages are by weight and all compositions are water balanced. Composition B contained 1.35% ammonium dodecyl sulfate (ALS) and 0.3% triclosan (TCS). Composition C contained 1.35% ALS and 0.0% TCS. Composition D contained 0.25% ALS, 14.4% DPG, 10.0% SXS, and 0.3% TCS, and Composition E contained 0.25% ALS, 14.4% DPG, 10.0% SXS, and 0. 0% TCS. Compound F contained 2.5% alkyl polyglucose (APGTM) and 0.3% TCS. Compound G contained 0.3% APG, 14.4% dipropylene glycol (DPG), 10% sodium xylene sulfonate (SXS), and 0.3% TCS. The compound Η contains 0.3% APG, 14.4% DPG, 10% SXS, and 0.0% TCS. Composition I contained 1.25% sodium cocoamphoacetate (SCA) and 0.3% TCS. Composition J contained 0.25% SCA, 14.4% DPG, 10.0% SXS, and 0.3% TCS. Composition K contained 0.25% SCA, 14.4% DPG, 10.0% SXS, and 0.0% TCS. Composition L contained 1.75% cocoamidipropyl triammonium lactone (CAPB) and 0.3% TCS. Composition Μ contains 0.25% CAPB, -84- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) (please read the note on the back to write this page) Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed 1284020 A7 — __B7___ V. Description of invention (δ2) 14.4% DPG, 10.0% SXS, and .0.3% TCS. Composition N contained 0.25% CAPB, 14.4% DPG, 10.0% SXS, and 0. 0% TCS. Composition 0 contained 4% of octoxynol_9 (TRITON Χ-100ΤΜ, ΤΧ100). The composition Ρ contains 0.75% ΤΧ100, 14.4% DPG, 10.0% SXS, and 0.3% TCS. Composition Q contained 1.25% sodium lauryl ether sulfate (1 EO, SLES-1) and 0.3% TCS. Composition R contained 0.25% SLES-Bu 14.4% DPG, 10.0% SXS, and 0.3% TCS. • 1 1 IU ϋ ϋ 1 n I ϋ I n I · ϋ ·ϋ n II 1_1 · ϋ a— ·ϋ Ί — ι ·ϋ - (Please read the note on the back first to write this page) Ministry of Economic Affairs Intellectual Property Office staff Consumer Cooperatives Printed 5 8 Paper Scales Applicable to China National Standard (CNS) A4 Specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (S3, Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed a C TJ ΓΏ σ n CO 〇'〇2 ο •LO ο S UJ •o 〇•LO •O 〇Uj l·, 〇•NJ GO η &gt; • σ ρ 〇00 X 00 ο NJ on 〇&gt; • σ ρ ο ο 00 X 00 Μ 00 η &gt; ο Lj &gt; -ο ρ • 二•σ &quot;0 ρ •ο CO X GO ο •UJ S -d ρ αα Π3 ρ ο ο CO K) &gt; o 〇to &gt; Ξ 〇p 5 〇GO &gt;&lt; CO o *NJ &gt; • What a υ po § CO □ &gt; ·: L/i &gt; Pull. 〇丄ο 丄ο Ο 上 ο 丄o on o 厶ο o 丄〇ν〇〇&quot;〇〇σ\ 〇be oc V UJ VC Uj VO ρ &lt;b 3 SV as ν〇CN ν〇VO •LO '— ·: V LO g LO •g V LO v 〇V UJ VC V UJ v〇岑VO Ό i&gt;3 c§ 玄 i ro Ό Ο *s V ό ρ V ν〇Ο LLn .〇La OC V bv VC V Sx bv v〇V ro •2 vC V* public oo V •UJ OO UUj oc ό •i CD •LO V〇UJ •v〇§ s ----.-----------(Please read the note on the back to write this page) ·- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. INSTRUCTIONS (84 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 7〇Ο -3 Ο 2 X 广 • e 〇 • UJ Ο S ο 二 .〇Ui o U&gt; W • ^ 〇N) 00 r cn CO 1 Ξ σ -α ρ ρ ο GO X 00 CO rm CO 1 XX ο •Ξ α ρ 5 ο 00 X 00 What X '〇ο *fO n &gt; *·Ό CD • What ap •oo GO X! 00 o io n &gt; -a C3 σ &quot;T3 po 00 X 0Q n &gt;&quot;O Cd ο 上上上上 丄ο lo 〇上o ν〇•NJ V •ΟΝ ο -CX •ΟΝ ν 〇Ό Lj s V UJ g LO V UJ v〇% UJ VC V UJ UJ O a ^ i Xuan 1 _ _ %, ten % brother V α\ % CNCN Ό 〇〇 〇〇V •ΟΝ V* 么ΟΝ ν〇 90 V 'lo oc LO OC ό o 6 go Ui VC UJ Ό C/3 ~· 87 . This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 )) ---1----------装---^--^(Please read the note on the back first to write this page) ϋ an one, ϋ ·ϋ Ί§ I βϋ - 1284020 A7 V. INSTRUCTIONS INSTRUCTIONS (The results of the time-limited killing test described above are very unexpected. The use of (iv) agents and solubilizers allows the use of only low to medium efficacy surfactant/TCS combinations to produce south antibacterial activity ( That is, the composition F is compared to G; I versus J 'L versus Μ ' and Q versus R < efficacy). The solvent and solubilizing agent can also result in a higher activity of the active composition in a shorter contact time (i.e., comparing the component Β to D). In particular, it has been observed that hydrazine solvents and solubilizers can even produce compositions against non-ionic surfactants (ie, 〇-〇1-9) against E. coli (comparative composition 〇 p) . This result is due to the fact that the phenolic antibacterial agent is inactivated by the surfactants known to be multi-ethylene, π &gt; w heart, and 虱 虱. Example 10 This example illustrates the importance of % saturation in a group of people containing hydroxy solvents and solubilizers. As observed in the surfactant/TCS composition; the relative % saturation of the microbial agent in the aqueous phase of the composition is also substantial: the antibacterial activity of the composition of the plastic, antisolvent and solubilizing agent. For example, the topping θ contains hydroxy _, and the lower cf 士要# shows that the effect on the antibacterial activity is particularly obvious in the case of the gram-negative bacterium. - Around the pneumonia Cray - --- (Please read the note on the back to write this page) 1 ^ 1 line! Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed-88- Table Paper Scale Applicable to China National Standard (CNS) A4 Specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (S6) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumption Cooperative Print N ·&lt; X &lt; C Η ζΛ P b 〇UJ 〇UJ 〇•UJ 〇〇s 2 2 ·〇〇goo ο ο ro &gt; 2 § § &gt;&gt;&gt;&gt;&gt;&gt;&gt; NJ La Κ) to s: •ξ 〇α σ La o 〇o α • σσ P 〇〇pss *Τ3 ρ ·〇ρ 5 ·〇〇〇ρ ·〇〇O 5 ο ο ο C/D 00 〇r^so 京O ο X OQ X 00 Pan X m 00 X 00 00 00 X CO .cn X 00 〇Λ X Λ l mmm o ώ Η (λ ι •Μ» -89 - (Please read the back of the note first) Write this page) i binding ·- . This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 __B7 V. Invention Description (87)

N -&lt; X &lt; C H OQ AX 1 1 1 1 1 1 1 1 o s VC 3 δ LO V LO •On NJ •CN fO V U) bs NJ LO •ON ro If 1 1 1 1 * 着 1 1 LO |NJ iSr U Ό 乂 l/» Ό \7 •EX v〇 乂 VO V* 么 VO V Ό \7 么 v〇 !§: 1 t 1 ,1 • 1 » 1 〇 •to 〇〇 s 〇 '〇〇 Ό U) (〇 *Cn v〇 NJ LO %&lt;X *5 σ\ S 11 bo Ο to to *u&gt; UJ •NJ NJ OC UJ UJ •VC v〇 UJ VC ro V* LO *0C Ln o V LO OC l-n V UJ bo \7 LO OC V-Tl V UJ OC n7 LO OC II -90- ---------------裝—— (請先閱讀背面之注意事寫本頁) · 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) l284〇2〇 五、 發明說明( B7 88 經 濟 部 智 慧 財 產 局 ^ ^數冑其明顯可知抗菌活性之增加(其如限時減 奴執驗所測)係與抗菌劑在特 時減 相1此—實㈣—、且°物水相中/°飽和〈增加 Λ例尚顯不,在維持活性抗菌劑之高%飽# :係有含::菌劑'界面活性劑如^ tMdi 此-實例,協同實例10,說明似之%飽和在含有幾溶 :炅増溶劑、及界面活性劑之组合物中之作用。如 早f面活性劑/TCS组合物所觀察到者,抗菌劑在組合物; ,相對。/。飽和亦影響含有幾溶劑及/或增落劑之組合物之 杬因活:。自摘述於實例10之表及下表中之數據,其明顯 I知抗因活性又顯著增加(其如限時滅殺試驗所測)係與抗 菌劑在特定類型组合物中%飽和之增加相關。該 自兩個不同方面說明此種作用。實例1〇之表係顯示,在使 其他組合物组成份之量維持怪定時,改變界面活性劑濃度 〈作用。下表則係顯示’在使所有其他组成份之濃度唯ς 怪定時,改變TCS濃度之作用4實例1〇之表中,有關%飽 和之資料係相對性者,因%飽和難以直接計算。就算是使 用此種足性數據,Test %飽和之作用亦可自兩表中之所有 試驗微生物明顯得見。 rt-4----------裝 (請先閱讀背面之注豸^-^^豸本頁yN -&lt; X &lt; CH OQ AX 1 1 1 1 1 1 1 1 os VC 3 δ LO V LO • On NJ • CN fO VU) bs NJ LO • ON ro If 1 1 1 1 * With 1 1 LO | NJ iSr U Ό 乂l/» Ό \7 •EX v〇乂VO V* VO V Ό \7 么 v〇!§: 1 t 1 ,1 • 1 » 1 〇•to 〇〇s 〇'〇〇 Ό U) (〇*Cn v〇NJ LO %&lt;X *5 σ\ S 11 bo Ο to to *u&gt; UJ •NJ NJ OC UJ UJ •VC v〇UJ VC ro V* LO *0C Ln o V LO OC ln V UJ bo \7 LO OC V-Tl V UJ OC n7 LO OC II -90- --------------- Packing - (Please read the note on the back first) On this page) · This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) l284〇2〇5, invention description (B7 88 Ministry of Economic Affairs Intellectual Property Bureau ^ ^ number, it is obvious that the increase of antibacterial activity (It is measured by the time limit reduction test) and the antibacterial agent is depleted in the special time 1 - the actual (four) -, and the water phase / ° saturation < increase the example is not, in the maintenance of active antibacterial agent High % saturated # : The system contains:: bacteria agent 'surfactant such as ^ tMdi this - example, synergistic example 10, indicating that it seems to be saturated in a few solvents: 炅The role of the oxime solvent, and the composition of the surfactant. As observed in the early surfactant/TCS composition, the antimicrobial agent is in the composition; and the relative saturation also affects the inclusion of several solvents and/or additions. The activity of the composition of the tableting agent: from the data summarized in the table of Example 10 and the table below, it is apparent that the activity of the agent is significantly increased (as measured by the time-limited killing test) and the antibacterial agent. The increase in % saturation is associated with a particular type of composition. This is illustrated by two different aspects. The appearance of Example 1 shows that the concentration of surfactant is varied while maintaining the composition of the other components. The following table shows that in the table of the example of the effect of changing the concentration of all other components, the effect of changing the concentration of TCS 4, the relative saturation of the data on % saturation is difficult to calculate directly because of % saturation. Even with this kind of footing data, the effect of Test % saturation can be clearly seen from all the test organisms in the two tables. rt-4---------- loaded (please read the note on the back first)豸^-^^豸this page y

• n n I -----訂-· .線· 消 費 合 社 印 製 -91 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(89) 0.103 0.166 0.207 0.248 P300 0.330 P372 o.±3 wfllt % 5%DPG,• nn I -----订-· . . . · Consumer Co-operative Printing -91 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Description of invention (89) 0.103 0.166 0.207 0.248 P300 0.330 P372 o.±3 wfllt % 5%DPG,

5%DPP5% DPP

5%DPP5% DPP

5%DPP5% DPP

5%DPP5% DPP

5%DPP5% DPP

5%DPP5% DPP

5%DPP (請先閱讀背面之注意事5% DPP (please read the notes on the back first)

5%SXS, 0.75%ALS5% SXS, 0.75% ALS

5%sxsro.75%ALS5% sxsro.75% ALS

5%sxso.75%ALS5% sxso.75% ALS

5%SXS5% SXS

0.75%&gt;LS0.75%&gt;LS

5%SXS 0.75%Ars5% SXS 0.75% Ars

5%SXS 0.75%Ars 5%SXS, 0.75%Ars5% SXS 0.75% Ars 5% SXS, 0.75% Ars

5%SXS, 0.75%ALS 和多Λ/ν 25 50 60 73 80 90 i % &lt;? 1.72/1.93 1.94/2.15 1.96/3.05 302/4.05 〉4.55/&gt;4.55 〉4.55/&gt;4.55 V4.55/V4.55 V4.55/V4.55 •s*. ires (30S/60S)5% SXS, 0.75% ALS and multi-Λ/ν 25 50 60 73 80 90 i % &lt;? 1.72/1.93 1.94/2.15 1.96/3.05 302/4.05 〉4.55/&gt;4.55 〉4.55/&gt;4.55 V4.55 /V4.55 V4.55/V4.55 •s*. ires (30S/60S)

HQ 寫本頁) 裝 «. 經濟部智慧財產局員工消費合·作社印製 .^/2.78 2.30/V3.8 2.45/V3.8 2.73/V3.8 3.40/V3.8 3.46/&gt;3.8 3.81/&gt;3.8 V3.81/V3.81 K. pneum· (30S/60S) 漳犛糸:&gt;'(γξη€:&amp;) -92- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7HQ Write this page) Install «. Ministry of Economic Affairs Intellectual Property Bureau employee consumption and production company printing. ^/2.78 2.30/V3.8 2.45/V3.8 2.73/V3.8 3.40/V3.8 3.46/&gt;3.8 3.81/&gt;3.8 V3.81/V3.81 K. pneum· (30S/60S) 漳牦糸:&gt;'(γξη€:&amp;) -92- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7

此-實例說明不同含量_劑及增溶㈣於抗菌功效々 =。特定言之,摘述於下表之數我明改㈣溶劑㈣ /合剑相對含量 &lt; 作用。尚應注記者,香精(pF)及/或防肩 4 ( DMDM)在组合物中之添加對於组合物之抗菌功效僅具肩 微量影響,如其有任何影響時。 ---^----------裝 i . (請先閱讀背面之注意事寫本頁} 訂 線 經濟部智慧財產局員工消費合作社印製 -93- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 91 五、發明說明() 經濟部智慧財產局員工消費合作社印製This - examples illustrate different levels of _ agents and solubilization (four) in the antibacterial effect 々 =. In particular, the number of the following table is summarized in the following table: (4) solvent (four) / relative content of the sword &lt; role. It should be noted that the addition of flavor (pF) and/or vestibule 4 (DMDM) to the composition has only a minor effect on the antimicrobial efficacy of the composition, if any. ---^---------- Install i. (Please read the note on the back first to write this page} Customize the Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -93- This paper scale applies to China Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 91 V. Invention description () Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing

-94- (請先閱讀背面之注意事 裳--- 寫本頁) · .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(92) 經濟部智慧財產局員工消費合作社印製-94- (Please read the note on the back first---write this page) · This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention description (92) Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperative, printing

-95 - (請先閱讀背面之注意事 寫本頁) -裝 ϋ n I— 1 ,fl 11 IV ^IBi in an · -\-口 ' 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 經濟部智慧財產局員工消費合作社印製 A7 _B7 五、發明說明(93) 96 CD σ &gt; &gt; &gt; 吟 ο *〇 ο |π ^ Ρ &gt; •么 α ο &gt; Ξ •么 α rs ρ ο 00 X 00 % Zj ^ 11 Vr B ο ro 〇〇 ρ NJ οο V Ό La ν〇 〇 ^ m ^ S g ^ CN 。 gl i沁 g.- •-----------------(請先閱讀背面之注意事寫本頁) -Γ . 本紙張尺度適用中國國家標準(CNS)A4規格(210 χ 297公釐) 1284020 經濟部智慧財產局員工消費合作社印製 A7 五、發明說明( 就組合物S、T、U觀察到,對抗金黃葡萄球菌及肺炎 克雷伯氏捍菌之抗菌活性特別會隨W界面活性劑之減 少(亦即,丁以之%飽和之增加)而增加。組合物cc、HH、 MM、及RR顯示,在含有羥溶劑及增溶劑之組合物中,約 15=或以上之SXS係較佳者,以產生對抗肺炎克雷伯氏桿菌 ,同活性。此一觀祭結果建議,增溶劑可能可作為之佐 劑,因顯著抗菌滅殺(亦即,至少2之對數減少作用)所需之 時間可獲得縮減。 實例13 摘述於下表之數據可支持一理論,說明改良抗菌功效之 兩項主要因子係相對於含有界面活性劑、羥溶劑、及抗菌 ,之組,物中抗菌劑含量之界面活性劑及增溶劑相對含 I。軚尚百分比之界面活性劑可減少%飽和,並因而減少 组合物之抗菌活性。另一方面,較高百分比之增溶劑似乎 可提供較高之活性對抗部分微生物,b,肺炎克雷伯氏捍 菌及霍亂沙門氏桿菌。因此推論,組合物中較高百分比之 增溶劑可在组合物之水(亦即,非微膠粒)相中提供較大量 之活性抗菌劑,因而提供較高之限時減殺活性。因此,該 溶劑可在此等組合物中同時作為增進抗菌活性及提供較i 物理穩定性之添加物。 -97- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐)-95 - (Please read the note on the back to write this page) -Installation n I-1, fl 11 IV ^IBi in an · -\-口' This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 _B7 V. Invention description (93) 96 CD σ &gt;&gt;&gt; 吟ο *〇ο |π ^ Ρ &gt; • αα ο &gt ; α •α α rs ρ ο 00 X 00 % Zj ^ 11 Vr B ο ro 〇〇ρ NJ οο V Ό La ν〇〇^ m ^ S g ^ CN . Gl i沁g.- •-----------------(Please read the note on the back to write this page) -Γ . This paper scale applies to China National Standard (CNS) A4 Specifications (210 χ 297 mm) 1284020 Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative, Printed A7 V. Invention Description (Antibacterial against Staphylococcus aureus and Klebsiella pneumoniae observed in composition S, T, U) The activity will increase in particular with a decrease in the W surfactant (i.e., an increase in the saturation of the butyl group). The compositions cc, HH, MM, and RR show that in compositions containing a hydroxy solvent and a solubilizing agent, 15= or more of the SXS system is preferred to produce the same activity against Klebsiella pneumoniae. This observation result suggests that the solubilizing agent may be used as an adjuvant due to significant antibacterial killing (ie, at least The logarithmic reduction of 2) can be reduced by the time required. Example 13 The data summarized in the table below supports a theory that two major factors that improve antimicrobial efficacy are relative to surfactants, hydroxyl solvents, and antimicrobials. , the group, the surfactant and the solubilizer of the antibacterial agent content The surfactant containing a percentage relative to I can reduce % saturation and thus reduce the antimicrobial activity of the composition. On the other hand, a higher percentage of solubilizer appears to provide higher activity against some microorganisms, b, pneumonia Salmonella typhimurium and Salmonella cholerae. It is therefore inferred that a higher percentage of solubilizer in the composition provides a greater amount of active antimicrobial agent in the water (i.e., non-microcapsule) phase of the composition, thus providing The higher limit is to reduce the activity. Therefore, the solvent can be used as an additive to enhance the antibacterial activity and provide more physical stability in the composition. -97- The paper scale is applicable to the Chinese National Standard (CNS) A4 specification ( 21〇x 297 mm)

裝--- (請先閱讀背面之注意事寫本頁) . · 1284020 A7 石- 5 9 經濟部智慧財產局員工消費合作社印製 | 1 O ΓΠ s Ό n 1 S 1 GO 1 d •Ξ .肩 CO 2 '8 2 Q % d 2 p u to 1“ X in GO - ο Ξ I! ρ§ Ι&gt; ο 二 •S专 ^ α ξ δ ι&gt; ο s ^ ^ σ ^ ρ g 1貪 § ξ X ^ ρ p G § Ξ p P r Ο ζΛ on sx S O GO -g I s KJ\ o oo is p 0 5&gt; o zn I: 1 s g p i oo CO s g § oo 00 % ϊ ν〇 ν〇 ν〇 ν〇 \j\ ν〇 1 VO s ίο Lj s Ui •s s E s g S - bo s g i CTN LO UJ s 11 S UJ V V OJ .¾ h v〇 二 v〇 vC \ VO h v〇 卜 K&gt; X Lj oo UJ oo S 之 乂 00 ρ ζ 1 1 么 S 〇〇 | 2 v〇 Ui ro s u&gt; .s NJ 2 LO ! Ui L/i 2 S v〇 11 -S5 5 UJ V 乂 N&gt; 2 oc LA Ui s 3 - oc La - bo \j\ - ·〇〇 - be NJ 5 V 2 Cv 乂 ρ (請先閱讀背面之注意事 ---裝--- 寫本頁) % 1284020 A7 五 \ly 6 9 經濟部智慧財產局員工消費合作社印製 | &lt; | in 00 00 o o o o 1 •Ξ s I s S 1 •s 2 d | GO δ 2 H - s 5 Ω In 一 〇 P ^ P “ 11 5 S b ^ IB P — o .° -η Ο 妄g ο P •o ·〇 li 〇§ w p « Ml 〇产 •O · 么 5 S ·〇 S 絆 x y1 y — O产 S § 5 S O 以 X .00 y - o十 S $ 11 11 x - o丘 尋g -a 5 S §5 O.^ SI 11 託 j^3么 S § 〇§ I? X in 00 - Ο么 •o · 么 Is % UJ •NJ UJ l UJ δ U&gt; h UJ oo V V S UJ S O LO OO s i a 凉. 2 B NJ Ϊ Κ&gt; \ f〇 s \ NJ .I ? 、\ I UJ 3 乂 V V GO 11 NJ •Os OJ UJ to · oo LO b\ uj •i i '5 K&gt; OJ 'i UJ I Ln i •s LJ •g 飞 11 S5 3 , - be ! 〇〇 - bo - oo Ϊ OO - bo \ oc - oo bo - oc UJ oc f〇 | l \ UJ •g \ l ;1 11 (請先閱讀背面之注意事 ---裝---- 寫本頁) 訂· Γ . 99 1284020 A7 B7 五、發明說明(97) 經濟部智慧財產局員工消費合作社印製 Ό Ό Ό α n n n n σ CD a CD &gt; &gt; &gt; &gt; N N N &lt; -&lt; X X X η in UJ H n 00 〇 Lj H 〇 00 L〇 n C/3 0&quot;^ i d U&gt; n 00 CD •υυ w ^ P ο kj\ ^ 以 in &gt; X r OJ 〇〇 P ·&lt; 〇 a 5 2 • ^ §g cn &gt; o • V-Λ τι Ο o (-Λ 00 &gt; x r 〇〇 oo w &gt;* 〇 u* O 〇 a 2 P 5 S • ^ §g 〇〇 O s § # s p -P 〇 Uo 〇 〇 0s s ^ &gt; 00 广 ^ &gt;&lt;^ σ,r 2 〇 ^ ^ ^ a &quot;n p o 〇 〇 o^ isj ^ &gt; G c/3 r H⑺ a .00 - 2: 〇产 a 〇 ^ ^ ^ a -Γ1 p —ο .° '〇 §g C/D X in CO -- 、0 a Ip &gt; 乂 O -Ds. 〇 V 二 o o V o % o V o ο •么 oc NJ V LO '〇〇 V UJ oo UJ 乂 NJ LO 么 NJ UJ 1» % Vt U) •丄x oc LO OC NJ La uj LO o $ •NJ OC UJ •g 1 s Ui % Xu V 么 λ. V V '〇 ro 二 On ΓΌ i ^ in § δ g ^ o •v〇 NJ 〇 λ. Ό UJ Ln ON o SJ ^J\ δ N) UJ 5 UJ •ON CN o UJ oc NJ OO V* u&gt; NJ •么 $ 3; 11 f I o o o ίο ΓΟ •Ό UJ V UJ Lj o •Ό hO g UJ NJ 〇J ro 〇 v〇 LO .么 V u&gt; Lo v〇 - Ln \〇 - cc 'v uj be s ^ g ^ 8 (請先閱讀背面之注意事項寫本頁)Loading --- (Please read the note on the back to write this page) · 1284020 A7 Stone - 5 9 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing | 1 O ΓΠ s Ό n 1 S 1 GO 1 d • Ξ . Shoulder CO 2 '8 2 Q % d 2 pu to 1" X in GO - ο Ξ I! ρ§ Ι&gt; ο 二•S Special^ α ξ δ ι&gt; ο s ^ ^ σ ^ ρ g 1 贪§ ξ X ^ ρ p G § Ξ p P r Ο ζΛ on sx SO GO -g I s KJ\ o oo is p 0 5&gt; o zn I: 1 sgpi oo CO sg § oo 00 % ϊ ν〇ν〇ν〇ν〇 \j\ ν〇1 VO s ίο Lj s Ui •ss E sg S - bo sgi CTN LO UJ s 11 S UJ VV OJ .3⁄4 hv〇2 v〇vC \ VO hv〇卜K&gt; X Lj oo UJ oo S乂 00 ρ ζ 1 1 SS 〇〇| 2 v〇Ui ro s u&gt; .s NJ 2 LO ! Ui L/i 2 S v〇11 -S5 5 UJ V 乂N&gt; 2 oc LA Ui s 3 - Oc La - bo \j\ - ·〇〇- be NJ 5 V 2 Cv 乂ρ (Please read the note on the back---install--- write this page) % 1284020 A7 五\ly 6 9 Ministry of Economics Printed by the Property Bureau Staff Consumer Cooperative | &lt; | in 00 00 oooo 1 •Ξ s I s S 1 •s 2 d | GO δ 2 H - s 5 Ω In 〇 P ^ P “ 11 5 S b ^ IB P — o .° -η Ο 妄g ο P •o ·〇li 〇§ wp « Ml • • • O · 么 5 S · 〇S 绊x y1 y — O production S § 5 SO to X .00 y - o 十 S $ 11 11 x - o 丘寻 g -a 5 S §5 O.^ SI 11 托 j^3么 S § 〇§ I? X in 00 - Ο么•o · 么Is % UJ •NJ UJ l UJ δ U&gt; h UJ oo VVS UJ SO LO OO sia cool. 2 B NJ Ϊ Κ&gt; \ f〇s \ NJ .I ? , \ I UJ 3 乂VV GO 11 NJ •Os OJ UJ to · oo LO b\ uj •ii '5 K&gt; OJ 'i UJ I Ln i •s LJ •g fly 11 S5 3 , - be ! 〇〇- bo - oo Ϊ OO - bo \ oc - oo bo - oc UJ Oc f〇| l \ UJ •g \ l ;1 11 (Please read the note on the back---install----write this page) ·· Γ . 99 1284020 A7 B7 V. Description of invention (97) Economy Ministry of Intellectual Property Bureau employee consumption cooperative printing Ό Ό Ό α nnnn σ CD a CD &gt;&gt;&gt;&gt; NNN &lt;-&lt; XXX η in UJ H n 00 〇Lj H 〇00 L〇n C/3 0&quot;^ id U&gt; n 00 CD •υυ w ^ P ο kj\ ^ with in &gt; X r OJ 〇〇P ·&lt; 〇a 5 2 • ^ §g cn &gt; o • V-Λ τι Ο o (-Λ 00 &gt; xr 〇 〇oo w &gt;* 〇u* O 〇a 2 P 5 S • ^ §g 〇〇O s § # sp -P 〇Uo 〇〇0s s ^ &gt; 00 广^ &gt;&lt;^ σ,r 2 〇^ ^ ^ a &quot;npo 〇〇o^ isj ^ &gt; G c/3 r H(7) a .00 - 2: 〇 a 〇^ ^ ^ a -Γ1 p —ο .° '〇§g C/DX In CO -- , 0 a Ip &gt; 乂O -Ds. 〇V 2 oo V o % o V o ο • What oc NJ V LO '〇〇V UJ oo UJ 乂NJ LO 么NJ UJ 1» % Vt U • 丄x oc LO OC NJ La uj LO o $ •NJ OC UJ •g 1 s Ui % Xu V λ. VV '〇ro 二 On ΓΌ i ^ in § δ g ^ o •v〇NJ 〇λ. Ό UJ Ln ON o SJ ^J\ δ N) UJ 5 UJ • ON CN o UJ oc NJ OO V* u&gt; NJ • What $ 3; 11 f I ooo ίο ΓΟ • Ό UJ V UJ Lj o • Ό hO g UJ NJ 〇J ro 〇v〇LO .Vu&gt; Lo v〇- Ln \〇- cc 'v uj be s ^ g ^ 8 (Please read the note on the back first to write this page)

__襄 P .- -本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 98 五、發明說明( 實例14 此一實例顯示可用於本發明組合物中之其他羥溶劑 (請先閱讀背面之注意事&amp; -I --- π填寫本頁) · 經濟部智慧財產局員工消費合作社印製 -101 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(&quot;) 經濟部智慧財產局員工消費合作社印製 Ο ο § -σ -ο -Ό 〇 〇 〇 〇 ζ 2: I z 2 2 2 r h · w Ml 塞 Ο Ο Ο Ο 写 rn ΓΠ m m 命 〇 ο Οί LO o o ο ν-ο O O o _〇 o UJ UJ ο UJ ο ο f^s Uj 〇 Lj 1”· ^ pt 〇 ·〇〇 &gt; 5 〇 T3 p V-n ·〇 GO X 00 ο oc GO 5 ο ρ Ο 00 X cn ΟΟ 00 Ξ •ο -d ρ ο C0 X GO o &gt; ·〇 -o p p o 00 X CO ο &gt; μ Ο &quot;Τ3 Ο ρ ο 00 &gt;&lt;ί 00 o &gt; g o p o o 00 X 00 o ϋι &gt; iNj •o •o -〇 p o o in X 00 L/&gt; &gt; o -a p p o cn X in o La &gt; •O s o o on X GO o &gt; o o -D p Ξ O CO X 00 Ο Ρ ο X ^ 00 ^ 卜 ο -&gt; Ρ r Ο 00 S 二 ^g π _ S o pr &gt; P r o in ^二 a 5 X *〇 00 ^ H p o D! H ^ &quot;3 &gt; l〇 &amp;5 lu X ^ GO , l· 乂 NJ 3 •Ό V V* 产 U) •ro ro vi •s V UJ •S % UJ •S - •s % UJ oc V UJ v〇 VO - Ό VC V OJ Ό v〇 V* UJ •v〇 v〇 V LO v〇 v〇 V UJ •Ό v〇 V \7 二 .十 V χχ λ. λ '«CX ·&amp;· _〇 isj La v〇 UJ On U&gt; ro UJ VC UJ ^ 〇 Q » ON ON Ui Μ Ln NJ Ο % bv UJ Uj ON n7 ’么 V •為 •為 K) La oe LO La V •么 L/i 么 λ. 〇〇 --4 oc CO Ν/ OC LO •g I Xt. o V LO 么 V \7 ^ 〇 § g. ο UJ La OS UJ bo O k&gt; I UJ bs ON i I 1 、 - L〇 〇 UJ \/ -fc. 1 1 I I 1 雇 1 1 f 1 ON i •么 Ό *v〇 SJ Ό NJ fo UJ o E § UJ to ON OJ *O 二 •二 LJ •ro UJ 2 ^ 1 1 I 1 1 1 V; OC to V I 1 1 1 I 1 1 1 1 1 1 I [%k •Ό LO UJ ON •s 'as oc s ·- -102- ---------------裝---(請先閱讀背面之注意事項寫本頁) 訂: .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7__襄P .- -This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 98 V. INSTRUCTIONS (Example 14 This example shows other compounds that can be used in the composition of the present invention Hydroxyl Solvent (Please read the note on the back &amp; -I --- π fill this page) · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed -101 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (&quot;) Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed ο § -σ -ο -Ό 〇〇〇〇ζ 2: I z 2 2 2 rh · w Ml Ο Ο Ο Ο rn rn ΓΠ mm 〇 〇 Ο LO LO LO oo ο ν-ο OO o _〇o UJ UJ ο UJ ο ο f^s Uj 〇Lj 1”· ^ pt 〇·〇〇&gt; 5 〇T3 p Vn ·〇GO X 00 ο oc GO 5 ο ρ Ο 00 X cn 00 00 Ξ •ο -d ρ ο C0 X GO o &gt; ·〇-oppo 00 X CO ο &gt; μ Ο &quot;Τ3 Ο ρ ο 00 &gt;&lt;ί 00 o &gt; gopoo 00 X 00 o ϋι &gt; iNj •o •o -〇poo in X 00 L/&gt;&gt; o -appo cn X in o La &gt; •O soo on X GO o &gt; oo -D p Ξ O CO X 00 Ο Ρ ο X ^ 00 ^ Bu ο -&gt; Ρ r Ο 00 S 二^g π _ S o pr &gt; P ro in ^ 二 a 5 X * 〇00 ^ H po D! H ^ &quot;3 &gt;l〇&amp;5 lu X ^ GO , l· 乂NJ 3 •Ό VV* produces U) •ro ro vi •s V UJ •S % UJ •S - • s % UJ oc V UJ v〇VO - Ό VC V OJ Ό v〇V* UJ • v〇v〇V LO v〇v〇V UJ • Ό v〇V \7 II. Ten V χχ λ. λ '«CX ·&amp;· _〇isj La v〇UJ On U&gt; ro UJ VC UJ ^ 〇Q » ON ON Ui Μ Ln NJ Ο % bv UJ Uj ON n7 'What V • is • K) La oe LO La V • What L/i λ. 〇〇--4 oc CO Ν/ OC LO •g I Xt. o V LO V \7 ^ 〇§ g. ο UJ La OS UJ bo O k> I UJ bs ON i I 1 , - L〇〇UJ \/ -fc. 1 1 II 1 Employment 1 1 f 1 ON i • Ό Ό *v〇SJ Ό NJ fo UJ o E § UJ to ON OJ *O 2•2 LJ •ro UJ 2 ^ 1 1 I 1 1 1 V; OC to VI 1 1 1 I 1 1 1 1 1 1 I [%k •Ό LO UJ ON •s 'as oc s ·- -102- ---- -----------Install---(Please read the notes on the back first) Write this page) book: This paper scales applicable Chinese National Standard (CNS) A4 size (210 X 297 mm) 1284020 A7

1284020 A7 B7 五、發明說明() 除觀察到其他溶劑(如,PG及TPG)亦可用於本發明之組合 物中外,產物JJJJ至0000可說明抗菌劑在系統中相對飽和度 之其他作用。前三種組合物之相對%飽和(最高至最低)係 JJJJ〉KKKK&gt;LLLL。組合物KKKK具有組合物JJJJ三分之一量之 TCS溶於相同含量(0.5% )之ALS中,而組合物LLLL含有0% TCS。當組合物中TCS之相對%飽和減少時,活性之顯著減 少可就肺炎克雷伯氏桿菌及霍亂沙門氏桿菌觀察得見。亦 觀察到,當相對%飽和實質上相等時(亦即,約100% ),活 性及維持實質上之恆定,甚至是在組合物中TCS之絕對含量 減少直(亦即,比較組合物MMMM對NNNN)。此等數據可進 一步支持實例7所述有關%飽和之重要性之觀察。 此外,對於組合物IIII與組合物TTTT之比較顯示,組合物 TTTT含有些微較少之ALS ( 0.9°/。對IIII之1.0% ),相同含量之PG (10.0%),以及二分之一含量之SXS ( 5.0%對IIII之10.0%)。實 驗之觀察結果指出,組合物IIII及TTTT係100%飽和或接近 100%飽和。然而,組合物TTTT對於大腸桿菌之對數減少作 用卻顯著較低(約4 log)。此一觀察結果進一步支持實例8所 述之數據,其中顯示可能需要最低含量之增溶劑以產生高 抗菌活性對抗至少部分格藍氏陰性細菌。 實例15 製備下列之組合物15-A至15-D,以說明本發明組合物相較 於控制組組合物(亦即,不含抗菌劑之組合物)所提供之較 佳細菌滅殺作用,甚至是在其中存在極低含量消毒醇之情 形下。組合物15A-15D係使用技藝中所知之標準混合技術製 -104- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事 寫本頁) 經濟部智慧財產局員工消費合作社印製 1284020 A7 五、發明說明( 備。下表4列出組合物成分。下矣$ Β|ϊ 4士丄1284020 A7 B7 V. INSTRUCTIONS () In addition to the observation that other solvents (e.g., PG and TPG) can also be used in the compositions of the present invention, products JJJJ through 0000 can illustrate other effects of the relative saturation of the antimicrobial agent in the system. The relative % saturation (highest to lowest) of the first three compositions is JJJJ>KKKK&gt;LLLL. Composition KKKK has a composition of JJJJ one-third the amount of TCS dissolved in the same amount (0.5%) of ALS, while composition LLLL contains 0% TCS. Significant reduction in activity can be observed for Klebsiella pneumoniae and Salmonella cholerae when the relative % saturation of TCS is reduced in the composition. It has also been observed that when the relative % saturation is substantially equal (i.e., about 100%), the activity and maintenance are substantially constant, even if the absolute content of TCS is reduced in the composition (i.e., the comparative composition MMMM pair NNNN). These data can further support the observations on the importance of % saturation as described in Example 7. In addition, a comparison of composition IIII with composition TTTT showed that the composition TTTT contained slightly less ALS (0.9°/. 1.0% for IIII), the same amount of PG (10.0%), and one-half the content. SXS (5.0% vs. 13.1% of IIII). Experimental observations indicate that compositions IIII and TTTT are 100% saturated or nearly 100% saturated. However, the log reduction of the composition TTTT against E. coli was significantly lower (about 4 log). This observation further supports the data described in Example 8, which shows that a minimum level of solubilizer may be required to produce high antibacterial activity against at least some of the Gram-negative bacteria. Example 15 The following compositions 15-A to 15-D were prepared to illustrate the preferred bacterial killing effect of the compositions of the present invention over control group compositions (i.e., compositions containing no antimicrobial agents), Even in the case where there is a very low level of disinfecting alcohol. Composition 15A-15D is made using standard mixing techniques known in the art -104- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) (please read the note on the back first) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1284020 A7 V. Description of the invention (Ready. Table 4 below shows the composition of the composition. 矣$ Β|ϊ 4士丄

Κ刀下表5則摘述組合物15-Α至15-D 之抗菌功效,其係以限時滅殺試驗測得。 ---r----------裝--- (請先閱讀背面之注意事H填寫本頁) ·. 經濟部智慧財產局員工消費合作社印製 表5 組合物 15秒/ 30秒之對數減少 S. aureus E. coli K· pneum. S. chol 15·Α 0.55/1.73 0.18/0.43 1.15/0.71 2.51/4.24 15-Β 3.27/&gt;4.43 3.75/&gt;4.51 1.33/3.10 4.09/4.34 15-C 0.01/0.0 0.17/0.12 0.4/0.H 0.18/0.17 15-D &gt;4.43/&gt;4.43 3.20/3.48 3.19/4.03 2.86/3.99 實例15說明本發明組合物(15-B及15-D)意外之高效,其中 -105-Sickle Table 5 below summarizes the antimicrobial efficacy of the compositions 15-Α to 15-D, as measured by a time-limited kill test. ---r----------装--- (Please read the note on the back of the page to fill in this page) ·. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed table 5 composition 15 seconds / Logarithmic reduction of 30 seconds S. aureus E. coli K· pneum. S. chol 15·Α 0.55/1.73 0.18/0.43 1.15/0.71 2.51/4.24 15-Β 3.27/&gt;4.43 3.75/&gt;4.51 1.33/3.10 4.09 /4.34 15-C 0.01/0.0 0.17/0.12 0.4/0.H 0.18/0.17 15-D &gt;4.43/&gt;4.43 3.20/3.48 3.19/4.03 2.86/3.99 Example 15 illustrates the composition of the present invention (15-B and 15-D) Accidental efficiency, where -105-

表4 組合物 %重量友| 匕(以活性物質計) TCS 乙醇 PPG-9 DPG 水 15-A (控制組) 0 25.86 11.5 平衡 15·Β 0.10 25.86 11.5 — 平衡 15_C (控制組) 0 23.0 — 11.18 平衡 15-D 0.10 23.0 — 11.18 平衡 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 Β7 _ 五、發明說明(1()3) 可觀祭到南對數減少對抗格藍氏陽性及格藍氏陰性細菌兩 者,甚至是就含有少於26%乙醇之組合物而言。此等結果 相對於先前揭示文獻中所述之組合物,其係依賴高醇濃度 (亦即,超過約40%)以達成高而範圍廣泛之抗菌活性。 t例16 實例16顯示本發明組合物可提供優良、範圍廣泛之抗菌活 性,甚至是在進一步減少之醇濃度下。因此,製備組合物 16-A,其含有 0.15% TCS、11.18% 乙醇、25.71%DPG,並以水平 衡(以活性化合物之重量百分比計)。為進行比較,製備相 同之控制組組合物16-B,惟組合物16-B不含TCS。下表摘述組 合物16-A及16-B以限時滅殺試驗測得之抗菌功效結 ——.l·----------裝· — — (請先閱讀背面之注意事寫本頁)Table 4 Composition % Weight Friends | 匕 (based on active material) TCS Ethanol PPG-9 DPG Water 15-A (Control Group) 0 25.86 11.5 Equilibrium 15·Β 0.10 25.86 11.5 — Balance 15_C (Control Group) 0 23.0 — 11.18 Balance 15-D 0.10 23.0 — 11.18 Balance This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 Β7 _ V. Invention description (1()3) Observable sacrifice to the south logarithm reduction Both blue positive and negative blue negative bacteria, even for compositions containing less than 26% ethanol. These results are dependent on high alcohol concentrations (i.e., greater than about 40%) relative to the compositions described in the previously disclosed documents to achieve a high and wide range of antimicrobial activity. Example 16 Example 16 shows that the compositions of the present invention provide excellent, broad range of antimicrobial activity, even at further reduced alcohol concentrations. Thus, Composition 16-A was prepared containing 0.15% TCS, 11.18% ethanol, 25.71% DPG, and was weighed as a weight percent of the active compound. For comparison, the same control group composition 16-B was prepared except that composition 16-B contained no TCS. The following table summarizes the antibacterial efficacy of the compositions 16-A and 16-B measured by the time-limited killing test -.l·----------Install·—— — (Please read the back of the note first) Write this page)

II

緩濟部智慧財產局員X消費合作社印製 實例16進一步說明,本發明組合物中之醇濃度可減㈧、至極 低之含量而不會犧牲抗菌活性。因此,可製備出提供優、 抗菌功效,且不會使皮膚乾燥之組合物。先前仰賴高醇濃 度以取得抗菌功效之組合物會使皮膚乾燥,且通常會刺= 皮膚。 曰、7 Χμλι -106 - 1 1284020 A7 B7 五、發明說明() 實例17說明本發明之高效組合物可納入對-氯-間-二甲苯 酚(PCMX)作為抗菌活性劑。藉由混合0.1% PCMX、13.42%乙 醇,並以水平衡(以活性化合物之重量百分比計),以製備 組合物17_A。以限時滅殺試驗評估組合物17-A之抗菌功效, 且其在30秒之接觸時間内,對抗金黃葡萄球菌、大腸桿 菌、肺炎克雷伯氏样菌、及霍亂沙門氏桿菌分別具有4.16、 &gt;4.34、3.99、及&gt;4.04之對數減少。因此,組合物17-A係一種高 效之抗菌組合物,儘管該組合物含有非常低濃度之乙醇。 實例18 實例18說明一種含有陽離子凝膠劑CELQUAT CS-230M之本發 明組合物。藉由混合0.15%TCS、28%乙醇、11.18% DPG、及 2% CELQUAT CS-230M,並以水平衡(以活性化合物之重量百分 比計,除外CELQUAT CS-230M,其係「如其本身」而計),以 製備組合物18-A。以限時滅殺試驗評估組合物18-A之抗菌功 效。組合物18-A在30秒之接觸時間内,對抗金黃葡萄球菌、 大腸桿菌、肺炎克雷伯氏桿菌、及霍亂沙門氏桿菌分別具 有。&gt;3.83、4.33、&gt;4.43、及&gt;3.55之對數減少。因此,組合物18-A係一種高效之抗菌組合物,儘管該組合物含有非常低濃度 之乙醇。 實例19 本發明之組合物可含有範圍廣泛之各種凝膠劑、羥溶 劑、及抗菌活性劑,其如下列實例說明。在下表6中,所有 之重量百分比皆係以活性物質計,除外以「*」指明者,其 代表「如其本身」之重量。此等組合物係以熟習技藝者所 -107- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事 寫本頁) 經濟部智慧財產局員工消費合作社印製 1284020 A7 B7 五、發明說明(1〇5) 熟知之混合及凝膠製備技術製備。此等組合物具有可接受 之澄清度、穩定性、及表現。 (請先閱讀背面之注意事 寫本頁) 裝 經濟部智慧財產局員工消費合作社印製 -108- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(1〇6) 經濟部智慧財產局員工消費合作社印製 l· a C Η g N Ξ 箐 -a η X η m c &gt; H Q r〇 I 普 n &gt; 〇 z m x r* 〇 黃 σ &quot;D -ϋ o V〇 fN l· 器 -5 &gt; r- iS &gt; o r σ &lt; 普 ^Γ d 〇\ Ξ OC l-Λ 3: •s 〇 &gt; K) UJ Ξ 3: ·〇 CD ro UJ ο 〇 η Lo r〇 LO S 〇 σ CN 3 s 〇 oo h〇 u&gt; ο s 〇 ΤΙ UJ 5 •S 〇 Ο •Νύ LA ο 〇 3: 工 oc ro u&gt; ο S 〇 &quot; ·: jo vC LO 〇 «Μ -109 - (請先閱讀背面之注意事4 -I --- iiw寫本頁) · -Γ . .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1071284020 A7 B7 五、發明說明() 經濟部智慧財產局員工消費合作社印製 抽 C Η cn N JO s X η CT3 C &gt; Η Q NJ LO Ο 2 朞 r &gt; &quot;3 o z m X r 〇 * a *T3 o o sy l· =5 &gt; 广 c CD &gt; a m r a &lt; * 00 ON c: •NJ p c: I: ^r\ •o Γ to OO o 2 oc LO s o NJ o o LO Ky\ s o 〇 NJ o *ro oo K&gt; oo -g o &quot;Ο ro o o oo to 00 s p 〇 〇 〇 Lj ο z z ro U) s 〇 •S 〇 LO •Ο l to oo o 00 〇 〇 L» ο &quot;S Η -110 - (請先閱讀背面之注意事填寫本頁) •裝 訂: -Γ . .本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明(1()8) 所有上述表列及實例所示之數據皆顯示,組合物水相中 抗菌劑之%飽和可直接與細菌之對數減少相關。舉例而 ’如前述表列所示,在水相中具有TCS 5〇%飽和之組合物 顯示1.96(30秒)及3·05 ( 60秒)之對數減少對抗金黃葡萄球菌, 以及2.45 ( 30秒)及大於3.81 ( 60秒)之對數減少對抗大腸桿菌。 75%飽和及1〇〇%飽和之組合物具有大於4 55 ( 3〇及6〇秒)之對 數減少對抗金黃葡萄球菌(亦即,超過分析偵測限制之對數 減少)。泫等75%及1〇〇%飽和之組合物分別具有3 4〇 ( 3〇秒)及 大於3.81 ( 60秒),以及大於3.81 ( 3〇及6〇秒)之對數減少對抗大 腸桿菌。因此,本發明抗菌組合物之特徵可為具有至少約 2 ( 30秒後)或至少約3 ( 60秒後)之對數減少對抗金黃葡萄球 菌,或是具有至少約2.5 (30秒後)或至少約35(6〇秒後)之對 數減少對抗大样桿菌。 本發明之抗菌組合物可具有數種實施終用途,包括手部 清潔劑、漱口水、手術刷洗劑、身體喷劑、手部消毒凝 膠、及類似之個人保健產品。其他類型之組合物包括泡沫 組合物(諸如,乳霜、慕斯等),以及含有有機或無機填充 物質之組合物(諸如,乳劑、乳液、乳霜、膏劑等)。此等 組合物尚可作為硬表面(例如,醫院之水槽及臺面、食物供 給區域、及肉品加工廠)之抗菌清潔劑。本發明之抗菌組合 物可以稀釋之即用組合物形式製造,或可以在使用前稀釋 之濃縮物形式製造。 此等組合物亦可被納入網狀物質中,以提供抗菌擦拭物 件。該擦拭物件可用於清潔及消毒皮膚及無生命表面。 -111 - 本紙張尺度適用中國國家標準(CNS)A4規格(21了7_297公爱)一 (請先閱讀背面之注意事填寫本頁) 裝 訂: 經濟部智慧財產局員工消費合作社印製 1284020 A7 109, 五、發明說明( 本發明(抗囷組合物可提供在短 玫 &gt; 匕也a a切斗 實接觸時間内廣泛滅殺 格監氏險性及格監氏陰性細菌之 设.、,古。就一般用於清潔並 消母皮膚及無生命表面之丨5至6〇秒之 ·、 y &lt;呼間期而了,取得顯菩 細菌對數減少之短暫接觸時間係非常重要者。 ·、 本發明之組合物可在短暫之接觸時間内呈現有效 囷劑係存在於能合物之水連續相+,^ 膠粒中。目此,該抗菌劑可立即開始減少細菌族群,= 附者在皮膚上,以提供殘留抗菌功效。此外,由於抗菌劑 係存在於落液中,而非界面活性劑微膠粒中,可減少組人 物中抗菌劑之絕對含量,而不會逆向影響其功效,且抗二 劑不會在展現其柷菌功能之前,與界面活性一同自皮膚上 洗去。此外,本發明抗菌組合物中之界面活性劑含量二妒 皆相當低,因而提供額外之環保優點β 又 下列之實例說明本發明之各種組合物。 實例20 洗手劑組合物 製備適合作為洗手劑之本發明組合物。該組合物含有所 指重量百分比之下列組成份: 口 (請先閲讀背面之注意事!填寫本頁) •-襄 . 經濟部智慧財產局員工消費合作社印製 -112- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐 1284020 A7 五、發明說明(UG)The Intellectual Property Department of the Ministry of Economic and Social Affairs X Consumer Cooperative Printed Example 16 further illustrates that the alcohol concentration in the composition of the present invention can be reduced by (eight) to very low levels without sacrificing antimicrobial activity. Therefore, a composition which provides excellent antibacterial effects without drying the skin can be prepared. Compositions that previously relied on high alcohol concentrations to achieve antimicrobial efficacy will dry the skin and will usually puncture the skin.曰, 7 Χμλι -106 - 1 1284020 A7 B7 V. INSTRUCTION DESCRIPTION () Example 17 illustrates that the high-efficiency composition of the present invention can incorporate p-chloro-m-xylphenol (PCMX) as an antibacterial active agent. Composition 17_A was prepared by mixing 0.1% PCMX, 13.42% ethanol, and water equilibration (based on weight percent of active compound). The antibacterial efficacy of composition 17-A was evaluated by a time-limited killing test, and it had 4.16 against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Salmonella cholerae, respectively, within a contact time of 30 seconds. &gt;4.34, 3.99, and &gt; 4.04 log reduction. Thus, Composition 17-A is an effective antimicrobial composition, although the composition contains very low concentrations of ethanol. Example 18 Example 18 illustrates a composition of the invention containing a cationic gelling agent CELQUAT CS-230M. By mixing 0.15% TCS, 28% ethanol, 11.18% DPG, and 2% CELQUAT CS-230M, and in water balance (except CELQUAT CS-230M, which is "as such" by weight of active compound) ) to prepare composition 18-A. The antibacterial efficacy of Composition 18-A was evaluated by a time-limited killing test. Composition 18-A was found to be resistant to Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Salmonella cholerae, respectively, within a contact time of 30 seconds. &gt; 3.83, 4.33, &gt; 4.43, and &gt; 3.55 log reduction. Thus, Composition 18-A is a highly effective antimicrobial composition, although the composition contains very low concentrations of ethanol. EXAMPLE 19 The compositions of the present invention may contain a wide variety of gelling agents, hydroxy solvents, and antibacterial active agents, as illustrated by the following examples. In Table 6 below, all weight percentages are based on the active substance, except those specified by "*", which represents the weight of "as it is". These compositions are based on the Chinese National Standard (CNS) A4 specification (210 X 297 mm). (Please read the note on the back to write this page.) Ministry of Economic Affairs Intellectual Property Office staff Consumer Cooperatives Printed 1284020 A7 B7 V. INSTRUCTIONS (1〇5) Well-known mixing and gel preparation techniques. These compositions have acceptable clarity, stability, and performance. (Please read the note on the back to write this page) Installed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff and Consumer Cooperatives -108- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Description of the invention (1〇6) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed l· a C Η g N Ξ 箐-a η X η mc &gt; HQ r〇I 普 n &gt; 〇zmxr* 〇黄σ &quot; D -ϋ o V〇fN l·器-5 &gt; r- iS &gt; or σ &lt; 普^Γ d 〇\ Ξ OC l-Λ 3: •s 〇&gt; K) UJ Ξ 3: ·〇CD Ro UJ ο 〇η Lo r〇LO S 〇σ CN 3 s 〇oo h〇u&gt; ο s 〇ΤΙ UJ 5 •S 〇Ο •Νύ LA ο 〇3: work oc ro u&gt; ο S 〇&quot; ·: Jo vC LO 〇«Μ -109 - (Please read the note on the back 4 -I --- iiw write this page) · -Γ . . This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) PCT) 1071284020 A7 B7 V. INSTRUCTIONS () Employees of the Intellectual Property Office of the Ministry of Economic Affairs Consumer Cooperatives Printing C Η cn N JO s X η CT3 C &gt; Η Q NJ LO Ο 2 issues r &gt;&quot;3 ozm X r 〇* a *T3 oo sy l· =5 &gt; Wide c CD &gt ; amra &lt; * 00 ON c: •NJ pc: I: ^r\ •o Γ to OO o 2 oc LO so NJ oo LO Ky\ so 〇NJ o *ro oo K&gt; oo -go &quot;Ο ro oo Oo to 00 sp 〇〇〇Lj ο zz ro U) s 〇•S 〇LO •Ο l to oo o 00 〇〇L» ο &quot;S Η -110 - (Please read the note on the back to fill out this page) • Binding: -Γ . . This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. Invention Description (1()8) All the data shown in the above table and example are It is shown that the % saturation of the antimicrobial agent in the aqueous phase of the composition can be directly related to the log reduction of the bacteria. By way of example, as shown in the preceding table, the composition having a TCS 5〇% saturation in the aqueous phase shows a log reduction of 1.96 (30 seconds) and 3.05 (60 seconds) against Staphylococcus aureus, and 2.45 (30 seconds) And a logarithmic reduction of greater than 3.81 (60 seconds) against E. coli. The 75% saturated and 1% saturated compositions have a log reduction of greater than 4 55 (3 and 6 sec) against Staphylococcus aureus (i.e., a log reduction in excess of analytical detection limits). The 75% and 1% saturated compositions of 泫 and so on have 34 〇 (3 〇 seconds) and greater than 3.81 (60 sec), respectively, and logarithmic reductions greater than 3.81 (3 〇 and 6 〇 seconds) against E. coli. Accordingly, the antimicrobial compositions of the present invention can be characterized as having a log reduction of at least about 2 (after 30 seconds) or at least about 3 (after 60 seconds) against Staphylococcus aureus, or having at least about 2.5 (after 30 seconds) or at least The logarithm of about 35 (after 6 sec) is reduced against the large bacilli. The antimicrobial compositions of the present invention can have a number of end-use applications including hand cleansers, mouthwashes, surgical scrubs, body sprays, hand sanitizing gels, and the like. Other types of compositions include foam compositions (such as creams, mousses, and the like), as well as compositions containing organic or inorganic fillers (such as emulsions, lotions, creams, ointments, and the like). These compositions are also useful as antibacterial cleansers for hard surfaces such as hospital sinks and countertops, food supply areas, and meat processing plants. The antibacterial composition of the present invention can be produced as a diluted ready-to-use composition or can be prepared as a concentrate diluted before use. These compositions can also be incorporated into a mesh material to provide an antimicrobial wipe. The wipe can be used to clean and disinfect skin and inanimate surfaces. -111 - This paper size is applicable to China National Standard (CNS) A4 specification (21 7_297 publicity) one (please read the note on the back to fill out this page) Binding: Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1284020 A7 109 5, the invention description (the invention (anti-caries composition can be provided in the short rose> 匕 also aa cut in the actual contact time to kill the stagnation of the dangerous singularity of the singular bacteria.., ancient. It is generally used to clean and eliminate the maternal skin and the inanimate surface of the 丨 5 to 6 〇 · 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 The composition can exhibit an effective sputum present in the continuous phase of the water of the composition in a short contact time. Thus, the antibacterial agent can immediately begin to reduce the bacterial population, = attached to the skin In order to provide residual antibacterial effect. In addition, since the antibacterial agent is present in the falling liquid instead of the surfactant microcapsule, the absolute content of the antibacterial agent in the group can be reduced without adversely affecting its efficacy, and resistance Two doses will not be on display Before the fungicidal function, it is washed away from the skin together with the interfacial activity. In addition, the surfactant content in the antibacterial composition of the present invention is relatively low, thus providing an additional environmental benefit. The following examples illustrate the present invention. Various compositions.Example 20 Hand Wash Compositions The compositions of the present invention are suitable for use as hand-washing agents. The compositions contain the following percentages by weight: mouth (please read the notes on the back! Fill in this page) •-襄. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -112- This paper scale applies China National Standard (CNS) A4 specification (210 X 297 mm 1284020 A7 V. Invention Description (UG)

成分 ------ 重量百分比 三氯生 -―^~_ 0.3 十二燒基硫酸按 -〜~_ 0.75 二丙二醇 ----- 5.0 二甲苯磺酸鈉 --------- 10.0 香精 0.05 水 q.s. -―-_J (請先閱讀背面之注意事ΐ --裝 i — &gt;填寫本頁) 該組合物之製備係藉由混合二丙二醇、TCS、及香精直到 均勻(約5分鐘)而進行。在三氯生完全溶解後(其如無未溶 解之固體物質證實),將二甲苯磺酸鈉加入溶液中。再攪: 所得之混合物,直到二甲苯磺酸鈉完全溶解(約5分鐘)。最 後,將十二烷基硫酸銨及水加入所得之溶液中,並攪拌該 組合物直到均勻(約5分鐘)。 Λ 孩組合物具有2.5:1之界面活性劑··三氯生重量比,且係至 少約90%三氣生飽和。使用限時滅殺試驗評估該組合物對 柷金黃葡萄球菌及大腸样菌之抗菌功效。對抗金黃葡萄球 菌,該組合物在30秒中具有&gt;4·07之對數減少作用,而對抗大 腸桿菌,該組合物在30秒中具有3.90之對數減少作 。因 此,該組合物具有優良之廣泛範圍抗菌活 同時, 疼級 石物在實際之使用試驗中係一種優良之洗手劑組合物,可 對手部同時提供優良之清潔及平滑之感覺。 · 經濟部智慧財產局員工消費合作社印製 -113-Ingredients ------ Weight percent triclosan--^~_ 0.3 12-base sulfuric acid press -~~_ 0.75 dipropylene glycol----- 5.0 sodium xylene sulfonate-------- - 10.0 Fragrance 0.05 Water qs - "-_J (Please read the note on the back first - install i - &gt; fill this page) This composition is prepared by mixing dipropylene glycol, TCS, and fragrance until uniform (about 5 minutes). After the triclosan is completely dissolved (as confirmed by the undissolved solid matter), sodium xylene sulfonate is added to the solution. Stir again: The resulting mixture was dissolved until sodium xylene sulfonate was completely dissolved (about 5 minutes). Finally, ammonium lauryl sulfate and water were added to the resulting solution, and the composition was stirred until homogeneous (about 5 minutes). The Λ composition has a 2.5:1 surfactant/·Triclosan weight ratio and is at least about 90% trisaturated. The antibacterial efficacy of the composition against Staphylococcus aureus and colonic bacteria was evaluated using a time-limited killing test. Against the Staphylococcus aureus, the composition had a logarithmic reduction of &gt; 4·07 in 30 seconds, whereas against E. coli, the composition had a logarithmic reduction of 3.90 in 30 seconds. Therefore, the composition has an excellent wide range of antibacterial activity. At the same time, the pain grade stone is an excellent hand lotion composition in the actual use test, and can provide an excellent clean and smooth feeling at the same time. · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed -113-

1284020 A7 B7 五、發明說明() 實例21 身體噴劑組合物 使用所指重量百分比之下列組成份,製備適合作為身體 噴劑之本發明組合物: 成分 重量百分比 三氯生 0.3 烷基聚葡糖 0.3 丙二醇 14.41284020 A7 B7 V. INSTRUCTIONS (Example 2) Body Spray Compositions The compositions of the present invention suitable for use as body sprays are prepared using the following percentages by weight: Component Weight Percentage Triclosan 0.3 Alkyl Polyglucose 0.3 propylene glycol 14.4

該組合物之製備係藉由結合三氣生、丙二醇、香精、 乙醇,並混合此等組成份,直到所有三氣生溶解(並Z盔 溶解之固體物質證實)而進行。再加入二甲苯磺酸鈉,並 拌所得之混合物,直到二甲苯磺酸鈉完全溶解。最後, 入烷基聚葡糖及水,再攪拌該混合物直到均句。所得之 合物形成優良及清爽之身體噴劑,其提供使用者皮S 2 標程度之細菌減少作用。 ^^122The composition is prepared by combining tri-male, propylene glycol, perfume, ethanol, and mixing the components until all three gas is dissolved (and confirmed by the Z-helster dissolved solid matter). Further, sodium xylene sulfonate was added, and the resulting mixture was mixed until the sodium xylene sulfonate was completely dissolved. Finally, the alkyl polyglucose and water were added and the mixture was stirred until the same sentence. The resulting composition forms a fine and refreshing body spray which provides a bacterial reduction of the user's skin S 2 scale. ^^122

(請先閱讀背面之注意事S U5T--- 1填寫本頁) 經濟部智慧財產局員工消費合作社印製(Please read the note on the back first. S U5T--- 1 Fill in this page) Printed by the Intellectual Property Office of the Ministry of Economic Affairs

-114--114-

1284020 A7 五、發明說明(112) 漱口水組合物 使用所指重量百分比之下列组成份,製備適合作為漱口 水之本發明組合物: 0.3 0.3 14.4 10.0 10.0 0.05 q.s. 該組合物之製備係藉由結合m醇、加味劑、 及$性醇,並以任何習知之方法混合此等組成份,直到所 有二虱生溶解(其如無未溶解之固體物質證實)而進行。 經濟部智慧財產局員工消費合作社印製1284020 A7 V. INSTRUCTIONS (112) Mouthwash Compositions The compositions of the invention suitable for use as mouthwashes are prepared using the following percentages by weight: 0.3 0.3 14.4 10.0 10.0 0.05 qs The preparation of the composition is by combination The alcohol, the odorant, and the pharmaceutically acceptable alcohol are mixed in any conventional manner until all of the bismuth is dissolved (which is confirmed if there is no undissolved solid matter). Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperative, printing

重量百分比 ----1----------裝--- (請先閱讀背面之注意事*填寫本頁) =入一甲苯磺酸鈉,並攪拌所得之混合物,直到二甲—碏 酸鈉完全溶解。最後’加入烷基聚葡糖及水,再攪拌:: 合物直到均勾°所得之组合物形成優良及清爽之十口厂 =供使用者牙齒、牙銀、及舌頭上目標程度之細'囷、少 實例23 -115-Percent by weight----1---------- Pack--- (Please read the note on the back* to fill out this page) = Add sodium mono-toluenesulfonate and stir the mixture until two Sodium formate is completely dissolved. Finally, 'adding alkyl polyglucose and water, and then stirring: the composition until the hook is obtained to form a fine and refreshing ten-mouth factory = for the user's teeth, silver teeth, and the degree of the target on the tongue'囷, less examples 23 -115-

1284020 A7 一 --------------- B7 五、發明說明(113) 溼巾組合物 使用所指重量百分比之下列組成份,製備適合浸透非織 性物質製備溼巾物件之本發明組合物: 成分 重量百分比 三氯生 ----------— 0.3 十二燒基硫酸按 0.75 二丙二醇 5.0 二甲苯磺酸鈉 15.0 水 q.s. 泫、’且6物之製備係藉由結合三氯生及二丙二醇,並混合 此等組成份,直到所有三氯生溶解(其如無未溶解之固體物 質證實)而進行。再加入二甲苯磺酸鈉,並攪拌所得之混合 物,直到二甲苯磺酸鈉完全溶解。最後,加入十二烷基硫 酸銨及水,並再攪拌該混合物直到均句。 鳥 再將一片非織性纖維素網狀物質(亦即, t浸入該組合物中,以形成一澄巾物件,適用於擦拭並清 2表面,例如,手。該物件形成優良之溼巾,而浸透之抗 菌組合物可自該網自由表現,提供範圍廣泛之抗菌活性。几 實例24 洗手劑組 製備適合作為洗手劑之本發明組合物。該組合物含有所 (請先閱讀背面之注意事ί -裝--- 1填寫本頁&gt; ·. 經濟部智慧財產局員工消費合作社印製 -116·1284020 A7 I--------------- B7 V. INSTRUCTIONS (113) Wet wipes compositions are prepared by using the following components in the weight percentages to prepare wet wipes suitable for impregnating non-woven materials. The composition of the present invention: component weight percentage triclosan---------- 0.3 decyl sulphuric acid 0.75 dipropylene glycol 5.0 sodium xylene sulfonate 15.0 water qs 泫, 'and 6 The preparation is carried out by combining triclosan and dipropylene glycol and mixing the components until all triclosan is dissolved (as confirmed by the absence of undissolved solid matter). Further sodium xylene sulfonate was added and the resulting mixture was stirred until the sodium xylene sulfonate was completely dissolved. Finally, ammonium lauryl sulfate and water were added, and the mixture was stirred until the same sentence. The bird then dipped a piece of non-woven cellulosic material (i.e., t into the composition to form a scouring article suitable for wiping and clearing the surface, for example, a hand. The article forms an excellent wet wipe, The impregnated antimicrobial composition can be freely expressed from the web to provide a wide range of antibacterial activity. Several Examples 24 Hand Wash Groups Prepare a composition of the present invention suitable as a hand lotion. The composition contains a solution (please read the back note first) ί -装--- 1 Fill in this page&gt; ·. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -116·

1284020 A7 B7 五、發明說明( 指重量百分比之下列組成份 成分 氯生 二垸基硫酸铵 丙二醇 一甲笨橫酸納 水1284020 A7 B7 V. INSTRUCTIONS INSTRUCTIONS (refers to the following components by weight) Chloramphenicyl ammonium dithiocarbamate Propylene glycol

(請先閱讀背面之注意事填寫本頁) 裝 經濟部智慧財產局員工消費合作社印製 I 组合物之製備係藉由首先混合三氣生及二丙二醇直到 均勻(約5分鐘)而進行。在三氣生完全溶解後(其如盔未々 解之固體物質證實),將二甲苯橫酸釣加入溶液中。再^ 所得之混合物,以完全溶解二甲苯磺酸鈉(約5分鐘)二最 後,將十二烷基硫酸銨及水加入所得之溶液中,並攪拌該 組合物直到均勻(約5分鐘)。 該組合物具有2.5:1之界面活性劑:三氯生重量比,且係至 少約9〇〇/〇二氯生飽和。使用限時滅殺試驗,以及30秒之接觸 時間,評估該组合物對抗金黃葡萄球菌、大腸桿菌、肺炎 克雷伯氏桿菌、及霍亂沙門氏桿菌之抗菌功效。該組合物 對抗四種試驗微生物分別具有&gt;3 59、&gt;4 49、&gt;3 2〇、及&gt;4刀之 對數減少。 ^因此,該組合物具有優良之廣泛範圍抗菌活性。此外, 二、且口物在只際之使用試驗中係一種優良之洗手劑組合 -117-(Please read the note on the back to fill out this page.) Installation Printed by the Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative I. The preparation of the composition was carried out by first mixing tri-gas and dipropylene glycol until uniform (about 5 minutes). After the three gas is completely dissolved (as confirmed by the solid matter of the helmet), the xylene cross-acid is added to the solution. Further, the resulting mixture was completely dissolved in sodium xylene sulfonate (about 5 minutes). Finally, ammonium lauryl sulfate and water were added to the resulting solution, and the composition was stirred until homogeneous (about 5 minutes). The composition has a 2.5:1 surfactant: triclosan weight ratio and is at least about 9 angstroms per liter of diclosan. The antibacterial efficacy of the composition against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Salmonella cholerae was evaluated using a time-limited killing test and a contact time of 30 seconds. The composition had a logarithmic reduction of &gt; 3 59, &gt; 4 49, &gt; 3 2〇, and &gt; 4 knives against the four test microorganisms, respectively. ^ Therefore, the composition has an excellent range of antibacterial activity. In addition, the oral substance is an excellent hand-washing agent combination in the use test only -117-

1284020 A7 B7 五、發明說明(115) 物’可對手部同時提供優良之清潔及平滑之感覺。 實例25 與先如經揭7JT組合物之比齡 此一 5例比較本發明抗菌組合物及一種先前經揭示組合 物之抗菌功效。因此,比較實例24之組合物及揭示於w〇 98/01110之單一實例。在兩種組合物中,活性抗菌劑皆為三 氯生(TCS)。兩種組合物皆以限時滅殺試驗,評估對抗金黃 葡萄球菌、大腸桿菌、肺炎克雷伯氏桿菌、及霍亂^門2 桿菌之抗菌功效。根據黏性組合物之試驗流程,以50%之 稀釋度試驗w〇98/01110之實例。下列之數據摘述試驗稀釋度 下(亦即,試驗稀釋度就實例24之組合物係1〇〇%,而就w〇 98/01110之實例係50% )各組合物中活性抗菌劑之百分比,以 及在限時滅殺試驗中於歸接觸時間所觀察到之對數減 少 0 裝--- (請先閲讀背面之注意事填寫本頁) · · 經濟部智慧財產局員工消費合作社印製1284020 A7 B7 V. INSTRUCTIONS (115) The object can provide an excellent clean and smooth feeling at the same time. Example 25 vs. Pre-existing 7JT Compositions This 5 cases compare the antibacterial efficacy of the antibacterial compositions of the present invention with a previously disclosed composition. Thus, the composition of Example 24 was compared to a single example disclosed in w〇 98/01110. In both compositions, the active antibacterial agent is triclosan (TCS). Both compositions were tested for their antibacterial efficacy against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Cholera cholerae in a time-limited killing test. An example of w〇98/01110 was tested at a 50% dilution according to the test procedure for the viscous composition. The following data summarizes the percentage of active antimicrobial agent in each composition at the test dilution (i.e., the test dilution is 1% for the composition of Example 24, and 50% for the example of w〇98/01110). And the logarithm reduction observed in the contact time in the time-limited killing test is 0--- (please read the note on the back to fill out this page) · · Printed by the Intellectual Property Office of the Ministry of Economic Affairs

此一實例說明本發明組合物相較 千乂 y无則組合物之較佳限 時滅殺表現,特別是在對抗格藍\ u性細菌万面。此一優 -118-This example illustrates the preferred time-limited killing performance of the compositions of the present invention over the composition of the millennium y, especially against the smectic bacteria. This one excellent -118-

1284020 A7 116、 五、發明說明( 異性甚至可由含有較本發明組合物顯著更具活性抗菌劑之 比車义性組合物說明。因此,本發明之組合物可更有效的使 用活性劑,其可以使用低濃度抗菌劑時之較高對數減少結 果說明。 實例261284020 A7 116, V. Description of the invention (The opposite sex may even be described by a specific composition containing a significantly more active antibacterial agent than the composition of the invention. Thus, the composition of the invention may be more effective in the use of an active agent, which may A higher log reduction result when using a low concentration of antimicrobial agent. Example 26

II

與i前經揭示組合物之比卓I 訂 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 此一貫例比較本發明抗菌組合物及一種先前經揭示組合 物足抗菌功效。因此,比較實例24之組合物及揭示於w〇 96/06152之組合物。w〇 96/〇6152揭示有效之組合物,其含有 TCS、陰離子界面活性劑、增溶劑、羥溶劑,且尚含有一種 有機酸,特定言之為擰檬酸。w〇96/〇6152含有額外之pH調節 ^渚如,單乙醇胺及氫氧化鈉。同時,揭示於WO 96/06152 之見例白具有4或9.1之pH值,沒有任一實例具有約7之所欲 中性pH值。約7之阳值係接觸皮膚或無生命表面之組合物所 也者,因為具有顯著不同於7之阳值(諸如,4或9 1)之組合 物較有可能損傷其所接觸之表面。因此,製備w〇96/〇6i52^ 例1之組合物(其於後文稱為組合物26_A)。為進行比較,如 上製備組合物26-A,惟再添加額外之單乙醇胺以將pH調整至 7(此組合物於後文稱為組合物26-B)。為提供額外之比較, 製備W〇 96/06152實例3之組合物,惟其係藉由添加額外之單 乙醇胺以製備為pH 7 (此組合物於後文稱為組合物26·〇。下 表摘述此一實例之諸等組合物在限時滅殺試驗中於%秒之 接觸時間對抗指明細菌之結果。 -119- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1284020 A7 B7 五、發明說明( 117、 — 組合物 pH %TCS 30秒之對數減少 S. aureus Ε· coli Κ· pnenm. S· choler. 實例24 7.1 0.3 &gt;4.54 &gt;4.25 3.67 &gt;4.77 比較性 26-A 4 0.075 — &gt;4.84 -- 比較性 26-B 7 0.075 — — 0.07 一 比較性 26-C 7 0.15 4.44 2.91 0.28 4.67 閱 讀 背 面 之 此一貫例說明’在約7之PH值下時,本發明組合物相較於 先則組合物之較佳限時減殺表現,特別是在對抗格藍氏陰 性細菌方面。自此實例所示之數據可總結言之,W0 96/06152 之組合物係實質上依賴相對極端之pH值(4或9」,如其所揭 示)來達成所欲之快速且範圍廣泛之細菌族群減少。此與本 發明之實例18相反,其可在約7之所欲pH值下,提供快速之 範圍廣泛細菌滅殺。 實例27 含PCMX之抗茼細厶鉍 製備含有對-氯-間-二甲苯酚(PCMX)作為活性抗菌劑之本 發明組合物。該組合物含有所指重量百分比之下列組成 份·· -120- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐) 訂 經濟部智慧財產局員工消費合作社印製 1284020 A7 一 ---------— R7_ 五、發明說明(118)Compared with the previously disclosed composition, the composition of the composition of the present invention is compared with the antibacterial composition of the previously disclosed composition of the antibacterial composition of the present invention. Thus, the composition of Example 24 and the composition disclosed in WO 96/06152 were compared. W〇 96/〇6152 discloses an effective composition comprising TCS, an anionic surfactant, a solubilizing agent, a hydroxy solvent, and an organic acid, specifically a citric acid. W〇96/〇6152 contains additional pH adjustments such as monoethanolamine and sodium hydroxide. Meanwhile, the example disclosed in WO 96/06152 has a pH of 4 or 9.1, and none of the examples has a desired neutral pH of about 7. A positive value of about 7 is a composition that contacts the skin or an inanimate surface, as compositions having a positive value other than 7 (such as 4 or 9 1) are more likely to damage the surface to which they are exposed. Thus, a composition of Example 1 (which is hereinafter referred to as Composition 26_A) was prepared. For comparison, composition 26-A was prepared as above, except that additional monoethanolamine was added to adjust the pH to 7 (this composition is hereinafter referred to as composition 26-B). To provide an additional comparison, the composition of Example 3 of W〇96/06152 was prepared, except that it was prepared by adding additional monoethanolamine to pH 7 (this composition is hereinafter referred to as composition 26·〇. The compositions of this example are tested against the indicated bacteria in a time limit of % seconds in a time-limited killing test. -119- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1284020 A7 B7 V. INSTRUCTIONS (117, - Composition pH %TCS 30-second log reduction S. aureus Ε· coli Κ· pnenm. S· choler. Example 24 7.1 0.3 &gt;4.54 &gt;4.25 3.67 &gt;4.77 Comparative 26-A 4 0.075 — &gt;4.84 --Comparative 26-B 7 0.075 — — 0.07 A comparative 26-C 7 0.15 4.44 2.91 0.28 4.67 Read this consistent example on the back side 'At a pH of about 7 The composition of the present invention has a better time-limited killing performance than the prior composition, particularly in the case of against Gram-negative bacteria. The data shown in this example can be concluded, the composition of WO 96/06152 is essential Relying on relatively extreme pH values (4 or 9), It is disclosed to achieve a rapid and wide range of bacterial population reductions. This, in contrast to Example 18 of the present invention, provides a rapid range of bacterial killing at a desired pH of about 7. Example 27 The composition of the present invention containing p-chloro-m-xylenol (PCMX) as an active antibacterial agent is prepared by the antibacterial fineness containing PCMX. The composition contains the following components by weight percentage: · -120- The paper scale applies to the Chinese National Standard (CNS) A4 specification (21〇x 297 mm). The Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative prints 1284020 A7 I--------- R7_ V. Invention Description (118 )

f請先閱讀背面之注意- 裝 訂·. 該組合物係至少約9〇%pCMX飽和。使用限時滅殺試驗評 估該組合物對抗金黃葡萄球菌、大腸样菌、肺炎克雷伯^ 桿菌、及霍亂沙門氏捍菌之抗菌功效。對抗金黃葡萄球 菌’該組合物在30秒中具有416之對數減少作用;對抗大腸 桿菌’該組合物在30秒中具有&gt;4.34之對數減少作用;對抗肺 炎克雷伯氏桿菌,該組合物在3〇秒中具有3 99之對數減少作 用,且對抗霍亂沙門氏捍菌,該組合物在30秒中具有&gt;4.04之 對數減少作用。因此,該組合物具有優良之廣泛範園抗菌 經濟部智慧財產局員工消費合作社印製 活性。 實例28 含PCMX之括茼組合物 製備納入對-氯-間-二曱苯S分作為活性抗菌劑之本發明組 合物。該組合物含有所指重量百分比之下列組成份: -121 - 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐) 1284020 A7 B7 119 五、發明說明() 成分 重量百分比 PCMX 0.3 十二烷基硫酸銨 0.8 水 q.s. 該組合物之製備係藉由首先結合PCMX及水,再加入十二 烷基硫酸銨,並混合該等組成份,直到完全混和該等組成 份並溶解PCMX (約2小時)而進行。 該組合物係至少約90% PCMX飽和。使用限時滅殺試驗評 估該组合物對抗金黃葡萄球菌及大腸桿菌之抗菌功效。對 抗金黃葡萄球菌,該組合物在30秒中具有&gt;3.57之對數減少作 用;且對抗大腸桿菌,該組合物在30秒中具有&gt;4.17之對數減 少作用。因此,該組合物具有優良之廣泛範圍抗菌活性。 顯然,可對前文所述之本發明進行諸多修飾及變化而不 篇離其精神及範圍,因此,僅有本文所附之申請專利範圍 可為本發明之限制。 --------------裝--- (請先閱讀背面之注意事填寫本頁) 經濟部智慧財產局員工消費合作社印製f Please read the note on the back - binding ·. The composition is at least about 9〇% pCMX saturated. The antibacterial efficacy of the composition against Staphylococcus aureus, colonic bacteria, Klebsiella pneumoniae, and Salmonella choleraesuis was evaluated using a time-limited killing test. Against Staphylococcus aureus 'The composition has a logarithmic reduction of 416 in 30 seconds; against E. coli' the composition has a logarithmic reduction of &gt; 4.34 in 30 seconds; against Klebsiella pneumoniae, the composition With a logarithmic reduction of 3 99 in 3 sec and against Salmonella choleraesuis, the composition had a logarithmic reduction of &gt; 4.04 in 30 seconds. Therefore, the composition has excellent activity of printing in a wide range of Fanyuan Antibacterial Economic Department Intellectual Property Bureau employee consumption cooperatives. Example 28 A scab composition containing PCMX A composition of the present invention incorporating p-chloro-m-nonylbenzene S as an active antibacterial agent was prepared. The composition contains the following components by weight: -121 - This paper size applies to the Chinese National Standard (CNS) A4 specification (21〇x 297 mm) 1284020 A7 B7 119 V. Inventive Note () Component Weight Percentage PCMX 0.3 Ammonium dodecyl sulfate 0.8 water qs The composition is prepared by first combining PCMX and water, then adding ammonium lauryl sulfate, and mixing the components until the components are completely mixed and the PCMX is dissolved. (about 2 hours). The composition is at least about 90% PCMX saturated. The antibacterial efficacy of the composition against Staphylococcus aureus and Escherichia coli was evaluated using a time-limited killing test. For Staphylococcus aureus, the composition had a logarithmic reduction of &gt; 3.57 in 30 seconds; and against E. coli, the composition had a logarithmic reduction of &gt; 4.17 in 30 seconds. Therefore, the composition has an excellent range of antibacterial activity. It is to be understood that the invention may be modified and varied without departing from the spirit and scope of the invention. --------------装--- (Please read the note on the back to fill out this page) Printed by the Intellectual Property Office of the Ministry of Economic Affairs

If · -122- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)If · -122- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm)

Claims (1)

1284Q卻112409號專利^案4:去、|貪丨 中文申請專利範圍替滅朱^篆年法@ i&gt;\1284Q but 112409 patent ^ case 4: go, | greed Chinese application for patent scope for the elimination of Zhu ^ 篆年法 @ i&gt;\ 六、申請專利範園 1. 一種抗菌組合物,其包含: (a) 0.001%至5%重量比之三氯生作為抗菌劑; (b ) 0.1%至15%重量比之界面活性劑,其係選自陰離子界面 活性劑、兩性界面活性劑或其混合物; (c ) 2%至40%重量比之增溶劑; (d ) 2%至60%重量比之水溶性經溶劑; (e)水, 其中該組合物具有5至8之p Η值, 且其中當在室溫下測量時,該抗菌劑係以至少5〇%飽和濃 度之量存在。 2·根據申請專利範圍第1項之组合物,其中該界面活性劑係 以至高5%重量比之量存在。 3·根據申請專利範圍第2項之組合物,其中該界面活性劑係 以至高2%重量比之量存在。 4·根據申請專利範圍第1至3項中任一項之組合物,其包含增 溶劑及經溶劑。 5.根據申請專利範圍第4項之組合物,其中該抗菌劑 少75%飽和濃度之量存在。 &quot; 6·根據申請專利範圍第5項之組合物,其中該抗菌劑係以至 少95%飽和濃度之量存在。 &quot; 7·根據申請專利範圍第1至3項中任一項之組合物,其中梦辦 溶劑係以2%至25%重量比之量存在。 、以曰 8·根據申請專利範圍第7項之組合物’其中該增溶劑係以州 至20%重量比之量存在。 &quot; ° 64808-960419.doc β1 . 本紙張尺度適中Η @家料(CNS) Α4規格(210 X 297公釐) ----___ A8 B8 C8 D8 1284020 六、申請專利範園 9·根據申請專利範圍第丨至3項中任一項之組合物,其中該麫 溶劑係以2%至20%重量比之量存在。 二 10. 根據申請專利範圍第9項之組合物,其中該羥溶劑係以抓 至15%重量比之量存在。 11. 根據申請專利範圍第1至3項中任一項之組合物,其中該羥 溶劑包含醇、二醇、三醇及其混合物。 12·根據申請專利範圍第1至3項中任一項之組合物,其中該羥 /春劑包含甲醇、乙醇、異丙醇、正-丁醇、正-丙醇、乙二 醇、丙二醇、甘油、二乙二醇、二丙二醇、三丙二醇、己 二醇、丁二醇、1,2,6_己三醇、甘露糖醇、PEG_4或其混 合物。 13·根據申請專利範圍第1至3項中任一項之組合物,其中該增 劑係選自異丙基苯續酸鈉、異丙基苯橫酸銨、二甲苯橫 fei铵、甲苯橫酸奸、甲苯磺酸納、二甲苯續酸納、甲苯橫 酸、二甲苯磺酸、聚蓁續酸鈉、聚苯乙烯磺酸鈉、甲基萘 磺酸鈉、琥珀酸二鈉及其混合物。 14.根據申請專利範圍第1至3項中任一項之組合物,其中該三 乳生係以〇 · 〇 5%至2%重量比之量存在。 15·根據申請專利範圍第丨至3項中任一項之組合物,其中該界 面活性劑係選自十二烷基硫酸納、十二烷基硫酸銨、單乙 醇胺十二烷基硫酸鹽、三乙醇胺十二烷基硫酸鹽、十二烷 基硫酸鐘、十二烷基硫酸鎂、辛基硫酸鈉、2_乙基己基硫 酸鋼、癸基硫酸鈉、十三烷基硫酸鈉、C ! 2 ·〗8烷基硫酸 鈉、椰子油酸鉀、油酸鉀、月桂酸鉀、十二烷基醚硫酸 64808-960419.doc _ 2 _ 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) A8 B8 C8 D8 1284020 六、申請專利範園 鈉、十四烷基醚-4羧酸鈉、辛苯昔醇-9、氧化十二胺、十 二醯基肌胺酸鈉、十二烷基磺酸琥珀酸二鈉、十二烷基橫 基乙酸鈉、磺酸甲酯、α -晞烴續酸鹽、c 1 〇 (直鏈)氧化 二苯基二續酸鋼、椰子油兩性乙酸鋼、椰子醯胺基丙基甜 菜鹼及烷基聚葡萄糖。 16·根據申請專利範圍第1 5項之組合物,其中該界面活性劑包 含十二烷基硫酸鈉、辛基硫酸鈉、2 -乙基己基硫酸鈉或氧 化十二胺。 17·根據申請專利範圍第1項之組合物,其包含 (a) 0.01%至0.5%重量比之三氯生; (b ) 0.1%至5%重量比之界面活性劑; (c ) 5%至20%重量比之增溶劑;及 (d ) 2%至15%重量比之經溶劑。 18.根據申請專利範圍第1至3項中任一項之組合物,其在3〇秒 之接觸後,對抗格藍氏陽性細菌具有至少2之對數減少(其 如對抗金黃葡萄球菌又所測),且其在3〇秒之接觸後, 對抗格藍氏陰性細菌具有至少2.5之對數減少(其如對抗大 腸桿菌五.cW所測)。 19·根據申請專利範圍第1至3項中任一項之組合物,其係用於 一種減少哺乳動物皮膚上細菌族群之方法中,該方法包含 使該表面接觸該組合物30秒,以達成對抗金黃葡萄球菌至 少2及對抗大腸桿菌至少2.5之對數減少,再自該皮膚洗去 該組合物。 20·根據申請專利範圍第19項之組合物,其中該組合物接觸該 64808-960419.docVI. Application for Patent Park 1. An antibacterial composition comprising: (a) 3% to 5% by weight of triclosan as an antibacterial agent; (b) 0.1% to 15% by weight of a surfactant, Or a mixture of anionic surfactants, amphoteric surfactants or mixtures thereof; (c) 2% to 40% by weight of solubilizer; (d) 2% to 60% by weight of water-soluble solvent; (e) water Wherein the composition has a p Η value of 5 to 8, and wherein the antimicrobial agent is present in an amount of at least 5% saturation concentration when measured at room temperature. 2. The composition of claim 1, wherein the surfactant is present in an amount of up to 5% by weight. 3. The composition of claim 2, wherein the surfactant is present in an amount of up to 2% by weight. The composition according to any one of claims 1 to 3, which comprises a solubilizing agent and a solvent. 5. The composition of claim 4, wherein the antibacterial agent is present in an amount of 75% less saturated. &lt;6. The composition of claim 5, wherein the antibacterial agent is present in an amount of at least 95% saturated concentration. The composition according to any one of claims 1 to 3, wherein the dream solvent is present in an amount of from 2% to 25% by weight. 8. The composition according to item 7 of the patent application' wherein the solubilizing agent is present in an amount of from state to 20% by weight. &quot; ° 64808-960419.doc β1 . The paper size is moderate Η @家料(CNS) Α4 specification (210 X 297 mm) ----___ A8 B8 C8 D8 1284020 VI. Application for patent garden 9·According to application The composition of any one of the preceding claims, wherein the hydrazine solvent is present in an amount from 2% to 20% by weight. A composition according to claim 9 wherein the hydroxy solvent is present in an amount of up to 15% by weight. The composition according to any one of claims 1 to 3, wherein the hydroxy solvent comprises an alcohol, a diol, a triol, and a mixture thereof. The composition according to any one of claims 1 to 3, wherein the hydroxy/spring agent comprises methanol, ethanol, isopropanol, n-butanol, n-propanol, ethylene glycol, propylene glycol, Glycerin, diethylene glycol, dipropylene glycol, tripropylene glycol, hexanediol, butanediol, 1,2,6-hexanetriol, mannitol, PEG-4 or a mixture thereof. The composition according to any one of claims 1 to 3, wherein the enhancer is selected from the group consisting of sodium cumyl sulfonate, ammonium isopropyl phthalate, xylene dimethyl ammonium, and toluene. Sour rape, sodium toluenesulfonate, sodium dihydrochloride, toluic acid, xylenesulfonic acid, sodium polysodium citrate, sodium polystyrene sulfonate, sodium methylnaphthalene sulfonate, disodium succinate and mixtures thereof . The composition according to any one of claims 1 to 3, wherein the three milks are present in an amount of from 5% to 2% by weight of 〇·〇. The composition according to any one of claims 3 to 3, wherein the surfactant is selected from the group consisting of sodium lauryl sulfate, ammonium lauryl sulfate, monoethanolamine lauryl sulfate, Triethanolamine lauryl sulfate, dodecyl sulfate clock, magnesium lauryl sulfate, sodium octyl sulfate, 2-ethylhexyl sulfate steel, sodium decyl sulfate, sodium tridecyl sulfate, C! 2 ·〗 8-alkyl sodium sulfate, potassium coconut oleate, potassium oleate, potassium laurate, dodecyl ether sulfuric acid 64808-960419.doc _ 2 _ This paper scale applies to China National Standard (CNS) A4 specifications (210 X 297 mm) A8 B8 C8 D8 1284020 VI. Application for patents Fan Sodium, tetradecyl ether-4 carboxylate, octoxynol-9, oxidized dodecylamine, sodium dodecyl sarcosinate, Disodium lauryl sulfosuccinate, sodium lauryl sulphate, methyl sulphonate, α-indole hydroxamate, c 1 〇 (linear) oxidized diphenyl sulphate, coconut Oil amphoteric acetate steel, coconut melamine propyl betaine and alkyl polydextrose. The composition according to claim 15 wherein the surfactant comprises sodium lauryl sulfate, sodium octyl sulfate, sodium 2-ethylhexyl sulfate or oxidized dodecylamine. 17. The composition according to claim 1, which comprises (a) 0.01% to 0.5% by weight of triclosan; (b) 0.1% to 5% by weight of a surfactant; (c) 5% a solubilizer to 20% by weight; and (d) a solvent of 2% to 15% by weight. The composition according to any one of claims 1 to 3, which has a logarithmic reduction of at least 2 against Gram-positive bacteria after contact for 3 sec (which is measured against Staphylococcus aureus) And it has a log reduction of at least 2.5 against Glan-negative bacteria after 3 sec. contact (as measured against E. coli 5. cW). The composition of any one of claims 1 to 3 for use in a method of reducing bacterial populations on the skin of a mammal, the method comprising contacting the surface with the composition for 30 seconds to achieve The composition is washed away from the skin by against at least 2 against Staphylococcus aureus and at least 2.5 against E. coli. 20. The composition according to claim 19, wherein the composition is in contact with the 64808-960419.doc Order 1284020 申請專利範圍 U表兩60秒,以達成對抗金黃葡萄球菌至少3之對數減少。 ·=據申請專利範圍第19項之組合物,其中該組合物接觸該 表面60秒,以達成對抗大腸桿菌至少3·75之對數減少。 22·:據申請專利範圍第19項之組合物,其中該組合物接觸該 表兩30秒’以達成對抗肺炎克雷伯氏桿紅辦祖至少2之 對數減少。 23 種減少表面上細菌族群之方法,其包含使該表面接觸根 據申請專利範圍第!至i 8項中任一項之組合物3〇秒,以達 成對抗金黃葡萄球菌至少2及對抗大腸桿菌至少2·5之對數 減少’再自該表面洗去該組合物。 24_根據申請專利範圍第2 3項之方法,其中該組合物接觸該表 面60秒’以達成對抗金黃葡萄球菌至少3之對數減少。 25·根據申請專利範圍第23項之方法,其中該組合物接觸該表 面60秒,以達成對抗大腸桿菌至少3·75之對數減少。 26·根據申請專利範圍第2 3項之方法,其中該組合物接觸該表 面30秒,以達成對抗肺炎克雷伯氏桿菌至少2之對數減 .少。 '1284020 Patent application scope U table for 60 seconds to achieve a logarithmic reduction of at least 3 against Staphylococcus aureus. The composition of claim 19, wherein the composition contacts the surface for 60 seconds to achieve a log reduction of at least 3.75 against E. coli. 22: The composition of claim 19, wherein the composition contacts the watch for 30 seconds to achieve a log reduction of at least 2 against Klebsiella pneumoniae. 23 ways to reduce the bacterial population on the surface, including bringing the surface into contact according to the scope of the patent application! The composition of any of items 8 to 3 seconds to achieve a log reduction of at least 2 against Staphylococcus aureus and at least 2. 5 against E. coli and the composition is washed away from the surface. 24_ The method of claim 23, wherein the composition contacts the surface for 60 seconds to achieve a log reduction of at least 3 against Staphylococcus aureus. The method of claim 23, wherein the composition contacts the surface for 60 seconds to achieve a log reduction of at least 3.75 against E. coli. 26. The method of claim 23, wherein the composition contacts the surface for 30 seconds to achieve a log reduction of at least 2 against Klebsiella pneumoniae. ' Λ 訂Λ 64808-960419.doc 本紙張尺度適用中國國家標準(CNS) Α4規格(210X297公釐)64808-960419.doc This paper size is applicable to China National Standard (CNS) Α4 specification (210X297 mm)
TW089112409A 1999-06-23 2000-06-23 Antibacterial compositions TWI284020B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/338,654 US6107261A (en) 1999-06-23 1999-06-23 Compositions containing a high percent saturation concentration of antibacterial agent
US09/425,521 US6136771A (en) 1999-06-23 1999-10-22 Compositions containing a high percent saturation concentration of antibacterial agent

Publications (1)

Publication Number Publication Date
TWI284020B true TWI284020B (en) 2007-07-21

Family

ID=26991292

Family Applications (1)

Application Number Title Priority Date Filing Date
TW089112409A TWI284020B (en) 1999-06-23 2000-06-23 Antibacterial compositions

Country Status (8)

Country Link
EP (1) EP1191843A2 (en)
JP (1) JP2003502353A (en)
AU (1) AU777059B2 (en)
BR (1) BR0011860A (en)
CA (1) CA2371925C (en)
MX (1) MXPA01013312A (en)
TW (1) TWI284020B (en)
WO (1) WO2000078275A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861397B2 (en) * 1999-06-23 2005-03-01 The Dial Corporation Compositions having enhanced deposition of a topically active compound on a surface
JP2006519841A (en) * 2003-03-10 2006-08-31 ザンテック ファーマスーティカルズ,インク. Surface disinfecting composition with improved antibacterial performance
JP2005029532A (en) * 2003-07-09 2005-02-03 Asahi Kasei Chemicals Corp Skin-cleansing agent
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
EP1830638A2 (en) * 2004-12-09 2007-09-12 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
CA2588802A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
CA2588782A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
GB0802189D0 (en) * 2008-02-07 2008-03-12 Reckitt Benckiser Inc Topical antimicrobial compositions
US9451763B2 (en) 2008-04-08 2016-09-27 Laboratoire M2 Disinfectant formulation
US10405544B2 (en) 2008-04-08 2019-09-10 Laboratoire M2 Disinfectant formulation
US9609864B2 (en) 2008-04-08 2017-04-04 Laboratoire M2 Disinfectant formulation
US10111425B2 (en) 2008-04-08 2018-10-30 Laboratoire M2 Disinfectant formulation
KR101621337B1 (en) 2008-04-08 2016-05-16 라보라뚜아르 엠므2 Aqueous disinfectant formulation comprising a phenolic compound, a surfactant, and a solvent
EP2436754A1 (en) * 2011-09-30 2012-04-04 Basf Se Antimicrobial cleaning compound
US8415286B1 (en) * 2012-06-13 2013-04-09 Green On Industries Inc. Solvent-free oil dispersant
JP6800585B2 (en) * 2015-01-19 2020-12-16 花王株式会社 Water-absorbent resin composition and its manufacturing method
JP6956462B2 (en) * 2015-10-07 2021-11-02 花王株式会社 Absorbent article
WO2016117523A1 (en) * 2015-01-19 2016-07-28 花王株式会社 Material for absorbent article, method for manufacturing same, and absorbent article using same
MX2017010497A (en) 2015-02-16 2018-04-24 Laboratoire M2 Aqueous compositions for controlling pests or regulating plant growth, said compositions comprising thymol or carvacrol, a surfactant, and a solvent.
JP6785600B2 (en) * 2015-08-31 2020-11-18 アース製薬株式会社 Sterilizing agent for hard surface and sterilizing method
WO2017063848A1 (en) * 2015-10-12 2017-04-20 Unilever N.V. Sanitising and disinfecting compositions
JP2019071853A (en) * 2017-10-18 2019-05-16 北海道公立大学法人 札幌医科大学 Methods for screening antimicrobial agents
US11419797B2 (en) 2017-12-27 2022-08-23 Kao Corporation Method for producing composition containing hardly water-soluble aromatic compound
CN112898696A (en) * 2021-01-21 2021-06-04 南亚塑胶工业(南通)有限公司 Preparation method of mildew-proof antibacterial adhesive tape

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB743984A (en) * 1952-09-03 1956-01-25 Monsanto Chemicals Improvements relating to germicides
US3326808A (en) * 1965-08-25 1967-06-20 Pfizer & Co C Antiseptic detergent composition
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
JPS6345217A (en) * 1986-07-23 1988-02-26 チバ−ガイギ アクチエンゲゼルシヤフト Fungicidal composition
EP0259249A3 (en) * 1986-07-23 1990-09-19 Ciba-Geigy Ag Microbicidal preparations
JPS63222766A (en) * 1987-03-12 1988-09-16 株式会社ハッチ Preparatory sanitation treatment of beddings
BR8900685A (en) * 1988-02-17 1989-10-10 Ciba Geigy Ag COMPOSITION OF ANTIMICROBIAL SOAP AND APPLICATION
FR2629095B1 (en) * 1988-03-22 1990-09-28 Reckitt Colman CLEANING COMPOSITION FOR HARD SURFACES
NZ241579A (en) * 1991-03-25 1994-04-27 Becton Dickinson Co Antimicrobial formulations for treating the skin
JP2533723B2 (en) * 1992-12-28 1996-09-11 東興薬品工業株式会社 Quick-drying gel type hand sanitizer
US5403864A (en) * 1993-04-01 1995-04-04 John A. Manfuso, Jr. Rapidly-acting topical antimicrobial composition
WO1995009605A1 (en) * 1993-10-06 1995-04-13 Henkel Corporation Improving phenolic disinfectant cleaning compositions with alkylpolyglucoside surfactants
US5635462A (en) * 1994-07-08 1997-06-03 Gojo Industries, Inc. Antimicrobial cleansing compositions
AU3345295A (en) * 1994-08-25 1996-03-14 Ciba-Geigy Ag Surface-active formulations
DE19530833A1 (en) * 1994-08-25 1996-02-29 Ciba Geigy Ag Surfactant mixts. for use as disinfectants
WO1996006152A2 (en) * 1994-08-25 1996-02-29 Ciba Specialty Chemicals Holding Inc. Surface-active formulations
ES2182077T3 (en) * 1996-06-04 2003-03-01 Ciba Sc Holding Ag CONCENTRATED LIQUID FORMULATIONS THAT INCLUDE A MICROBICIDALLY ACTIVE INGREDIENT.
EP0855440A1 (en) * 1997-01-24 1998-07-29 The Procter & Gamble Company Antibacterial liquid dishwashing detergent compositions
JP2002501542A (en) * 1997-06-04 2002-01-15 ザ、プロクター、エンド、ギャンブル、カンパニー Liquid antimicrobial cleansing composition providing residual effect against gram negative bacteria

Also Published As

Publication number Publication date
WO2000078275A3 (en) 2001-09-27
AU5472000A (en) 2001-01-09
WO2000078275A2 (en) 2000-12-28
EP1191843A2 (en) 2002-04-03
MXPA01013312A (en) 2003-09-04
BR0011860A (en) 2002-04-30
AU777059B2 (en) 2004-09-30
CA2371925A1 (en) 2000-12-28
CA2371925C (en) 2009-02-17
JP2003502353A (en) 2003-01-21

Similar Documents

Publication Publication Date Title
TWI284020B (en) Antibacterial compositions
US6861397B2 (en) Compositions having enhanced deposition of a topically active compound on a surface
US6136771A (en) Compositions containing a high percent saturation concentration of antibacterial agent
US4010252A (en) Antimicrobial compositions
JP2001518943A (en) Antibacterial, mild rinse-off liquid cleaning composition containing salicylic acid
JP2001518944A (en) Antibacterial, mild rinse-off liquid cleaning composition containing acidic surfactant
JP2001518940A (en) Antibacterial, mild rinse-off liquid cleaning composition
RU2325203C2 (en) Antimicrobic compositions of aromatic carboxylic acid and alcoholic solution
EP2782549B1 (en) Antimicrobial preservative compositions for personal care products
KR20010013376A (en) Leave-on antimicrobial compositions
WO2006029213A2 (en) Silver dihydrogen citrate compositions
JP6987862B2 (en) Antibacterial composition containing trace-acting metals
TW546149B (en) Antibacterial compositions
CA2588802A1 (en) Compositions having a high antiviral and antibacterial efficacy
JP2001518941A (en) Mild leave-on antimicrobial composition
EP2488018B1 (en) Methods and compositions for novel liquid crystal delivery systems
CZ425499A3 (en) Topic antimicrobial preparations
MXPA99011303A (en) Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants
MXPA99011324A (en) Mild, rinse-off antimicrobial liquid cleansing compositions
MXPA99011300A (en) Mild, leave-on antimicrobial compositions

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees